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New genomics tools and strategies for studying antibiotics and antibiotic-resistance in 
Staphylococcus aureus 
 
Abstract 
Staphylococcus aureus is a gram positive coccoid pathogen that causes intractable 
infections in hospitals and communities around the world, and tens of thousands of people die 
of these infections every year. In order to combat these antibiotic-resistant infections, we need 
to better understand the genes involved in resistance to the cell stress caused by antibiotic 
treatment, which will enable the discovery of new antimicrobials and the development of novel 
therapeutic strategies. We chose to use an approach to this problem that utilizes a new phage-
based high frequency of transposition system. In this work, we adapted this system so that 
transposon mutant libraries can be made and sequenced using next-generation sequencing 
(NGS) in any strain of S. aureus. We validated our new platform by performing a temperature 
screen and identifying mutants that are significantly resistant or sensitive to temperature-stress. 
Next, we created transposon libraries in two MRSA strains to show that this system can be 
broadly applied to other S. aureus strains, and we used one of these libraries to identify a new 
interaction between two genes involved in the secretion of sortase-anchored surface proteins. 
To better understand antibiotic-resistance, we performed Tn-Seq on transposon libraries treated 
with a small panel of six different antibiotics to identify intrinsic resistance factors to these 
antibiotics. We identified two new intrinsic resistance factors, SAOUHSC_01025 and 
SAOUHSC_01050, that sensitize to many cell envelope targeting antibiotics and may be 
involved in hemolysin regulation. Finally, we expanded this approach to sequence transposon 
libraries treated with 25 different antibiotics. Based on these data, we were able to develop 
methods for predicting the mechanism of action of new antibiotics. These methods involve 
iv 
 
identifying genes upregulated by transposon insertion and applying machine learning algorithms 
to identify similarities to a curated panel of well-studied antibiotics with known mechanisms of 
action. This work will enable many new functional genomics studies in S. aureus, and it will 
allow us to gain a better understanding of antibiotic resistance in this dangerous pathogen.  
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Chapter 1. Introduction 
1.1. Antibiotic resistant infections 
 
Antibiotics and Antibiotic-resistance 
 Antibiotics have been in the clinic so long they are often taken for granted. The first 
widely-used antimicrobials were the sulfonamides, which were introduced in the 1930’s (1), but 
it was the discovery of the first β-lactam antibiotic, penicillin, by Alexander Fleming in 1928 (2), 
and its mass production in the 1940’s that began the golden era of antibiotic discovery (3). Many 
new antibiotics were discovered by pharmaceutical companies. Most of these new antibiotics 
were natural products that were extracted from bacteria or fungi in much the same way that 
penicillin was (3). For many years after the discovery of penicillin, the vast majority of bacterial 
infections have been treatable with these antibiotics.  
More recently, the situation has changed. Resistance to antibiotics has become very 
common, and now resistance in the clinic has been observed to every class of antibiotics 
(Figure 1) (4). Antibiotic resistance can develop through the evolution of new functions or 
through the acquisition of resistance factors through horizontal gene transfer (5). There are 
three major classes of antibiotic resistance (6): 1) Resistance through the increased export of 
the antibiotic by multi-drug resistance pumps, which prevent the antibiotic from reaching its 
target (ex: NorA is a pump whose expression is upregulated with ciprofloxacin resistance (7)); 2) 
resistance through the modification of the structure of the antibiotic (by adding moieties or by 
breaking the antibiotic apart), which prevents the antibiotic from properly binding its target (ex: 
FosB can hydrolyze the epoxide ring of fosfomycin, rendering it inactive (8)); 3) Resistance 
through some structural change in the antibiotic’s target which prevents the antibiotic from 
properly binding it (ex: PBP2a is a transpeptidase with a low affinity for β-lactam antibiotics, 
which prevents it from becoming inactivated (9)).  
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Figure 1. Antibiotic-resistance has been observed to every class of antibiotic (Adapted 
from Clatworthy et al. 2007 Nature Chemical Biology – Fig1 (4)). These antibiotics belong to 
some of the major clinical antibiotic classes. These classes include the sulfonamides which 
inhibit folate synthesis by binding dihydropteroate synthase (10), the β-lactams (penicillin, 
methicillin, cephalosporins, and ampicillin) which inhibit peptidoglycan biosynthesis by binding 
the peptidoglycan biosynthetic proteins (PBPs) (11), the aminoglycosides (streptomycin) which 
perturbs the 30S unit of the ribosome resulting in inaccurate mRNA translation (12, 13), the 
macrolides (erythromycin) which also inhibit protein synthesis by binding to the 50S ribosomal 
subunit (14), the glycopeptides (vancomycin) which inhibit peptidoglycan synthesis by binding to 
and sequestering peptidoglycan precursors (15, 16), the oxazolidinones (linezolid) which binds 
to the 50S subunit of the ribosome preventing the protein translation initiation complex (17), the 
lipopeptides (daptomycin) which disrupt the membrane and delocalize peptidoglycan 
biosynthetic machinery (18, 19), and the tetracyclines bind to the 30S ribosomal subunit (20) 
while chloramphenicol binds to the 50S ribosomal subunit (21). Continued page 3.  
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Figure 1 continued. Each bar begins when an antibiotic was deployed in the clinic. The bar 
ends when clinical resistance was observed. This figure also highlights the Golden Age of 
antibiotic development in the 1940’s through the 1960’s as well as the dearth of new antibiotics 
in the 1970’s, 1980’s, and 1990’s(22).  
 
One of the reasons why antibiotic-resistance has become a major problem recently is 
that, from the 1970s through the 1990s, the antibiotic discovery pipeline almost completely dried 
up (23). This is not only because the low-hanging fruit (abundant natural products from easily 
cultured microbes) had been picked, which made the discovery of new antibiotics more 
challenging, but also because the economics and regulatory environment of antibacterial 
development made it difficult for newly-discovered antibiotics to come to market (24). The Food 
and Drug Administration in the United States had increased the requirements for bringing an 
antibiotic through the clinical trial process, which increased the cost of developing an antibiotic. 
Furthermore, antibiotics for humans do not make much money for pharmaceutical companies. 
This is because, unlike a cardiovascular drug the patient does not take antibiotics regularly for 
years of their life, and unlike cancer drugs, antibiotics are relatively inexpensively priced. Also, 
some antibiotics are narrow spectrum, and are only useful for certain classes or even species of 
bacteria. That means that a new antibiotic might not have a large number of people for whom it 
will be useful, and if it is a good antibiotic, the patient will not be taking it for a very long time 
(24). Moreover, high-quality rapid diagnostics are needed along with the antibiotic if a narrow-
spectrum antibiotic is to be very effective at treating patients (25). Having to develop a 
diagnostic to go along with an antibiotic further increases the cost of bringing a drug to market 
(25). If pharmaceutical companies increase the cost of an antibiotic in order to make up for 
these losses, patients and doctors rebel against what appears to be an unnecessarily-expensive 
drug. In order to make money on antibiotics, pharmaceutical companies may market their 
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antibiotic as a growth promoter in for livestock, which increases the likelihood that resistance to 
that antibiotic will develop (24). A vast shift in how we develop and use new antibiotics is 
needed to encourage major pharmaceutical companies to re-enter this field (26). 
Staphylococcus aureus is a dangerous pathogen 
 In 2008, the Infectious Diseases Society of America highlighted a group of pathogens 
that have the ability to “escape” normal antibiotic treatment. These bacteria, called the ESKAPE 
pathogens, are part of a new paradigm of antibiotic resistance that will require novel strategies 
to treat. The ESKAPE pathogens consist of Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter 
species (27). All of these are organisms of concern, but we are particularly interested in S. 
aureus infections because these infections can be highly-resistant to antibiotics and incredibly 
deadly.  Approximately 2 million people in the United States fall ill with antibiotic-resistant 
infections every year, resulting in 23,000 deaths. Though invasive MRSA infections only 
account for 80,000 of the 2 million infections, this organism causes almost half, or 11,000, of the 
23,000 deaths (28). 
Staphylococcus aureus is a gram-positive coccoid species of bacteria. It is a common 
human commensal, colonizing the skin, especially the nose and nares (29). Approximately 20-
30% of Americans are colonized by S. aureus without any ill effects (29, 30). However, some 
strains of S. aureus are pathogenic and can cause cutaneous abscesses that, if untreated, can 
lead to pneumonia, sepsis, necrotizing fasciitis, and death (31). Some S. aureus strains can be 
very virulent without having any antibiotic-resistance factors. S. aureus Newman, a classic 
example of one of these strains, is a virulent, but antibiotic-sensitive, strain isolated from a 
human infection in 1952 (32). At least thirty genes in this strain were shown to be important for 
S. aureus pathogenesis, and these genes are shared among many different strains (33). The 
virulence of S. aureus has been shown to be due to secreted enzymes and toxins such as 
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coagulases, hemolysins, toxic shock syndrome toxin (TSST-1), and Panton-Valentine leucocidin 
(34-36). S. aureus also produces staphyloxanthin, an antioxidant that protects the bacteria from 
reactive oxygen species (37) and allows the cell to survive longer in the presence of neutrophils 
(38).  
 Both methicillin-sensitive S. aureus (MSSA), and methicillin-resistanct S. aureus (MRSA) 
strains cause dangerous infections, but MRSA strains are also resistant to β-lactam antibiotics. 
MRSA strains can survive very high concentrations of β-lactam antibiotics because they contain 
the SCCmec cassette, a mobile genetic element encoding a penicillin-binding protein (PBP2a) 
with a low affinity for β-lactam antibiotics as well as the genes that regulate its expression 
(Figure 2) (9). β-lactam antibiotics function by binding to and inactivating the transpeptidase 
domain of penicillin-binding proteins (PBPs), which crosslink peptidoglycan strands to 
synthesize the cell wall (11). The expression of PBP2a permits the cell to continue to synthesize 
peptidoglycan, allowing it to grow and divide even when the other PBPs are inactivated by a β-
lactam antibiotic (9).  
 
Figure 2. The SCCmec mobile genetic element encodes β-lactam resistance. There are 
eight classes of the SCCmec element (shown in red), but they all encode some version of these 
genes (39). The SCCmec element is surrounded by Insertion Site Sequences (ISS) depicted as 
red rectangles which control where it inserts into the genome, at the 3’ end of orfX. ccrA and 
ccrB are responsible or integration and excision of the SCCmec element. mecA encodes 
PBP2a, the β-lactam resistant PBP, while mecR1 and mecI regulate the expression of PBP2a 
(39).  
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There are many types of MRSA strains. MRSA strains are broadly categorized as 
healthcare-associated (HA-MRSA) or community-acquired (CA-MRSA). HA-MRSA infections 
are one of the most common healthcare-associated infections, but better monitoring of hospitals 
and other clinical interventions have successfully decreased the number of HA-MRSA infections 
over the last ten years (40, 41). However, the number of CA-MRSA infections has remained 
constant (42, 43). In fact, one of the most common strains of MRSA in the United States, 
USA300, is a CA-MRSA strain (44). Other worrisome strains of MRSA include vancomycin 
intermediate resistant S. aureus (VISA) and vancomycin resistant S. aureus (VRSA) (28). 
Vancomycin, which kills cells by binding to a dipeptide found  in peptidoglycan precursors, 
preventing new peptidoglycan synthesis, is considered to be an antibiotic of last resort for S. 
aureus infections (45). VRSA strains have acquired the vancomycin resistance gene vanA, 
likely via horizontal gene transfer from Enterococcus faecalis. This gene confers high level 
resistance to vancomyin by changing the terminal amino acid residues on the stem peptide of 
peptidoglycan precursors D-ala-D-ala to D-ala-D-lactate (46). VRSA infections are currently not 
very common (between 2002 and 2013, only 13 cases were conclusively identified), but VISA 
infections are much more common (28, 47). Since 1997, they have been identified in Japan, the 
United Kingdom, France, the United States, and Brazil. These strains are less resistant to 
vancomycin than VRSA, but are more resistant than S. aureus and MRSA strains (48). It is 
impossible to treat VISA infections with vancomycin because at higher concentrations, 
vancomycin toxicity to the patient becomes a problem (49). Many types of mutations can confer 
the VISA phenotype, but a large number are in cell stress sensing regulatory systems which 
cause thickening of the cell wall, preventing vancomycin from reaching lipid II at the cell septum 
where new peptidoglycan biosynthesis is occurring (50).   
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Antibiotic resistance in S. aureus  
S. aureus does not have high-level resistance to all antibiotics, but even MSSA strains 
are well known to be highly adaptable to stressful conditions like antibiotic treatment. There are 
mechanisms for up- or down-regulating the expression of genes to promote the cell’s survival. 
Different genes are required for resistance to different antibiotics. Genes that become essential 
in the presence of antibiotic but are not acquired resistance genes are termed intrinsic 
resistance factors. For example, mprF is a lysylphosphatidylglycerol synthase (51) that is 
normally non-essential, but becomes essential during treatment with daptomycin (52). 
Daptomycin acts by binding to at least one calcium ion and inserting into the membrane in a 
phosphatidyl-glycerol dependent manner, depolarizing it and delocalizing the cell division 
machinery (18, 19, 53). Upregulation or activation of mprF results in an increased resistance to 
daptomycin (54, 55). Mechanisms like this exist for many other gene and antibiotic pairs. A 
better understanding of the intrinsic resistance factors could expose some of S. aureus’s 
vulnerabilities, which could be targeted and lead to new strategies for antibiotic development.  
Another form of antibiotic resistance in MRSA is the small colony variant (SCV) 
phenotype. Infections by SCV strains are persistent and often recurrent (56, 57). SCV infections 
are difficult to treat because they are highly antibiotic-resistant and difficult to isolate from an 
infection (58). These strains come about as a result of defects in the electron transport chain, 
often due to a mutation in the menaquinone or cytochrome biosynthetic pathways that causes a 
switch from oxidative to fermentative growth (59, 60). Slow growth can cause a decrease in 
susceptibility to antibiotics because the cells are not very metabolically active. Furthermore, 
these mutations can cause a decrease in membrane potential, which is required for the uptake 
of aminoglycoside antibiotics and cationic antimicrobial peptides (59). Therefore, these 
antibiotics are ineffective against SCV infections.  
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MRSA can cause some of the most dangerous infections because it is capable of 
responding rapidly and effectively to the stress caused by antibiotic treatment. And though 
everyday more bacteria evolve resistance to antibiotics, very few new antibiotics are being 
developed for treating these infections. These new antibiotics are generally chemical 
modifications of antibiotics currently in use. Ceftaroline and ceftobiprole are fifth generation 
cephalosporins, dalbavancin is a teicoplanin derivative, and tedizolid is another oxazolidinone. 
Or, they are combinations of currently-approved drugs combined with a potentiating compound. 
Examples of these include ceftazidime-avibactam and ceftolozane-tazobactam (61). Since the 
FDA approval of daptomycin in 2003, an antibiotic with a new chemical scaffold has not been 
developed (62). If we are to effectively combat antibiotic resistant infections, we must develop 
new tools for studying S. aureus as well as creative strategies for treating these infections. The 
tool we chose to use for studying S. aureus is the transposon mutant library. A history of how 
these tools have been used to better understand bacterial physiology follows.   
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1.2. History of transposons as genetic tools 
 
What is a transposon? 
 Transposons were discovered by Barbara McClintock in 1928 (63), but it was not until 
1950 after DNA was better understood that the scientific community comprehended their 
importance (64). Before their discovery, DNA was thought to be an unchangeable and linear set 
of genes on a chromosome. However, while studying chromosome breakage and fusion in 
maize, she identified two loci that that could change position (64). These were the first 
transposons, a class of mobile genetic elements. With the help of a transposase or other cellular 
factors, they can jump to different areas of the genome (65, 66). Transposons are incredibly 
common. They have been identified in all kingdoms of life, and they make up a large fraction of 
the 66% of the human genome that is made up of repetitive sequences (67, 68). In bacteria, 
transposons and other mobile genetic elements are associated with the acquisition of genes 
that increase their fitness such as virulence factors and antibiotic-resistance cassettes (69).   
 There are many different kinds of transposons. Class I transposons, or the 
retrotransposons, use an RNA-intermediate to move to a new location in the genome. Class II 
transposons encode a transposase that recognizes the transposon’s inverted terminal repeats, 
allowing the enzyme to “cut and paste” the transposon into a new location in the genome (70). 
In addition, transposons can integrate into specific sites in the genome or they may integrate 
randomly (71). Site-specific transposons require homology between the original and new site of 
insertion. These homologous sequences can vary from the AT-rich pentanucleotide sequences 
preferred by Helicobacter pylori’s IS605 element (72) to the 17-bp identical sequences used by 
the SXT transposon of Virbrio cholera (73). Other transposons can insert randomly throughout 
the genome. This class includes the phage-derived transposons which such as the Mu 
transposon (74) and the Drosophila-derived transposon, mariner (75). The mariner transposon 
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has been widely used for many genetics and genomics studies because of the ease in adapting 
it for various organisms and platforms (76). It can insert randomly into any TA dinucleotide site 
in the genome. This type of transposon may also someday be used for gene therapy in humans 
and was awarded Molecule of the Year in 2009 by The International Society for Molecular and 
Cell Biology and Biotechnology Protocols and Researches (77).  
Transposon applications in bacteria 
 Randomly-integrated transposons have been used for a variety of traditional applications 
including genetic footprinting, creating transcriptional and translational fusions, DNA 
sequencing, scanning-linker mutagenesis, signature-tagged mutagenesis, and transposon site 
hybridization. Genetic footprinting predicts whether a gene is essential in a condition of interest 
by performing PCR using a pair of primers that anneal to the transposon and the gene of 
interest after growth in a specific condition (78). Transcriptional and translational fusion libraries 
can be created by placing promoterless reporters (ex: lacZ, luxAB, xylE) inside a transposon 
and then creating the transposon mutant library library (79). This allows one to screen for genes 
that are differentially regulated in response to an environmental stimulus (80). DNA and cDNA 
sequencing can be performed using a transposon mutant library by using transposon-specific 
primers for sequencing the genomic regions next to the transposon insertion and assembling 
those segments into the full sequence (81). Scanning linker mutagenesis is a powerful tool for 
structure-function studies. This technique involves using transposons in create in-frame 
insertion mutants in a gene. Then, site-specific recombination removes the unnecessary DNA 
segments of the transposon itself, leaving only a small insertion in the gene (76, 82). Signature-
tagged mutagenesis involves making a transposon mutant library from a transposon containing 
different random sequences used as signature tags. This was an important development 
because it allowed for the simultaneous screening for multiple genes important for growth in a 
specific condition (83). It has traditionally been used for assessment of genes required for 
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virulence during infection (84, 85). Transposon-site hybridization (TraSH) uses a custom 
microarray to identify conditionally-essential genes in a high-throughput manner (86). In short, 
fluorescently-labeled probes derived from the transposon-genome junctions are created from a 
transposon mutant library and hybridized to an array containing every gene in the genome. 
Changes in fluorescence at each spot on the array after growth in a condition of interest are 
identified, and these correspond to transposon mutants with a change in fitness in that condition 
(86-88).  
Transposon mutagenesis and next-generation sequencing (NGS) 
 As the cost of DNA sequencing has decreased, high-throughput methods similar to 
signature-tagged mutagenesis and TraSH have become more common. Numerous tools and 
techniques for next-generation sequencing (NGS) of transposon mutant libraries have been 
created and published, but each follows a similar series of steps (89). For each, a transposon 
library is created and grown in a condition of interest. Because of the danger of antibiotic-
resistant bacterial infections, these conditions are often antibiotic treatment or growth in a model 
organism (90-95), but others have investigated the impact of other kinds of stress such as 
uranium stress (96) and changes in CO2 concentration (97). After growth in the condition of 
interest, the cells are collected, genomic DNA is isolated, and transposon-genome junctions are 
purified away from the rest of the DNA. The location of the transposon insertion is sequenced 
using NGS, and genes important for fitness in that condition are found by identifying genes with 
significant changes in numbers of reads that map to them (Figure 3). 
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Figure 3. Transposon libraries can be sequenced with NGS to discover genes required 
for survival in a condition of interest. To perform these experiments, a transposon mutant 
library is grown in the condition of interest (ex: antibiotic treatment) and a control condition. Cells 
with transposon insertions into genes which are required for growth in the condition of interest 
will die and drop out of the library (ex: blue cells). Once the cells have been collected, the DNA 
extracted, and transposon insertion locations identified using NGS, we can identify genes with 
significantly fewer reads mapping to them (ex: blue gene). This allows us to identify genes 
required for growth in a given condition.  
 
Tn-Seq, TraDIS, INSeq, and HITS are four similar techniques for sequencing the 
location of transposon insertions(89). They differ only in the method used to prepare 
transposon-genome junctions for DNA sequencing. Tn-Seq and InSeq take advantage of the 
MmeI restriction enzyme which cuts 20bp down from its recognition site (98, 99). With one base 
pair change, the MmeI recognition site can be incorporated near the end of the transposon’s 
inverted terminal repeats. This allows capture of the transposon as well as ~16bp of genomic 
DNA next to it, allowing mapping of the transposon insertion site to the S. aureus reference 
genome. A major difference between the Tn-Seq and INSeq protocol is a step in the INSeq 
protocol that uses a linear PCR with a biotinylated primer and purification with streptavidin 
beads. This step decreases the amount of DNA, enzymes, and other reagents required to 
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prepare the DNA for NGS. In addition, it may increase the sensitivity of the resulting sequencing 
data (89, 99). HITS and TraDIS do not use MmeI digestion to purify the transposon-genome 
junctions, but instead use DNA shearing (100, 101). After shearing, the ends of the DNA are 
repaired and a poly(A) overhang is added. In both, PCR is used to enrich for Tn-chromosome 
junctions, but while the PCR products are directly sequenced in the TraDIS method (101), HITS 
uses a biotinylated primer for the PCR, size selection by running the PCR product on a gel, and 
affinity purification of the DNA, before sequencing with NGS (100). All of these techniques have 
been widely used and broadly-applied to many different bacterial species to study answer 
different biological questions (89), though these techniques are all now largely referred to as 
“Tn-Seq” by the field. 
As these techniques have become more popular, there has been an effort to make the 
analysis of NGS data more accessible to the average biologist who has little computational 
experience. High-quality software is important for making these techniques widely available, and 
initially, most labs wrote their own custom scripts to understand the data. The best way of 
normalizing experimental data and assessing statistical significance likely depends on the 
characteristics of the transposon library, the experiment performed, and the question the 
transposon sequencing data is hoping to answer. Some of the custom methods for analysis of 
transposon sequencing data include using a Bayesian analysis (102) or a Hidden-Markov Model 
(103, 104) for predicting gene essentiality. Our lab has previously used the Mann-Whitney 
statistical test for identifying conditionally essential genes after growth in a non-lethal compound 
(95, 105). Furthermore, the Tufts Galaxy Server has its own custom Tn-Seq analysis pipeline 
which can be used by anyone sequencing transposon libraries through their sequencing facility 
(http://galaxy.med.tufts.edu/).  
One of the first “easy-to-use” programs published was ESSENTIALS, which did not 
require any knowledge of computing languages to run. This online software identifies essential 
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and conditionally-essential genes and can be used with single or multiple transposon libraries 
(106). However, other pipelines and software packages have since been published. These 
include the ARTIST package which combines the Hidden-Markov Model for predicting essential 
genes (EL-ARTIST) with the Mann-Whitney U test to identify conditionally-essential genes 
(CON-ARTIST) (107). Recently, PIMMS (Pragmatic Insertional Mutation Mapping System) 
(108), Tn-Seq Explorer (109), and TRANSIT (110) have been published. Though they differ in 
the methods used for analysis and the format of the output, these methods now allow even 
novices to transposon sequencing to more easily analyze their data which will increase the 
popularity of these techniques.  
Transposon studies in S. aureus.  
 Transposon mutagenesis has been used for studying the physiology of S. aureus for 
many years. In 1983, one of the first studies used Tn551 translocated into the chromosome of a 
strain of MRSA to discover the first chromosomal factors essential for methicillin resistance 
(111). These transposon mutants turned out to map to the femA gene which is involved in 
synthesizing the pentaglycine bridge of the cell wall (112). A larger library made up of 1,012 
isolated colonies was created in 1994. This library was used to expand the known number of 
genes that are important for β-lactam resistance. They identified 70 new insertional mutants that 
decrease resistance to β-lactam antibiotics (113). Studying these genes has increased our 
understanding not only of cell wall biosynthesis but also the requirements for β-lactam 
resistance in MRSA.  
Over the years, transposon mutant libraries have been used study many aspects of S. 
aureus physiology. These include (but are not limited to) capsule synthesis (114), autolysis 
(115), β-lactamase expression (116), clumping factors (117), virulence (118), abscess formation 
(119), pigment production (120), and biofilm formation (121). While these studies led to a much 
greater understanding of S. aureus biology, most of these transposon libraries contained at 
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most ~1000 unique mutants, meaning that many genes in the genome were still untested in 
these experiments. Furthermore, techniques such as arbitrarily-primed PCR or inverse PCR 
were used to sequence the location of transposon insertion (122, 123). Such techniques are 
robust, but they are not high-throughput as they can be performed on only one colony at a time.  
 Even though genetics on S. aureus can be difficult, two techniques for making larger 
libraries were published in the early 2000’s. One method uses the phage Mu and pre-
assembled transposon-DNA/transposase complexes, or transpososomes. These 
transpososomes are assembled in vitro and electroporated into S. aureus cells, where in the 
presence of divalent cations, they become activated and perform the transposition reaction. This 
method was used to create a 10,000 colony library (124). The second method uses a mariner- 
based bursa aurealis, transposon on a plasmid, which is electroporated into cells expressing the 
transposase. After transposition, a high-temperature plasmid-curing step is required to cure the 
cells of the plasmids. The authors created a library with 10,325 unique insertions and used it to 
identify essential genes and new virulence factors (125).  
These methods work well, and they set off an explosion of research utilizing genetic 
screens in S. aureus. Libraries and mutants created using these systems have been used to 
study many genes including those involved in L-form formation (126), lysostaphin resistance 
(127), biofilm formation (128), and fitness in blood (129).  Our lab has used a library created 
using the plasmid-based system to identify the genes required in the absence of wall teichoic 
acids (95), and the same library has been used to identify genes required for fitness in infection-
related ecologies such as blood and ocular fluids (90). Furthermore, the plasmid method was 
used to create the Nebraska Library,  a transposon library created in the United States epidemic 
strain USA300 (130). The makers of this library have arrayed it and made it available as a 
resource. Unfortunately, both of these techniques suffer from a set of disadvantages. Neither 
protocol is simple and easy to use, mostly because of the low efficiency of electroporation into 
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S. aureus (131). Furthermore, during the high-temperature plasmid curing step of the second 
method, all temperature-sensitive mutants die off (125, 132). This makes studying cell envelope 
and stress-response genes challenging because many of them are temperature-sensitive. 
In 2011, a new method was published that solved many of the problems described 
above. This method uses a Φ11 phage to transduce the donor plasmid containing the 
transposon into the S. aureus strain of interest (133). This happens at a much higher efficiency 
than electroporation. In addition, a high-temperature plasmid-curing step becomes unnecessary 
because the RepC element required for replication of the donor plasmid is encoded in trans in 
the donor strain, preventing transposon plasmid replication in the recipient strain. When 
selecting for erythromycin resistance, which is encoded within the transposon, only those cells 
with a successful transposition event will survive. This system is so efficient that the authors 
were able to combine different transposon constructs with outward-facing promoters of different 
strengths when creating the library (133). Depending on the location and orientation of 
transposon insertion, the expression of any gene may be upregulated or downregulated (genes 
can be simply inactivated as well). This phage-based system was designed for predicting the 
target of new antibacterial compounds (133, 134). Target upregulation is a common mechanism 
of resistance, but may come at a fitness cost; for other antibiotics, downregulation may confer 
resistance (135). A major advantage of this platform is that by selecting for resistant mutants in 
a library with a range of expression options, it should be possible to learn something about the 
mechanism of action of an antibiotic and, in a best case scenario, to identify the target. The 
downside of this system was that it was not compatible with NGS. This means that once 
resistant mutants are selected on plates, the location of the transposon insertion must be 
identified one colony one at a time.  
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Looking Forward 
 These developments have shaped the study of S. aureus. Each new development builds 
on the last, increasing the ease with which we understand the different aspects of bacterial 
physiology. In the past twenty-three years, we have gone from creating small transposon 
libraries and identifying the location of one of the mutants, to being able to create libraries 
consisting of thousands of unique mutants and simultaneously identifying the location of each 
mutant in the library using NGS. The new “omics” era has allowed us to build enormous 
datasets and to begin to take a systems-level approach to understanding cellular responses to 
environmental stimuli. This has resulted in the creation of many tools and databases for better 
understanding S. aureus, but questions still remain. However, with the increasing threat of 
antibiotic resistance, these techniques will enable many functional and comparative genomics 
studies, which will increase our understanding of bacterial physiology, antibiotic-resistance, and 
host-pathogen interactions. We can use these discoveries to further our fight against these 
dangerous infections. 
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Chapter 2. Adaptation and validation of a new Tn-Seq platform in S. aureus  
 
Contents of this chapter were published in BMC Genomics in 2011. 
This work was done in collaboration with Tim Meredith, Leigh Matano, and Samir Moussa. 
 
2.1 Introduction 
 
Staphylococcus aureus is a highly adaptable pathogen that is responsible for tens of 
thousands of serious infections every year in the United States (136-138). Many cellular factors 
in S. aureus contribute to antibiotic resistance by mounting a robust cellular response to 
antibiotic-induced stress (139, 140), including the cell envelope stress response and the 
stringent response (141-144). A better understanding of how these cellular components work 
together to combat environmental stresses could lead to new strategies for more efficacious 
dosing of existing antibacterial agents as well as the development of novel therapeutics. 
Transposon mutant libraries used in conjunction with NGS are powerful tools for probing 
bacterial physiology (89, 98-101, 134, 145). Creation of high-density transposon libraries in S. 
aureus has been challenging because its thick cell wall precludes high-efficiency electroporation 
of DNA containing the transposon, and there are no systems in S. aureus for transposon 
delivery via conjugation (124, 131). Thus, most high coverage transposon libraries in S. aureus 
typically utilize a temperature sensitive plasmid containing the transposon and require high-
temperature plasmid-curing steps to remove the plasmid delivery vehicle after transposition has 
occurred (90, 95, 125, 130, 146, 147). During this curing step, temperature-sensitive transposon 
mutants may be culled, making it challenging to differentiate essential genes from those that are 
required for growth at elevated temperatures. 
Here we report the design and application of a phage-based transposition method that is 
compatible with a new NGS protocol and surmounts the many challenges associated with 
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creating high-density transposon libraries in S. aureus. In fact, this method is so efficient that we 
were able to multiplex together transposon constructs with different regulatory elements that 
have the ability to over- and under-express as well as inactivate any gene in the genome to 
create a single highly-diverse library with more than 690,000 unique transposon mutants. We 
have used this library to identify genes essential for growth at 30°C and have assessed 
transposon mutant fitness at a set of low and high temperatures to identify temperature-
sensitive and resistant mutants. Nineteen genes identified as essential in previous studies were 
found to be conditionally-essential, demonstrating growth inhibition at elevated temperatures. In 
addition, mutants in the menaquinone biosynthesis pathway were found to be significantly 
enriched at high temperature. Mutations in this pathway have previously been found in small 
colony variant (SCV) strains isolated from in vivo infections that are resistant to antibiotics, and 
our results suggest that heat stress is one condition that may select for these mutants. The 
phage-based delivery and insertion site sequencing methodology described here will facilitate 
comprehensive functional genomic studies of S. aureus physiology. 
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2.2 Adaptation of the transposon library for next-generation sequencing and creation of 
the transposon library 
 
Adaptation of phage-based transposition for compatibility with any strain of S. aureus 
A phage-based approach for creating transposon libraries in S. aureus was developed 
by Meredith and co-workers (133), but this method, as it was described, was not compatible 
with next generation sequencing. This approach uses a conditionally replicative transposon 
donor plasmid, which is moved by generalized phage transduction to a Himar1 transposase-
expressing strain that cannot support plasmid replication (Figure 4). Following transduction, the 
transposase inserts the transposon into TA dinucleotide sites randomly across the genome. 
Whereas other transposon systems generate only null genotypes due to gene disruption, the 
phage-based system was designed to allow over- and under expression of genes as well as 
inactivation (133). This was achieved by building a set of transposon donor constructs harboring 
the mariner inverted terminal repeats (ITR) flanking an erythromycin resistance gene under the 
control of its own promoter and terminator along with an outward-facing promoter. Genes 
proximal to the insertion site can be upregulated or downregulated to different extents 
depending on the orientation of insertion and the strength of the promoter (Figure 4). This 
phage-based transposition system was shown to be useful for nominating antibiotic targets 
through gene upregulation and for identifying other cellular factors involved in antibiotic 
resistance through deletion/downregulation (133, 134). However, in its original format the 
phage-based system was limited to sequencing single colonies isolated after positive selection 
on agar plates. Thus, its use as a functional genomics discovery tool was limited and we sought 
to reengineer it to take full advantage of the power of next generation sequencing (Figure 4). 
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Figure 4. Strategy for using phage-based transposition to make high quality transposon 
libraries for NGS sequencing. (A) The transposon insertion library is made by creating a high-
frequency transducing lysate of the transposon cassette that is able to replicate as a plasmid in 
the donor strain (repC+). The lysate is mixed with the recipient strain (repC−) carrying a 
temperature sensitive plasmid from which the Himar1 transposase is expressed, and 
erythromycin resistant transposon insertion mutants are selected. (B) By fitting the transposon 
cassette with an outward-facing promoter, genes can be up- or down-regulated, or inactivated if 
non-essential, in a single library pool. Continued page 22. 
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Figure 4 continued. In order to cover a wide range of gene expression levels, different 
promoter containing transposon constructs can be multiplexed and then identified using NGS 
sequencing by unique DNA barcodes (purple bar) to collect fitness-gene dose relationships by 
monitoring read counts. By mapping NGS reads to transposon insertion sites, and comparing 
the number of reads that map to each gene in the control and condition of interest, we should be 
able to distinguish between upregulation, downregulation, and inactivation of genes by 
transposon insertion.  
 
We first modified the transposase plasmid used in the recipient strain to include orf5, the 
gene encoding the Φ11 cI-like repressor. The original phage-based transposon delivery system 
was used to make mutant libraries in S. aureus strains RN4220 and COL (133), and the 
transposon donor plasmids were designed with a 1 kb Φ11 homology region to stimulate 
efficient packaging of transposon donor plasmid DNA as concatemers by the phage. It proved 
necessary to integrate the Φ11 cI-like repressor (orf5) into the genome to prevent replication 
and lysis of the recipient strain by the wt Φ11 population that did not package plasmid. Because 
we wanted to use the phage-based transposition system in other S. aureus strains without 
having to first integrate the cI-like repressor into the genome, we moved the orf5 gene into the 
transposase plasmid (pORF5) to achieve transposase expression and inhibition of Φ11 
replication in a single step. 
We selected HG003 as our strain background for library preparation because a high 
quality plasmid-delivered library has been made in the same strain and provided a reference for 
validating our method (90, 95). However, in contrast to RN4220 and COL, a high number of 
ermR colonies was observed in HG003, even in the absence of functional transposase (<1% for 
RN4220 versus >90% for HG003; Figure 5A). We initially speculated that phage-transposon 
hybrid DNA containing an attP site was being integrated within a recipient HG003 subpopulation 
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where the chromosomal attB site had become available through spontaneous excision of the 
resident prophage, thus leading to the high background of non-transposase catalyzed events 
(Figure 5B). To confirm this possibility, we introduced the pORF5 transposase plasmid into wild 
type RN4220, which also contains an available attB site. As with HG003, we now observed a 
high background of non-transposase catalyzed ermR colonies in RN4220 attB+ (Figure 5A), 
consistent with a role for phage-mediated att-site specific integration in increasing background 
(Figure 5B). To block this pathway, we constructed a strictly virulent transducing phage (Φ11-
FRT) by replacing the attP-int site with a FRT site from the yeast 2-μm plasmid site-specific 
recombination system (148, 149) (Figure 5C), thereby preventing integration. The use of Φ11-
FRT decreased the background of non-transposase-catalyzed transposon integration in 
RN4220 as fewer ermR colonies were produced by the truncated transposase expressing strain 
(Figure 5A), but the background in HG003 remained unacceptably high (Figure 5A). We 
therefore considered a second mechanism for the production non-transposase catalyzed ermR 
colonies. Homologous recombination between phage-transposon hybrids carrying the ermR 
cassette and the resident Φ11 prophage in HG003 could also yield ermR colonies (Figure 5C). 
To determine whether this was occurring, we constructed a strain of HG003 where the Φ11 
prophage was specifically removed using the same att::FRT exchange strategy employed to 
create the Φ11-FRT donor phage. The combination of this recipient strain (HG003 Φ11−) with 
Φ11-FRT packaged transposon donors reduced non-transposase catalyzed ermR background 
colonies to less than 1% (Figure 5A). With removal of the Φ11 prophage, this strategy now 
allows us to create high-density transposon mutant libraries with a very low background of non-
transposase catalyzed transposon integration using the phage-based transposition system in 
any strain of S. aureus that is transducible by Φ11. 
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Figure 5. Elimination of non-transposase catalyzed transposon integration. (A) The ratio 
of ermR colonies arising from non-transposase catalyzed (hatched) to transposase dependent 
(solid) events was determined in the RN4220 (green) or HG003 (blue) strain backgrounds by 
comparing the number of colonies resulting from transduction of the transposon into the full 
transposase or truncated transposase expressing strains. The presence of the phage 
attachment site in the bacterial chromosome (attB), the phage attachment site in the donor 
lysate (attP-int), and a Φ11 prophage in the recipient is indicated. (B) Putative mechanisms for 
integration of the ermR cassette of the transposon into the recipient chromosome include 
transposase catalyzed (top), integrase-mediated (middle), and homologous recombination 
(bottom). (C) The integrase pathway was blocked by replacing the integrase (int) gene and the 
attL sequence with a FRT element by allelic replacement. To cure the resulting prophage, the 
attR site was replaced with a second FRT site and a phage donor lacking int-attP was isolated 
by introducing the FLP recombinase. In the process, a recipient HG003 strain was generated 
from which the Φ11 prophage was specifically cured, preventing homologous recombination. 
 25 
 
Adaptation of the phage-based transposition system for next-generation sequencing 
To adapt the transposon system for NGS, modifications to the donor plasmids were 
required. The initial design included the incorporation of: 1) the P7 Illumina adapter sequence 
within the transposon cassette to enable Illumina based NGS, 2) unique three base pair 
barcodes specific to each outward facing promoter element for de-multiplexing after 
sequencing, and 3) a MmeI site to capture the transposon-genome junction. The MmeI 
restriction site was embedded within one ITR of the transposon by a single base pair change, 
facilitating processing of transposon insertion sites by cutting non-specifically 20-base pairs 
downstream of its recognition site (16-base pairs downstream of the Himar1 TA dinucleotide 
insertion site) (99).  
Early efforts to prepare and sequence our transposon libraries using the reengineered 
constructs were plagued by high plasmid-transposon junction read counts, despite the fact that 
the vast majority of ermR colonies arose via bona fide transposition events. When we used PCR 
to probe the transposon junctions in isolated transposon mutant colonies, we observed a small 
population harboring both plasmid- and genomic-transposon junctions (Figure 6A), as 
previously reported (133). However, when a single base pair was changed in the canonical ITR 
DNA sequence to create the MmeI site, the population of transposon insertion mutants 
containing plasmid-transposon junctions increased to over 50%. We hypothesized that the 
MmeI modified base in the ITR was important for recognition by the Himar1 transposase in vivo, 
resulting in a transposase-DNA complex that often failed to engage the initially encountered ITR 
and instead read through to a downstream non, contiguous ITR within the concatemer (Figure 
6B) (150). The ensuing transposition event would thus capture and introduce the intervening 
plasmid region into the recipient genome. Therefore, we added two NotI sites to the plasmid, 
one immediately after the MmeI-modified ITR within the plasmid backbone and the second 
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immediately upstream of the P7 adapter sequence (Figure 5C). Following an added NotI 
digestion step, the plasmid-transposon junctions could now be selectively removed. (Figure 6D) 
 
Figure 6. Reduction of transposon-plasmid junction NGS reads with flanking NotI 
restriction sites. (A) Inverse PCR was used to amplify the ITR2 transposon junctions for twelve 
colonies as described (33). Three out of twelve of these colonies also contained transposon-
plasmid junctions (~160 bp DNA band). This ratio increased to seven out of twelve when the 
canonical ITR sequence was altered to incorporate a MmeI recognition site. Results are 
representative of multiple independent experimental replicates. (B) The putative mechanism for 
transposase catalyzed integration of transposon-plasmid junctions may involve engagement of 
non-contiguous ITR repeats (dashed lines), resulting in chromosomally integrated transposon 
multimers. In contrast, when both ITR sequences are optimal, contiguous ITRs are most 
frequently mobilized (solid lines). (C) Colors are used to identify the positions of the sequences 
in this drawing. To selectively remove transposon-plasmid junctions, we introduced two NotI 
recognition sites into the transposon construct that flanked the MmeI modified ITR2. We also 
included a P7 Illumina sequencing primer site and a unique 3-bp DNA barcode to identify the P 
out promoter that faces outward from ITR1 during NGS sequencing. (D) After first digesting 
genomic DNA with NotI, the transposon-plasmid junction content was substantially reduced. 
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Using these changes, we were able to create four different transposon constructs with 
outward-facing promoters of different strengths and orientations (in order of increasing strength 
Perm , Ppen, Pcap, and Ptuf,). In addition, we created a construct with the Ppen outward-facing 
promoter on one end and the erythromycin-resistance gene promoter (Perm) on the other but no 
intervening transcriptional terminator (Dual), and a transposon construct with no outward facing 
promoter elements (Blunt) (Figure 7). Each of the six constructs is identified from the NGS data 
using a unique barcode located inside the transposon. The Blunt construct is most similar to 
transposons used in traditional transposon screening experiments, and because it does not 
contain any promoter elements (besides the promoter driving ErmR expression), it can only 
inactivate genes. The rest of the construct, which contain outward-facing Perm , Ppen, Pcap, and 
Ptuf promoters, have the ability to upregulate nearby genes if these promoters are in the same 
orientation as that gene’s native promoter. The Perm construct is simply the Blunt construct 
without the transcriptional terminator at the end of the ErmR cassette, so the insertion 
orientation where it will upregulate nearby genes is opposite of the Ppen, Pcap, and Ptuf containing 
constructs. The Dual construct is unique in that, as a hybrid of the Perm and Ppen transposon 
constructs, it can upregulate both upstream and downstream genes. This is useful for genes 
such as tarGH. TarGH is the wall teichoic acid transporter and both components are required for 
its activity. Therefore, both components would have to be upregulated to increase export of wall 
teichoic acids, but though tarG is found next to tarH in the genome, they face opposite 
directions. Only the Dual transposon mutant would be able to upregulate both tarG and tarH at 
once.  
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Figure 7. Six different transposon constructs were used to create the transposon library. 
A schematic of the different transposon constructs, as well as the three base pair barcodes 
used to identify them, is shown. The Blunt construct only has the ability to inactivate genes, 
while the others (Erm, Pen, Cap, Dual, and Tuf) can upregulate nearby genes. The Dual 
transposon construct is unique in that it can upregulate genes on either side of the transposon 
insertion site.  
 
Our optimized sample preparation procedure for transposon mapping is outlined in 
Figure 8, and a detailed version can be found in Appendix C. Briefly, genomic DNA is extracted 
from a pooled transposon library and then digested with NotI followed by a size-selective poly-
ethylene glycol (PEG) precipitation to remove liberated plasmid-transposon junctions (151, 152). 
A PCR-based quality control check is performed to confirm that background due to transposon-
plasmid junctions is minimal. A biotinylated dsDNA adapter containing a NotI compatible 
overhang is then ligated and the DNA is digested with MmeI. The transposon-genome junctions 
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with 2-base overhangs are bound to streptavidin dynabeads and ligated to an adapter 
containing the indexing barcode and priming site for the Illumina sequencing primer. Primers 
containing the P5 and P7 sites are then used to amplify the transposon-genome junctions 
bound to the streptavidin dynabeads. The fragments are run on a 2% agarose gel to confirm 
size, extracted from the gel, and multiplexed with other samples prior to sequencing (Figure 8). 
Using this protocol, we routinely reduced the amount of contaminating plasmid-transposon 
reads to less than 1%. To confirm the quality of the DNA insert library for NGS, we developed a 
quality control procedure for determining level of background due to transposon-plasmid 
junctions (Figure 9). This strategy, which utilizes restriction enzyme digestion followed by size-
selective precipitations, can be generalized to other bacterial species and transposon library 
sequencing strategies to prepare transposon libraries for NGS. 
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Figure 8. Protocol for the preparation of a high quality transposon DNA library for NGS. 
(A) (1) Genomic DNA is isolated and digested with NotI. High molecular weight DNA is 
selectively precipitated using an 8%PEG + NaCl solution. A biotinylated dsDNA adapter with 
NotI overhang is ligated (2) before digestion with MmeI (3). Biotinylated fragments are bound to 
streptavidin beads (4), and an Illumina sequencing primer adapter containing an indexing 
barcode and MmeI compatible ends is ligated (5). Primers annealing to the P7 site and the 
Illumina sequencing primer adapter sequence (with a P5 site overhang) are used to PCR 
amplify the transposon-genome junctions (6), agarose gel purified, and submitted for Illumina 
sequencing (7).  Continued page 31. 
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Figure 8 continued. (B) Fragments arising from transposon-plasmid junctions are removed by 
size selective PEG-NaCl precipitation, while the remaining fragments lack both P7 annealing 
sites and MmeI sites for ligation of the Illumina sequencing primer adapter. These fragments are 
therefore not amplified in (6) of 4A. (C) By performing the size-selective precipitation on a 1 kb 
DNA ladder, we show that small 300 bp fragments of DNA are retained in the solution (SN), 
while larger DNA is precipitated (P). 
 
 
Figure 9. PCR and NGS library diversity analysis. (A) The amount of transposon-plasmid 
junction was quantified by removing aliquots of each PCR reaction at the indicated cycle 
number and analyzing by agarose gel electrophoresis. Continued page 32. 
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Figure 9 continued. The cycle at which a band was first observed for the transposon-plasmid 
junction had to be reduced by at least 6 cycles after NotI digestion in order for the sample to be 
further processed. Amplification of a genomic locus using control primers for tarK was used as 
control (top panel). (B) NGS library was cloned into a pUC19 vector with ends homologous to 
the P5 and P7 Illumina primers. Individual colonies were sequenced to confirm insert diversity 
before submitting for NGS. 
 
Creation and sequencing of a transposon library 
Using the strains and methods described above, we created a 2 million colony 
transposon library using the six different transposon donor constructs described above (Figure 
7). Library cultures were grown for 12-13 generations in tryptic soy broth (TSB), harvested 
between an OD of 1 and 1.5, and genomic DNA was isolated. After processing samples for 
NGS and sequencing, the Tufts Galaxy service was used to separate the data by sample index 
and donor construct barcodes (153-155). The data were filtered by Illumina quality score for 
high quality reads and mapped with Bowtie (ver1.1) to the S. aureus NCTC8325 reference 
genome (156).  
We used two biological replicates for our analyses and computationally de-multiplexed 
the data by transposon construct based on their unique barcode (Figure 7). For each of the 
donor constructs, we obtained 3 to 5 million reads that could be mapped to TA insertion sites. 
Depending on the constructs, insertions were identified in 105,000 to 130,000 of the ~270,000 
unique TA sites in the S. aureus genome (Table 1). On average, 3,897,389 ± 834,906 reads hit 
115,792 ± 9,416 TA sites for each of the six transposon constructs, with 36,794 TA sites in 
common between all six of the donor constructs, and 208,372 TA sites covered by at least one 
donor construct. 
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2.3 Validation of a new Tn-Seq platform in S. aureus by identification of essential genes 
and temperature sensitivity screening 
 
Identification of essential genes 
To validate the quality of the library and assess whether insertions due to individual 
transposon constructs could be reliably analyzed, we used the data obtained to identify 
essential genes. We first compared the number of reads per gene for each transposon donor 
construct using principal component analysis and found that the transposon constructs with 
outward-facing promoters co-clustered away from the promoterless (Blunt) and weakest 
promoter (Perm ) constructs (Figure 10). This suggests that transposon insertions in the same TA 
site by different transposon constructs are differentially tolerated due to polar effects on 
downstream genes. Therefore, different numbers of reads map to each gene depending on the 
identity of the transposon construct. However, because transposon constructs containing a 
medium to strong outward-facing promoter (Dual, Ppen , Pcap, and Ptuf) clustered together, the 
number of reads mapping to each gene for each of these constructs will be more similar to each 
other than to Blunt or Perm . Because of the similarity between the constructs with an outward-
facing promoter, the data from these constructs (Dual, Ppen , Pcap, and Ptuf) was combined for the 
gene essentiality analysis. 
We then identified essential genes using a recently published method, EL-ARTIST 
(Appendix D) (104, 107). This method uses a hidden Markov model (HMM) to categorize genes 
as essential, non-essential, or containing essential domains (domain essential). Because this 
method uses local context of the TA site as well as the number of reads in that TA site to 
determine essentiality, it lessens the impact of the intrinsic variability in the data and allows us 
to robustly ascertain the importance of every gene to cellular survival. There were 261 genes 
found to be essential in all three categories (Blunt, Perm, and other promoter constructs). The 
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Blunt construct had the greatest number of essential genes (321 genes), while the Perm 
construct had slightly fewer (295 genes), and the other promoter constructs had the least (277 
genes) (Figure 10).  
 
Figure 10. Transposon insertions by different transposon constructs are differentially 
tolerated. (A) Principal component analysis was used to compare the number of reads mapping 
to each gene for each of the six transposondonor constructs. The transposon constructs with 
outward-facing promoters clustered together, away from the Blunt and Perm constructs. Data for 
these constructs were combined and analyzed separately. (B) A Venn diagram depicting the 
number of essential genes for each category of donor construct as calculated using EL-ARTIST 
is shown (107). 
 
We were curious about the differences between the Blunt construct and constructs 
containing promoter elements. When a transposon inserts into the coding sequence of a gene, it 
not only interrupts the expression of that gene, but can also disrupt the expression of other 
genes due to polar effects. It is possible that some of these polar effects are abrogated by the 
promoters in the Perm and other promoter constructs, which allow downstream genes to be 
expressed from the promoter in the transposon instead of the native promoter. If this is true, 
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then the genes found to be essential with the Blunt construct, but non-essential with the other 
constructs, should be next to or near other essential genes. Of 20 essential genes found using 
the Blunt construct that were non-essential for the Perm construct and the other promoter 
constructs, 13 were immediately proximal to another essential gene. Another five were 
immediately proximal to a domain essential gene, and three of these were followed by another 
essential gene. Only two genes were not adjacent to an essential or domain essential gene. 
These data suggest that when a transposon containing an outward-facing promoter inserts into 
a region containing many essential and domain essential genes, the insertion may result in a 
less lethal phenotype than the standard transposon construct. Due to these differences and to 
compare our data with previous studies which did not have constructs containing promoters, we 
chose to use only the Blunt construct for subsequent analyses. 
The Blunt construct, which is not fitted with gene expression modulating elements, is 
most similar to previously used transposons (90, 125, 130, 146, 147). In two biological 
replicates, there were ~126,000 unique insertion sites due to the Blunt construct. Using the 
Circos program to display the number of reads per TA site (157), we visually confirmed 
randomly distributed insertions throughout the length of the genome (Figure 11A). Of the 2723 
coding regions of the genome that are not part of the Φ11 family lysogen, EL-ARTIST called 
2212 non-essential, 190 domain essential, and 321 essential (Appendix D). 
Essential genes are defined as those genes that are required for cellular growth. 
However, depending on the growth conditions, different sets of genes may be identified as 
essential, but there should be a subset of truly essential genes that are required for growth in all 
conditions. We expect these genes to be involved in core cellular functions such as DNA, RNA, 
and protein synthesis as well as the processes required for cell growth and division like 
peptidoglycan and membrane biosynthetic genes. A comparison with previous studies using 
transposon mutant analysis to identify essential genes in S. aureus should bring us closer to this 
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core set of essential genes because other studies were done using different growth media and 
analyzed using different methods. However, transposon mutagenesis and sequencing involves 
growing all the transposon mutants together in one culture, resulting in competition between 
mutants in the library. Therefore, non-essential genes with a fitness defect when knocked out 
may appear to be essential in these types of experiments because they are out-competed by 
other mutants in the library. We have observed this for genes such as those of the dlt operon, 
which though they can be deleted, appear essential in a Tn-Seq experiment.  
We compared these results to two previous studies that identified essential genes in S. 
aureus based on transposon mutant analysis, one in the HG003 genetic background (90) and 
the other in SH1000 (146). Both strains are derived from the NCTC 8325 parent strain. The 
transposon libraries were made, grown, and analyzed using different methods, but there were 
247 essential genes in common between this study and the previous study in HG003, and 211 
genes in common between all three studies (Figure 11, Table 2). There were 73 genes 
identified as essential in both previous studies that did not meet our cutoffs for essentiality. Of 
these, two are no longer considered to be genes, eight were in our list of non-essential genes, 
and 63 were found to be domain essential.  
Because the previous studies were done using transposon libraries made using a high-
temperature plasmid-curing step, we checked to see if any of these genes would be identified 
as essential at 43°C. Of the 63 domain essential genes, nine were identified as essential at high 
temperatures, with nine of the remainder found to be domain essential as at 30°C. One gene, 
SAOUHSC_01028, encoding the phosphor-carrier HPr was found to be non-essential at 43°C. 
Transposon insertions in domain essential genes are likely to result in cells that are weak and/or 
have growth defects, and depending on the stringency of the method of analysis, these mutants 
may be mistakenly classified as essential. In addition, at the more stressful high temperatures, 
some of these weakened mutants may no longer be able to survive. Finally, of the eight genes 
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we found to be non-essential that were previously identified as essential, four became essential 
at high temperatures, and one became domain essential. The four genes that became essential 
at 43°C include genes known to be important for high temperatures growth such as the heat 
shock genes, dnaJ (SAOUHSC_01682) and dnaK (SAOUHSC_01683), as well as sepF 
(SAOUHSC_01154). However, overall there was substantial agreement between our essential 
gene list and the lists generated in previous studies despite analytical and experimental 
differences (different growth media, growth temperature, and/or strain background) (Appendix 
E). The 212 genes essential in all studies comprise a core set of essential genes required for 
cell survival regardless of the experimental and analytical methods used to identify them (Table 
2). 
 
 
Figure 11. There are a core set of 211 essential genes in S. aureus. (A) The Circos program 
was used to map transposon insertion sites across the genome, with a histogram depicting the 
number of reads per TA site in purple. Continued page 39.  
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Figure 11 continued. The innermost blue rings depict the locations of non-essential genes for 
which a fitness cost was not observed, while the outermost red ring depicts those genes 
identified as essential. The middle green ring represents those genes that were found to be 
domain essential. (B) Venn diagram comparing our essential gene list to Chaudhuri et al. and 
Valentino et al (90, 146). There is extensive overlap between the three studies. 212 genes were 
classified as essential in all three works. These represent a core set of genes required for cell 
growth regardless of experimental and analytical variations. 
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Identification of genes important for growth at different temperatures 
 Because the phage-based method for transposon delivery does not involve a high 
temperature plasmid curing step, mutant libraries retain insertions in temperature sensitive 
genes. Hence, after validating the transposon library grown at 30°C, we identified transposon 
insertions that confer temperature-sensitive and resistant phenotypes by comparing mutant 
fitness at 16°C, 23°C, 37°C, and 43°C to that at the reference temperature 30°C. At each 
temperature the library was grown for 12-13 generations and the number of reads due to 
insertion of the Blunt transposon in each gene was compared to the number of reads obtained 
after outgrowth at 30°C. Two biological replicates were carried out for each condition and the 
data were analyzed using the Mann-Whitney U test, correcting for multiple hypothesis testing 
with the Benjamini-Hochberg procedure (95). Genes showing a greater than five-fold change 
(increase or decrease) in the number of reads at the test temperature compared to the 30°C 
control were considered significant if the corrected p-value was less than 0.05. A full list of 
affected genes can be found in Appendix F. 
At 16°C and 23°C, only one gene, SAOUHSC_01857, contained a significantly different 
number of reads due to transposon insertions compared to the 30°C control, with the number of 
reads being enriched six-fold and five-fold, respectively. At 37°C, reads due to transposon 
insertions were found to be enriched in five genes involved in branched chain amino acid 
degradation, ilvE (SAOUHSC_00536), SAOUHSC_01611, bkdA2 (SAOUHSC_01612), bkdA1 
(SAOUHSC_01613), and SAOUHSC_01614 (SAOUHSC_01611, bkdA1, bkdA2, and ilvE meet 
significance cutoffs) (Figure 12).  
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Figure 12. Enrichment of transposon insertions in the branched chain amino acid 
degradation pathway. (A) The number of reads in each gene per 5 million reads was 
normalized to the read count at 30°C and plotted for each temperature. (B) Four genes in the 
essential branched chain fatty acid pathway were found to have a statistically-significant 
increase in the number of reads and SAOUHSC_01614 was found to have a non-statistically-
significant increase in number of reads at 37°C, suggesting they have less impact on fitness at 
this temperature. 
 
Branched chain fatty acids are built from branched chain acyl-CoA primers, which in turn 
are derived from the degradation of branched chain amino acids (158). Branched chain fatty 
acids increase membrane fluidity upon incorporation into phospholipid bilayers (159). In Bacillus 
subtilis, enzymes that catalyze the degradation of branched-chain amino acids are induced 
during cold shock and are speculated to increase membrane fluidity by promoting the 
incorporation of branched chain fatty acids into membrane lipids (160). In our data there is a 
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bias against transposon insertions in the branched chain amino acid degradation pathway at 
temperatures lower than 37°C, in agreement with studies in S. aureus and Listeria 
monocytogenes implicating branched chain fatty acids in growth at low temperatures (159, 161). 
Two genes, SAOUHSC_01154, encoding SepF, and the hypothetical protein likely co-
transcribed with it, SAOUHSC_01153, proved to have significantly fewer reads at 37°C. SepF is 
a protein of unknown function thought to be involved in cell division, and was previously 
identified as essential in S. aureus (90, 125, 130, 146, 147), but these studies show it is 
essential for survival only at temperatures greater than 30°C. 
A significant number of genes were found to be affected by transposon insertion when 
grown at 43°C, with 42 being enriched and 77 being depleted. Because this method for creating 
transposon libraries does not involve a high-temperature plasmid curing step, we expected to 
retain many temperature-sensitive mutants. We used two methods for identifying temperature-
sensitive mutants represented in the library. The first was the Mann-Whitney U analysis used for 
every temperature. For the second analysis, we used the 43°C data and the essential gene 
analysis described in the previous section to identify genes essential at 43°C that were not 
identified as essential at 30°C. We confirmed that the number of reads mapping to these genes 
had decreased at 43°C from 30°C. We compared these genes to other essential genes lists (90, 
125, 130, 146, 147), and identified 19 genes that had been annotated as essential in at least 
two other transposon library analyses, but were only temperature-sensitive with our method 
(Table 3). To further analyze the temperature sensitive gene subset, we classified them 
according to cellular function (Figure 13A). 
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Because protection from temperature stress relies on the coordinated response of many 
different pathways regulated by signaling systems and alternative transcription factors, we were 
not surprised to find that 11 regulatory genes were significantly depleted at 43°C, including yycH 
(SAOUHSC_00022) and yycI (SAOUHSC_00023), which were identified as essential in another 
transposon library (90). The yycH and yycI genes negatively regulate the two component 
system, walKR, which is a major regulator of peptidoglycan metabolism that controls autolytic 
activity (162, 163). Deletions of yycH and yycI result in upregulation of walKR, which induces 
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cell wall defects (162, 164). As walKR positively regulates autolytic activity (165), increased 
autolysis of peptidoglycan could explain how derepression of walKR produces a temperature-
sensitive phenotype.  
We also found, as expected, that many genes implicated in the heat shock response 
were required for survival at 43°C. These included the chaperones dnaK (SAOUHSC_01683) 
and dnaJ (SAOUHSC_01682) (166), the transcriptional regulator hrcA (SAOUHSC_01685) 
(167), the protease clpC (SAOUHSC_00505) (168), and mcsB (SAOUHSC_00504; also known 
as yakI), an arginine phosphotransferase that negatively regulates the stress response 
repressor ctsR (169, 170). GrpE (SAOUHSC_01684), which acts in a complex with DnaK and 
DnaJ, narrowly missed our cutoffs (Figure 13B) (171). 
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Figure 13. Genes that influence fitness at high temperature. (A) Genes contributing to 
fitness at 43°C were classified by cellular function. Genes associated with the cell envelope 
constituted the largest fraction of the hits. (B) Six genes known to be associated with the heat-
shock response were found to be temperature-sensitive. The number of reads mapping to these 
genes at different temperatures normalized to 5 million reads is shown. 
 
 The largest category of genes with significant changes in number of reads when grown 
at 43°C included those involved in cell envelope related processes (44 genes) (Figure 13A). 
This category includes genes involved in peptidoglycan (PG) biosynthesis, cell shape/division, 
membrane lipid composition, transcriptional regulation of cell-envelope genes, and predicted 
membrane proteins. Transposon insertions into biosynthetic genes directly involved in PG 
biosynthesis were notably depleted, including pbp3 (SAOUHSC_01652) and pbp4 
(SAOUHSC_00646), which encode cell wall transpeptidases (172-174), one of two alleles of 
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murA (SAOUHSC_02337) involved in PG precursor biosynthesis (175), alr1 
(SAOUHSC_02305) which encodes one of two alleles of alanine racemase (176), and 
SAOUHSC_01739, which encodes an amiC-like peptidoglycan amidase (177). Insertions in 
several genes involved in cell shape/cell division were also affected at 43°C. For example, 
reads due to transposon insertion were depleted for rodA (SAOUHSC_02319), mreC 
(SAOUHSC_01759), and mreD (SAOUHSC_01758), which encode scaffolding proteins that 
coordinate PG biosynthesis and influence cell shape (178-181), and also for ezrA 
(SAOUHSC_01827), which is thought to coordinate Z-ring functions with PG synthesis (182), 
ftsH (SAOUHSC_00486) (183), sepF (SAOUHSC_01154) (184), gpsB (SAOUHSC_01462) 
(185), and SAOUHSC_01857. SAOUHSC_01857 encodes a 1200 amino acid FtsK-like protein 
suggested to be involved in chromosome localization (186). As noted above, insertions in this 
gene conferred a growth advantage at 16°C and 23°C, but are deleterious at high temperature. 
This gene was identified in other studies as essential in S. aureus (90, 125, 130, 146, 147). The 
putative cell wall teichoic acid ligases, lcpA (SAOUHSC_01361) and lcpB (SAOUHSC_00997), 
were also depleted at 43°C (25-fold and 5-fold, respectively), consistent with the vital role of wall 
teichoic acids in orchestrating PG assembly and maintaining envelope integrity (187-189). The 
integral membrane protein MprF (SAOUHSC_01359), which attaches lysine to 
phosphatidylglycerol, was also important for fitness at high temperatures (190). 
In addition to the mutants that were depleted at 43°C, we identified a number of 
processes for which disruption resulted in a significant growth advantage compared to growth at 
30°C. Pathway enrichment analysis using BioCyc (191) showed that the number of reads due to 
transposon insertion were significantly enriched in seven genes in the aromatic amino acid and 
menaquinol biosynthetic pathways (SAOUHSC_01481, aroB: SAOUHSC_01482, aroF: 
SAOUHSC_01483, menF: SAOUHSC_00982, menD: SAOUHSC_00983, aroE: 
SAOUHSC_01699, and aroA: SAOUHSC_01852) (Figure 14). In addition to producing 
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phenylalanine and tyrosine, the aromatic amino acid pathway provides precursors (chorismate) 
for menaquinone biosynthesis (192). Menaquinones are isoprenylated electron transport chain 
cofactors embedded in the membrane that are necessary for oxidative phosphorylation (193). 
Insertions in ispA (SAOUHSC_01618), which encodes a putative geranyltransferase, were also 
enriched at 43°C. Geranyltransferases initiate the condensation of isoprenoid units into longer 
chains used in the synthesis of menaquinones, and loss of ispA likely decreases the pool of 
menaquinones. We also identified insertions in hemY (SAOUHSC_01460), a gene involved in 
the production of protoheme (194). Loss of these factors is thought to shift S. aureus growth 
towards an anaerobic metabolic regime, which markedly impacts S. aureus membrane 
physiology and generates small colony variants (SCV) (195, 196). The observed growth 
advantage could also be related to more efficient anaerobic catabolism at high temperature, 
and/or decreased oxidative stress. Five subunit genes in the F-type ATPase involved in electron 
transport were found to be essential at 43°C (Figure 12B): α-subunit (SAOUHSC_02345), β-
subunit (SAOUHSC_02343), γ-subunit (SAOUHSC_02341), A subunit (SAOUHSC_02350), and 
B subunit (SAOUHSC_02347) (all were significantly depleted except the β-subunit), suggesting 
the electron transport system (ETS) mutations can have opposing effects on fitness at elevated 
temperatures depending on which step in the ETS is blocked.  
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Figure 14. The electron transport system influences sensitivity to high temperatures.  (A) 
Nine genes were identified as growth advantaged at 43°C in comparison to 30°C. The number 
of reads per gene normalized to 5 million reads is shown for each temperature. (B) Pathway 
analysis revealed that this subset of genes (highlighted in yellow) is involved in the biosynthesis 
of components within the electron transport system, including protoheme and menaquinones. 
Continued page 50.  
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Figure 14 Continued. (C) Blocking the electron transport system at the F-type ATPase level, 
however, decreased fitness at 43°C (genes highlighted in yellow). The number of reads per 
gene normalized to 5 million reads is shown for each temperature. 
 
Among cell envelope-related genes, reads due to transposon insertion were notably 
enriched in lytD (SAOUHSC_01895, also known as sagB), encoding β-N-acetylglucosaminidase 
(196, 197), and lyrA (SAOUHSC_02611), a polytopic membrane protein. Disruptions in lyrA 
were previously shown to increase lysostaphin resistance and are lethal when wall teichoic acid 
biosynthesis is blocked (95, 127), and both these phenotypes are consistent with an important 
role for lyrA in cell envelope biogenesis. 
To confirm the results of our automated transposon insertion analysis pipeline, we 
constructed and measured the growth rates of null mutants of lyrA (significantly overrepresented 
at 43°C) and mprF (significantly depleted at 43°C) (Figure 15A and B). While there were no 
differences in growth of the mutants compared to wild type at 30°C, growth related phenotypes 
became apparent at 43°C after 5 to 6 generations of outgrowth. The wild type strain grew more 
slowly at 43°C than at 30°C (doubling times were 65 min and 37 min, respectively), the ΔmprF 
strain ceased dividing altogether, and the doubling time of the ΔlyrA mutant decreased to 34 
minutes at 43°C from 41 minutes at 30°C (Figure 15C). A faster growth rate than wild type could 
signify that in the absence of lyrA, an important mechanism for regulation of growth rate during 
conditions of stress such as high heat has been disrupted. On the other hand, an increase in 
OD, does not necessarily mean that all the cells are alive and growing. There may be many 
dead cells in this condition, contributing to a higher OD, but not actually corresponding to an 
increase in fitness at 43°C. These results confirm the changes in fitness that were deduced from 
the changes in read number due to transposon insertion in lyrA and mprF at 43°C. 
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Figure 15. Confirmation that changes in read number correspond to changes in fitness. 
The number of reads in each gene normalized to 5 million sample reads is shown at the various 
temperatures tested. Loss of lyrA and mprF was found to have opposite phenotypes at 43°C, 
with an increase (A) and decrease (B), respectively, in number of reads mapping to each of 
these genes. (C) To validate these phenotypes, null mutants in S. aureus HG003 were grown to 
mid-log phase, diluted, and grown at 43°C. While ΔmprF did not grow, confirming temperature 
sensitivity, the ΔlyrA strain grew at nearly twice the rate of WT. Doubling times for WT and the 
ΔlyrA strains are shown.  
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2.4 Discussion 
 
Adaptation of the transposon library for NGS 
 We have adapted a phage-based transposition method to reliably create large and 
diverse transposon libraries that can be analyzed using high-throughput Illumina sequencing. 
The high background due to non-transposase-catalyzed recombination in the HG003 strain was 
reduced to negligible levels by removing the Φ11 family prophage and using a strictly virulent 
transposon donor phage (Φ11-FRT) for transduction. Other strains that harbor Φ11 family 
prophages, such as S. aureus Newman (198), may have a similar background problem that 
makes removing the Φ11 family prophage necessary for working in these genetic backgrounds. 
Fortunately, many commonly used S. aureus strains, including RN4220, COL, USA300, and 
MW2, do not harbor highly similar prophages and need not be reengineered. Indeed, we have 
successfully constructed ultra-high density transposon libraries in several other S. aureus 
strains, including the USA300 and MW2 backgrounds, using the same tools described here 
(See Chapter 3). 
To realize the full potential of the phage-based delivery system for transposon library 
generation, we optimized both the donor constructs and the NGS sample preparation 
procedure. Now, transposon libraries can easily and reproducibly be created in S. aureus and 
sequenced using NGS. Moreover, because transposition efficiency is high and the NGS library 
preparation protocol is robust, we are able to multiplex several different transposon constructs in 
the same library. By adding a DNA barcode that specifies the gene expression regulatory 
element in the transposon construct, the roles of over- and under- expression of genes as well 
as inactivation can be assessed under a given condition during data analysis. For functional 
genomics and systems level analyses, the ability to capture over- and under-expression 
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genotypes is particularly important. For the first time we will be able to probe the relationship of 
essential genes to a given cellular process through over/under expression of essential genes. 
Gene essentiality at a set of temperatures 
 The power of the redesigned phage-based transposition system was demonstrated 
through the preparation of a transposon mutant library containing ~694,000 independent 
insertions in the S. aureus HG003 strain background. We identified essential genes at 30°C, 
and found good agreement between our essential gene list and two other lists published 
previously, although 63 genes previously annotated as essential were classified by us as 
domain essential (90, 146). Taking advantage of the fact that the phage-based transposon 
delivery method does not involve a high temperature plasmid curing step, we also carried out a 
study of the genetic factors involved in withstanding temperature stress. Many genes responsive 
to heat- or cold-shock have been identified in S. aureus based on transcriptome data (199), but 
a systematic and comprehensive analysis of the fitness of temperature-sensitive or resistant 
mutants has not been reported. We assessed the importance of each gene at five different 
temperatures based on enrichment or depletion of corresponding NGS reads. While reads per 
gene were largely unchanged compared to the 30°C control between 16°C, 23°C, and 37°C, 
reads for 119 genes were significantly affected at 43°C. 
 In addition to genes previously linked to heat shock and stress responses, we also found 
that many genes involved in cell envelope processes contribute to fitness at elevated 
temperature. Some genes in which reads were depleted at 43°C, such as pbp3 and pbp4, 
directly participate in crosslinking PG (172, 173), but others play less well understood roles in 
PG synthesis. For example, our studies have implicated rodA, mreC, and mreD in withstanding 
temperature stress, as reads in all three genes were depleted by ~50-fold at 43°C. In rod-
shaped organisms, different biosynthetic machines are dedicated to septal and side wall PG 
synthesis. RodA, MreC, and MreD are components of the machine that makes side wall PG, 
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while FtsZ, FtsL, and Div1B interact with FtsW as part of the PG biosynthetic machinery at the 
septum (178, 200-202). S. aureus is a coccoid organism and is not known to have distinct PG 
biosynthetic machines, and yet it contains genetic elements suggestive of both a primary PG 
biosynthetic machine and a secondary machine (203-205). In contrast to RodA/MreC/MreD, 
FtsZ, FtsL, Div1B, and FtsW were deemed essential from our analysis and are likely part of the 
predominant PG biosynthetic apparatus. RodA/MreC/MreD may be part of a secondary machine 
that takes on an important cellular role under environmental stress conditions. 
 We also identified mprF as important for survival at 43°C (16.7 fold depletion). MprF 
attaches lysine to phosphatidylglycerol in the cell membrane and is involved in cationic 
antimicrobial peptide resistance (190, 206). Mutants in mprF have not previously been shown to 
be temperature sensitive. Therefore, we constructed an mprF deletion strain and confirmed that 
it exhibited a pronounced growth defect at high temperature (Figure 11) as it ceased growing 
completely by mid-log phase. When these cells were plated and grown at 30°C, colonies did not 
grow, confirming that without the mprF gene, high temperatures are lethal. 
 In contrast to mprF, loss of another cell envelope gene, lyrA, conferred a growth 
advantage. Reads due to transposon insertion in this gene were substantially enriched at 43°C 
compared to 30°C. The growth advantage of a ΔlyrA strain compared to wildtype S. aureus was 
confirmed (Figure 11). Deletion of lyrA was previously shown to impart resistance to 
lysostaphin, an oligopeptide protease that cleaves Gly-Gly bonds in crosslinked PG (127, 207, 
208). Recent work has implicated LyrA in display of cell surface proteins (209, 210), but how its 
deletion confers increased growth rates at higher temperature is not clear. As an integral 
membrane protein, LyrA may regulate multiple aspects of cell envelope structure. Perhaps 
through the loss of interactions with other protein partners, the absence of LyrA induces a 
pleiotropic cell envelope phenotype capable of withstanding a variety of cell envelope stressors. 
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Small colony variants withstand heat stress 
 Transposon insertion mutants with reads mapping to genes that are part of the aromatic 
amino acid and menaquinol biosynthetic pathways were significantly enriched at 43°C (Figure 
12). The small colony variant (SCV) phenotype of menaquinone (vitamin K2) mutants in S. 
aureus has been well studied (211-218). The loss of electron shuttling redox cofactors in the 
electron transport chain induces a characteristic colony morphology, noted for its slow growth, 
lack of pigmentation, and pinpoint colony size (216, 218-222). This reduction in flux through the 
electron transport chain decreases ATP pools by diminishing respiration, which shifts global 
metabolism towards fermentation (220, 223). Emergence of SCVs is closely associated with 
persistent infections (224, 225), and SCVs are particularly resistant to many clinically used 
antibiotics (226, 227). Interestingly, our data revealed a marked growth advantage for 
menaquinone biosynthetic mutants at 43°C, including menD, menC, and menF. Mutations in 
these same genes have been associated with SCV formation in S. aureus clinical isolates (211, 
216). Elevated temperature clearly acts as a selective pressure that favors the emergence and 
propagation of SCVs in vitro. Recently, strains with increased resistance to vancomycin were 
found to emerge in an in vivo mouse model independent of vancomycin treatment (228). 
Whether the host pyrogenic response induces SCV selection in vivo, however, remains an 
outstanding question. 
Conclusion 
 In conclusion, we have developed a phage-based method for reproducibly creating high 
quality, ultra-high density transposon libraries in any S. aureus strain transducible by Φ11. We 
have optimized this platform to selectively remove transposon-plasmid junctions, and our 
solutions for reducing background due to these junctions are likely to be useful for other S. 
aureus strains, other bacterial species, and other transposon systems. By multiplexing bar-
coded donor constructs, we showed that we can make massive transposon mutant libraries and 
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identify insertions due to each type of donor. In this study, we used the data for the Blunt 
transposon construct to identify genes important for S. aureus survival at high temperatures. 
Furthermore, we found that SCV mutants are selected for under conditions of heat stress. This 
system, including the gene expression modulating transposon cassettes, will be useful for future 
functional genomics analyses aimed at establishing novel strategies for the development of 
antibacterial agents and garnering insights into the biology of S. aureus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 57 
 
Chapter 3. Using β-lactams to predict gene functions in MRSA  
 
This work was done in collaboration with Tim Meredith and Samir Moussa. 
 
3.1 Introduction 
  
 Both methicillin-resistance (MRSA) and methicillin-sensitive (MSSA) strains of S. aureus 
can be highly-virulent and cause life-threatening infections, but it is MRSA that causes the vast 
majority of lethal infections (136, 138). MRSA strains are defined as those that have acquired 
the SCCmec mobile genetic element encoding penicillin binding protein 2a (PBP2a), a 
transpeptidase with a low affinity for β-lactam antibiotics (except for ceftaroline and ceftobiprole) 
(229, 230). PBP2a can perform the peptidoglycan transpeptidation reaction, which crosslinks 
the glycan strands of peptidoglycan, when the other PBPs are inactivated by a β-lactam 
antibiotic (230, 231).  
 MRSA encodes four other PBPs besides PBP2a, three high molecular weight PBPs 
(PBP1, PBP2, and PBP3) and one low molecular weight PBP (PBP4) (232). However, only 
PBP1 and PBP2 are essential for cell survival (233). PBP2 is the only class A PBP, with both a 
transpeptidase and glycosyltransferase domain. In the presence of β-lactam antibiotics, it is 
thought that the glycosyltransferase domain of PBP2 cooperates with PBP2a to synthesize 
peptidoglycan (231, 234-236). PBP1 and PBP3 are class B PBPs with a transpeptidase domain 
and another domain of unknown function (232). PBP1 is thought to have roles in cell division at 
the cell septum that are independent of its transpeptidase activity, and it has been suggested 
that it may mediate important protein-protein interactions (237, 238). Its function appears to be 
especially important for survival with daptomycin treatment (239). PBP3 is non-essential and 
has homology to the PBPs in rod shaped bacteria that work in the PG synthetic complex with 
RodA, EzrA, and the MreBCD system to elongate the cell prior to cell division (173, 240-242). 
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PBP4 is the only low molecular weight PBP, and it has roles in creating highly-crosslinked 
peptidoglycan (172, 243, 244). Furthermore, this PBP is required for glycopeptide resistance 
and β-lactam resistance, especially in CA-MRSA strains (245-248). The cellular functions of 
these PBPs remain incompletely understood. 
 There are many differences between S. aureus strains. Though the acquisition of PBP2a 
distinguishes MRSA from MSSA, other factors encoded by both MRSA and MSSA strains are 
required to maintain this resistance (139). In addition, some MRSA strains are heterogeneously-
resistant to β-lactams, i.e, not all the cells in a culture express the same level of antibiotic 
resistance, while others have high and homogeneous resistance (249). To make matters more 
complex, there appear to be genetic differences between the MRSA strains that cause 
nosocomial infections and the MRSA strains most commonly acquired in the community (250). 
Furthermore, MW2 and USA300 are both community-acquired (CA) strains, but USA300 has 
become the predominant cause of MRSA infections in the United States and Canada 
suggesting that there are differences between CA-MRSA strains that impact their success as a 
pathogen (251-253).  
 We wanted to validate our claim that the transposition platform described in Chapter 2 
would function in any strain and to compare the response of MRSA strains to β-lactam 
treatment so that we could identify conserved β-lactam resistance factors. Therefore, we 
created transposon mutant libraries in the MW2 and USA300 strains.  Then, we treated the 
transposon libraries with three different β-lactams that preferentially bind different PBP proteins 
and performed Tn-Seq. Treating the library with different β-lactams allows us to learn more 
about the function of each PBP as well as factors that are required for β-lactam resistance in 
general. These experiments allowed us to discover a new interaction between two genes, lyrA, 
which is of unknown function, and lytD, which encodes a glucosaminidase.  
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3.2 Tn-Seq on MRSA strains identifies interacting proteins 
 
Creating transposon libraries in MW2 and USA300 
The platform for Tn-Seq described in Chapter 2 can in theory be used to create 
transposon libraries in any strain that can be transduced by Φ11 (132). Therefore, to better 
study MRSA strains, we decided to create transposon libraries in two community-acquired 
MRSA strains, MW2 and USA300. We chose these strains because they are two of the most 
clinically-relevant strains in the United States and because neither contains an endogenous 
Φ11 prophage, which we would need to delete before constructing a library (254, 255).  
We still had to make some modifications to these strains before attempting to create a 
library. The USA300 strain we used (USA300_TCH1516) has a plasmid encoding both 
erythromycin and kanamycin/neomycin resistance, pUSA300HOUMR (254). We use an 
erythromycin resistance marker to select for transposon integration and a kanamycin/neomycin 
resistance cassette on the transposase plasmid, so we require the parent background to be 
sensitive to these antibiotics. We removed this plasmid using homologous recombination with a 
pKFC plasmid (256) encoding an in-frame deletion of the erythromycin-resistance gene, and 
isolation of colonies that had lost the unstable co-integrated plasmid (Figure 16A). We created a 
transposon library in this resulting strain as described in Chapter 2 (132). On the other hand, 
MW2 did not have intrinsic resistance to these antibiotics, but the efficiency of transposition was 
lower than expected (Figure 16B). We hypothesized that this was due to the fact that MW2 is 
part of a different clonal complex than the other strains. MW2 is a part of CC1 while USA300 
and HG003 belong to CC8 (254, 255, 257). The methylation system (hsdMS) of S. aureus 
strains belonging to different clonal complexes recognizes and methylates different sites (258). 
Therefore, when we make the phage lysate in a RN4220 which belongs to CC8 and use it to 
transduce the transposon into MW2 which belongs to CC1, MW2 recognizes the DNA as foreign 
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and subsequently digests the majority of it with restriction enzymes before the transposon can 
insert into the genome. Knocking out the hsdR restriction system in MW2 (Figure 16C) (259-
261), restored the expected efficiency of transposition, and we were able to use this strain to 
make a transposon library. Both of these libraries contained the same six donor constructs 
described in Chapter 2 (132). In case the hsdR knockout affected growth with β-lactam 
treatment, we created a control library in the WT MW2 strain using only the Blunt transposon 
construct as efficiency of transposition was too low to use all six transposon constructs. For this 
work, we concentrated on analyzing only the data from the inactivation constructs.  
 
Figure 16. Two MRSA strains were modified for creating transposon libraries. (A) 
USA300_TCH1516 carries two additional plasmids, one of which encodes resistance to 
erythromycin and kanamycin/neomycin, pUSA300HOUMR (254). This plasmid was removed via 
homologous recombination and curing of the co-integrated plasmid. (B) The efficiency of 
transposition for MW2 was lower than expected. Bars 1-4 show transposition effieciency for 
RN4220 and HG003, while bars 5 and 6 show approximately a 10 fold decrease in transposition 
efficiency for MW2. Continued page 61. 
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Figure 16 continued. This was calculated by comparing the number of erythromycin-resistant 
colonies produced from the same amount of transposon-carrying Φ11 phage. To correct this low 
efficiency of transposition, the hsdR restriction system was removed via homologous 
recombination. Upon hsdR deletion, efficiency of transposition was within the expected range 
(bars 7 and 8). 
  
Treatment of MRSA transposon libraries with β-lactam antibiotics 
           We chose to treat the transposon library with three different β-lactams that have affinities 
for different PBPs. Mecillinam binds to PBP3, cefoxitin has highest affinity for PBP4 but can also 
bind PBP2, and oxacillin has a relatively high affinity for PBP1, PBP2, and PBP3 (Figure 17A) 
(233). We wanted to treat the library with mecillinam and cefoxitin concentrations where only 
one PBP was inhibited so that we could learn more about the cellular roles of these non-
essential PBPs. We decided to treat the library with low (0.1µg/ml), medium (1ug/ml), and high 
(10ug/ml) concentrations of oxacillin. The data from the transposon libraries sequenced with low 
concentrations is useful for identifying factors essential for β-lactam resistance because cells 
with transposon insertions in genes essential for oxacillin resistance will die and drop out of the 
library, resulting in fewer reads mapping to these genes compared to the untreated control. 
Moreover, we will likely not identify many mutations conferring high-level resistance to oxacillin 
when treating the transposon library at low concentrations of oxacillin because there is not 
enough selective pressure. However, at the higher oxacillin concentrations, there will be more 
selective pressure, and there will be few mutants that can survive the antibiotic treatment. In this 
case, these high fitness mutants will grow better the other mutants in the library, and more 
reads should map to these genes compared to the untreated control. Therefore, at the higher 
oxacillin concentrations, it will be easier to identify mutations that can increase resistance to the 
β-lactam antibiotics.  
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 Traditionally, β-lactam concentrations where only one PBP is inhibited are identified by 
performing competition experiments using bocillin, a fluorescent β-lactam. However, while these 
experiments work well using membrane preparations, we wanted to identify β-lactam 
concentrations where the PBP of interest was inhibited in living cells. We attempted to perform 
the bocillin competition experiments using cells in mid-exponential phase, but results were 
inconclusive. Therefore, we devised an alternative approach. We identified the appropriate 
concentration for mecillinam treatment using data from the temperature screen in Chapter 2 
(132). We predicted that pbp3 would be a temperature-sensitive gene, and therefore, inhibition 
of PBP3 might also confer the same temperature-sensitive phenotype. Therefore, we compared 
the growth at 43°C of a pbp3 mutant (deletion mutant in MW2 from Ambrose Cheung, and 
inactivation mutant in USA300 from the Nebraska library) (130, 247) to the growth of a WT 
strain at 43°C treated with different concentrations of mecillinam. Then, we identified the 
concentration of mecillinam that phenocopied the growth defect of the pbp3 mutant (Figure 
17B). For pbp4, it is known that inactivating this gene sensitizes cells to β-lactam treatment. 
Therefore, we grew MW2 and USA300 with sub-MIC concentrations of oxacillin and increasing 
concentrations of cefoxitin, and compared their growth to pbp4 mutants (deletion mutant in 
MW2 from Ambrose Cheung, and inactivation mutant in USA300 from the Nebraska library) 
(130, 247). We identified the concentration of cefoxitin that best phenocopied the pbp4 mutants 
(Figure 17C). The transposon libraries were treated with these concentrations of oxacillin, 
mecillinam, and oxacillin, and the sites of transposon insertion were sequenced using Tn-Seq 
as described in Chapter 2.  
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Figure 17. The transposon libraries were treated with three different β-lactams with 
affinities for different PBPs. (A) Both the MW2 and USA300 libraries were treated with three 
different β-lactam antibiotics with affinities for different PBPs (233). (B) Appropriate 
concentrations for mecillinam treatment where only PBP3 is inhibited were identified by 
ascertaining the concentration at which mecillinam treatment phenocopies a pbp3 deletion 
strain when both are grown at high temperatures. (C) The appropriate concentration of cefoxitin 
was chosen in a similar way, except that instead of looking for sensitivity to high temperatures, 
we looked for a concentration of cefoxotin that could potentiate cells to oxacillin in the same way 
that a pbp4 deletion did. We have noticed that this strain of USA300 is somewhat more 
sensitive to oxacillin that MW2. At similar oxacillin concentrations, it grows to a much lower 
OD600 than MW2. However, we can still identify an oxacillin concentration where the pbp4 
mutation is lethal, and we can identify a cefoxitin concentration that phenocopies the pbp4 
mutant.  
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Identification of patterns among resistance factors 
 We analyzed the data as described in Chapter 2 using only the Blunt transposon 
construct and identified statistically-significant differences in number of reads mapping to each 
gene using a 10-fold cutoff (ratio in reads/gene > 10 or < 0.1) as a measure of practical 
significance (Appendix G) (132). We then manually curated the list to remove genes where 
there were a low number of reads in both the control and the oxacillin-treated condition. This 
resulted in 41 hits in USA300, 2 hits in WT MW2, and 5 hits in MW2 ∆hsdR when the libraries 
were treated with 0.1µg/ml oxacillin. A greater number of hits in one strain suggests that that 
strain is more sensitive to oxacillin treatment. We have observed that though these strains have 
the same growth rate normally, when treating with the same concentration of oxacillin, USA300 
grows more slowly and to a lower OD than MW2 (Figure 17C). At 1µg/ml and 10µg/ml oxacillin, 
there were very few mutants that survived.  Because transposon insertions in so many genes 
were substantially depleted, Appendix G only lists the genes with an increase in number of 
reads/gene for these two conditions. 
Next, we compared the mutations that conferred an increase or decrease in resistance 
to oxacillin to see if we could use the ∆hsdR library, which had a higher efficiency of 
transposition, as a parent strain for creating transposon libraries. With the exception of aapA, an 
amino acid permease, all the hits in the MW2 libraries were the result in an increase in number 
of reads that mapped to the gene. To better compare the two MW2 libraries, we needed more 
genes with a decrease in number of reads after oxacillin treatment. Therefore, we removed the 
p-value cutoff for depleted genes in the MW2 libraries and gained 11 and 2 hits for the WT and 
∆hsdR libraries respectively. We compared the data from both MW2 libraries with each other to 
see if the hsdR deletion had any effect by plotting the number of reads that map to each gene in 
the MW2 WT and ∆hsdR libraries for every gene in the untreated condition and the unique set 
of hits when treated with 0.1µg/ml oxacillin (Figure 18). We observed a linear pattern with a R2 
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equal to 0.9815 with oxacillin treatment, suggesting that the hdsR deletion strain and the WT 
strain are very similar, and we can use the higher efficiency ∆hsdR strain be used to make 
transposon libraries.  
 
 
Figure 18. hsdR deletion does not have a major effect on the β-lactam resistance factors 
of MW2. The number of reads that map to each gene for the WT and ∆hsdR libraries were 
normalized to 5 million total reads per library and plotted against each other in the untreated 
condition (left graph). The same was done for the genes that were hits in either the WT or the 
∆hsdR library (right graph). In general, the pattern is linear in the untreated condition suggesting 
that there are no major differences in essential genes when hsdR is deleted, and the same 
trend was observed with the hits when treating with oxacillin (R2 = 0.9815), suggesting that 
there are no major differences β-lactam resistance factors as well.  
 
 To gain a better understanding of the differences between MW2 and USA300, we 
identified the top 20 genes that conferred an increase or decrease in fitness when inactivated in 
the MW2 libraries and compared those to the top 20 genes in the USA300 library (Table 4). 
Surprisingly, there was only one gene in common between them, yjbH. YjbH is a ClpXP adaptor 
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protein which is known to have roles in disulfide stress and β-lactam resistance (262, 263). 
However, there were two other pathways which were represented among both libraries. 
Mutations in both purine biosynthesis and menaquinone biosynthesis are known to increase 
resistance to β-lactam antibiotics, and in both libraries, we see an increase in reads mapping to 
genes in these pathways (Table 4). To identify resistance factors in common between these two 
strains, we would have to treat the MW2 library at a slightly higher oxacillin concentration, so 
that the number of hits is closer to the number of hits found when we treated with USA300. 
These experiments confirm that the genes required for MRSA survival of different stress 
responses can vary between different strains. In fact, we were surprised by the extent of the 
differences, and these experiments have formed the basis of a comparative genomics approach 
that other members of the lab are now using to better understand the differences between these 
as well as other hospital-acquired MRSA strains.  
 
 
We then we identified genes with enriched or depleted reads in common among 
antibiotic treatments from each library. Each β-lactam we treated the transposon libraries with 
has affinity for different PBPs. Mecillinam has affinity for PBP3, cefoxitin has highest affinity for 
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PBP4, and oxacillin has similar affinities for PBP1, PBP2, and PBP3. Identifying transposon 
mutants that are only sensitive or resistant to cefoxitin or mecillinam treatment allows us to 
identify factors that are important for PBP3 or PBP4 function and may help us better understand 
the cellular roles of these PBPs. Because oxacillin targets multiple PBPs, we are more likely to 
discover genes that generally sensitize to β-lactams with this treatment. Therefore, we looked 
for genes with an increase or decrease in transposon reads in any subset of these treatments. 
We observed an interesting pattern in the data from the USA300 library. Reads mapping to four 
genes, tarO, mnaA, lyrA, and lytD, were depleted with oxacillin and mecillinam treatment but 
were enriched with cefoxitin treatment (Figure 19A). We confirmed that the increase in 
transposon insertions was not due to PCR or Bowtie “jackpotting”, which results in one TA site 
with many reads mapping to it, by plotting the number of reads per TA site in the gene of 
interest (Figure 19B). While lyrA, lytD, and mnaA all had more reads mapping to the entire gene 
with cefoxitin treatment, reads in tarO only mapped to the promoter region and the end of the 
gene. Though tarO is nonessential, it has a significant growth defect where it generally grows to 
only an OD of around 0.8, and it has a plating defect where the number of cfu’s observed is 
always less than the number of cfu’s plated. Because of these defects, there are essentially no 
knockout mutants of tarO present in the library. However, transposon insertions in the promoter 
region have the ability to interfere with a gene’s native promoter such that the gene is 
downregulated, and transposon insertions near the end of a gene could decrease the activity of 
the final protein product. Therefore, it is likely that downregulating tarO or decreasing the activity 
of TarO confers the fitness advantage with cefoxitin treatment that is observed as an increase in 
number of reads in these regions. An increase in number of reads mapping to a gene compared 
to a control signifies that inactivation of the gene confers either a protective effect or less of a 
penalty compared to every other mutant in the library allowing it to grow better than the other 
mutants.  
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Figure 19. A unique sensitivity when treating with a panel of β-lactams . (A) We looked for 
genes where the number of reads mapping to the gene was increased or decreased with at 
least two of the different β-lactam treatments, and we found four genes that when inactivated, 
produce a similar pattern of resistance and sensitivity: lyrA, lytD, tarO, and mnaA. Continued 
page 69. 
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Figure 19 continued. These plots show this pattern after normalization of the data to the same 
total number of reads. Transposon insertions in these genes appear to confer sensitivity to 
mecillinam and oxacillin (fewer reads than the control), but resistance to cefoxitin (more reads 
than the control). (B) We confirmed that the increase in number of reads in these genes was not 
due to “jackpotting”, where PCR or mis-mapping results in one TA site with many reads 
mapping to it. No genes showed evidence of “jackpotting”.  
 
TarO catalyzes the first step in wall teichoic acid biosynthesis and it can be inhibited by 
tunicamycin (264, 265), and mnaA is a UDP-GlcNAc epimerase that makes UDP-ManNAc, 
which is used by another enzyme in the WTA biosynthetic pathway (266). LyrA, also known as 
spdC, was initially discovered and named for its ability to confer lysostaphin resistance when 
inactivated (127). It is a large integral membrane protein with eight transmembrane domains 
and a large intracellular region at its C-terminus. It most closely resembles CAAX proteases that 
are involved in membrane anchoring of proteins in eukaryotes (267). However, though lyrA has 
all the conserved residue thought to be the active site residue for the CAAX proteases (127, 
268), mutating this residue does not affect its lysostaphin-sensitive phenotype, and LyrA is not 
thought to have protease activity (127).  LyrA mutants are also sensitive to tunicamycin (132). 
LytD (also known as sagB) was recently shown to be a β-N-glucosaminidase (197). This class 
of enzymes digests the cell wall between the GlcNAc and MurNAc sugars.  
An increased number of reads in a condition compared to the control suggests that 
inactivation of that gene confers either an increase in fitness compared to the other mutants in 
the library, or the transposon insertion confers less of a fitness disadvantage in the treated 
condition than the control. A fitness advantage could be a result of induction of stress 
responses, removal of a compound’s target, or alteration of the flow of metabolites in a pathway. 
In this case, the concentration of cefoxitin used was non-lethal and cefoxitin’s target, PBP4 is 
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non-essential, which made it surprising that there was enough selective pressure to produce 
this increase in number of reads. We hypothesized that some or all of these genes may 
physically interact as part of a multi-component machine. In this case, when one component of 
the machine is missing or inhibited, the fitness defect would be greater than when the machine 
is completely inactivated. To determine whether any of these proteins interacted with each 
other, Samir Moussa (a former post doc in the lab) performed co-immunoprecipitation 
experiments, crosslinking c-Myc-tagged LyrA to the proteins that it interacts with using DSP 
(Figure 20). After purification of the interacting proteins and purification using SDS-Page (this 
step also cleaves the crosslink), we observed three bands in both the uncrosslinked and 
crosslinked conditions (Figure 20). These proteins were identified by LC-MS/MS, and the 
second most abundant protein in the middle band with or without DSP was LytD (Table 5). 
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Figure 20. LyrA-interacting proteins were identified using co-immunoprecipitation. A c-
Myc tagged copy of LyrA (CPH for CAAX Protease Homologue) was expressed in a ∆lyrA 
strain. A crosslinker, DSP, was added to crosslink LyrA to any other protein it interacts with. 
Cells were disrupted and membrane proteins were solubilized. These solubilized proteins were 
purified over a column containing the c-Myc receptor. Specifically-interacting proteins were 
eluted, purified using SDS-PAGE which also cleaves the crosslinker, trypsin digested, and 
identified with LC-MS/MS as previously described (269). Addition of the crosslinker did not 
result in more bands, and the proteins identified by LC-MS/MS were very similar with and 
without DSP (Table 5).   
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Characterization of lytD 
 If lyrA and lytD physically interact, their phenotypes to a variety of stressors should be 
similar. Though there are many unanswered questions about the role of lyrA, we do know some 
of the phenotypes that result from deleting this gene. We know that ΔlyrA strains are resistant to 
lysostaphin (127), sensitive to tunicamycin (95), and that when it is inactivated, sortase-
anchored proteins are not properly attached to the peptidoglycan (209). Using a lytD transposon 
mutant from the Nebraska library, we confirmed that strains without functional lytD are also 
resistant to lysostaphin and sensitive to tunicamycin (Figure 21). Furthermore, overexpression 
of LytD in the ∆lyrA background rescues the ∆lyrA strain from tunicamycin treatment, and 
overexpression of LytD in the WT background sensitizes to lysostaphin treatment. This 
suggests that LyrA may be positivity regulating the activity of LytD, and the phenotype of ΔlyrA 
could be due to misregulation of LytD.  
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Figure 21. Inactivation of lytD phenocopies lyrA deletion. Plate dilution spotting assays 
were used to test sensitivity of tn::lytD to lysostaphin and tunicamycin. Both ∆lyrA and the lytD 
mutant were sensitive to tunicamycin and resistant to lysostaphin. Overexpression of LytD in 
WT increases sensitivity to lysostaphin, and overexpression of LytD when lyrA is deleted 
rescues the sensitivity of lyrA to tunicamycin. 
 
 ΔlyrA strains are reported to have more and thicker cross walls when viewed using TEM 
(transmission electron microscopy) (209). We also see an increased number of cross walls in 
the lytD mutant as well as a WT strain treated with cefoxitin at the same concentration with 
which we treated the transposon library, though this could result from a slowing of cell division 
when PBP4 is inhibited (Figure 22). Moreover, in the tn::lytD strain, we observed many pairs of 
dividing cells that are almost entirely separated, but still slightly attached at one end (Figure 22 
red arrows). This suggests that lytD may have an important role in the final stages of cell 
separation. This same phenotype was also observed when WT cells were treated with cefoxitin, 
suggesting that inhibition of PBP4 can also produce the same phenotype.  
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Figure 22. Inactivation of lytD results in cells with an increased number of septa. WT cells 
with and without cefoxitin treatment and tn::lytD cells were examined using TEM. 
Representative photos of WT (A) and tn::lytD (B) cells at 15,000x magnification are shown. We 
noticed that many of the tn::lytD cells had cell separation defects as they were still attached to 
each other after division had concluded. (C) To quantify this difference, we counted the total 
number of cells, the number of cells with septa, and the number of cells not currently dividing 
but still attached to each other in TEM images taken at 4,000x magnification (images not 
shown). Then, we calculated the fraction of the total number of cells with each phenotype. We 
found that many more tn::lytD and cefoxitin-treated WT cells had septa or were still attached 
suggesting that cell division and separation are slowed.  
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When lyrA is inactivated, there is a significant decrease in the amount of sortase-
anchored surface proteins attached to the cell surface (209). Sortase-anchored surface proteins 
contain an LPXTG cell wall sorting signal which directs it to the cell wall where it is covalently-
attached by a sortase (270, 271). We investigated whether lytD mutants also had this defect 
using Staphylococcal surface protein A (SspA) as a marker for proper protein secretion. SspA is 
an extraordinarily-abundant sortase-anchored surface protein with a YSIRK-G/S signal (271, 
272). These signals direct proteins to the cell septum where they are secreted by the Sec 
system and attached to the cell surface by a sortase. We used antibodies for this protein 
attached to gold nanobeads purchased from AbCam to observe the localization of SspA in WT 
as well as ΔlyrA and the tn::lytD strains (Figure 23). Using TEM, we observed large amounts of 
SspA on the surface of WT cells, often limited to a few different locations across the surface of 
the cell (Figure 23, red arrows). In the ΔlyrA strain, we sometimes see SspA, but when we do, 
there is much less than in WT (Figure 23, red arrows), and in the lytD mutant, we could not find 
evidence for any secreted SspA (Figure 23). lytD apparently plays a very important role in 
sortase-anchored surface protein export and/or attachment.  
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Figure 23. Cells without LyrA or LytD have defects in surface protein export/attachment. 
Antibodies to SspA were used in combination with antibodies conjugated to gold nanoparticles 
to assess how much SspA was attached to the cell surface in WT, ∆lyrA, and tn::lytD strains 
using TEM. Representative views of these cells are shown. WT cells had large clumps of SspA, 
often at the site of cell division (1 and 2), ∆lyrA had fewer and smaller clumps of SspA (3 and 4), 
and Tn:lyrA had no detectable SspA (5 and 6). The red arrows point towards clusters of SspA 
found on the outside of WT and ∆lyrA strains.   
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 Sortase-anchored surface proteins have an LPXTG motif and are thought to be attached 
to the peptide chains of growing peptidoglycan by the sortase enzymes (273, 274). In the 
absence of lyrA, there is a slight increase in resistance to vancomycin which binds to the D-Ala-
D-Ala portion of Lipid II, the peptidoglycan precursor (209). Without sortase-mediated protein 
attachment to the cell wall, there may be more Lipid II available for vancomycin to bind, resulting 
in more vancomycin required to inhibit peptidoglycan biosynthesis. This was also true for the 
lytD mutant (Figure 24), providing evidence that lytD inactivation may be inhibiting protein export 
through the same mechanism as lyrA deletion 
 
Figure 24. tn::lytD mutants are more resistant to vancomycin than WT. lyrA mutations are 
known to confer a small increase in resistance to vancomycin possibly by increasing the amount 
of extracellular lipid II available for binding to vancomycin (209). We grew WT (TM283) and 
Tn::lytD strains in 96 well plates overnight with vancomycin. We found that Tn::lytD is more 
resistant to vancomycin than WT.  
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3.3 Discussion 
 
Tn-Seq in MRSA strains 
 It is very important to perform experiments in the appropriate strain. In our case, as β-
lactam resistance is the key characteristic of the epidemic MRSA strains, it makes sense to 
perform Tn-Seq on MRSA strains. Fortunately, the transposon sequencing platform we have 
developed allows us to do this while only making minor modifications to the WT strains (254, 
255), and these modifications do not seem to affect the resistance factors identified. Another 
advantage of performing these screens in MRSA strains is that in general, MRSA strains are 
better able to survive stress, meaning that fewer genes are essential in the control condition. A 
previous member of the Walker lab, John Santa Maria, performed a Tn-Seq experiment, where 
he identified the genes which became essential in the absence of wall teichoic acids, by treating 
a transposon library with tunicamycin and performing Tn-Seq (95). This was how we knew that 
lyrA inactivation conferred a tunicamycin-sensitive phenotype. However, in the strain that screen 
was performed in, HG003, lytD inactivation seems confer a significant fitness defect because 
few reads map to this gene. If few reads map to a gene in the control, it is very difficult to 
identify significant depletions in read number in the experimental condition. Because we 
performed these experiments in MRSA strains, which are better at surviving cell envelope 
stress, we were able to identify lytD inactivation as sensitizing to oxacillin and mecillinam.  
Interacting genes have the same resistance and sensitization pattern 
 We identified four genes, lyrA, lytD, tarO, and mnaA, that had an increase in number of 
reads with cefoxitin treatment, but a decrease in number of reads with mecillinam and oxacillin 
treatment. There are many reasons why genes could have the same resistance pattern to these 
β-lactams. They could be in the same pathway or in parallel pathways, but in this case, it 
appears that at least two of these genes have a direct physical interaction. There are many 
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hypothetical genes in S. aureus, and it is likely that many of them have important roles in 
virulence and antibiotic resistance. This work shows that it is possible to predict interacting 
genes based on the similarity of the resistance and sensitization pattern across a panel of 
antibiotics. It is possible that this approach could be applied more generally across any 
unstudied gene in the genome, though it is likely that we would need more antibiotics with more 
varied targets in order to identify relevant fitness patterns for other genes that do not have roles 
in PG synthesis or cell division.  
Model for LyrA and LytD relationship 
 We believe that LyrA is likely regulating the activity of lytD, though we do not know the 
mechanism by which it regulates its activity. One of the major phenotypes of both of these 
mutants is that they are defective in the export of sortase-anchored surface proteins (197, 209). 
We can hypothesize a model for this interaction and how it is involved in sortase-anchored 
surface protein export based on the data described above (Figure 25). This model will help us 
design future experiments. LyrA is known to localize to the septum (127, 209), and so LytD may 
localize there as well. TarO is required for proper localization of PBP4 to the cell septum, and 
teichoic acids control the localization of the autolysin, Atl (188, 275). It is possible that TarO or 
teichoic acids could control the localization of LyrA and LytD to the septum as well. There, LyrA 
activates LytD to cut the glycan strands. LytD is known to control the length of the glycan 
strands that are used to create peptidoglycan (197). Glycan strands of a certain maximum 
length may be necessary for secreted proteins to be exported to the surface of the cell and/or 
attached to the outside of the cell wall by the sortase enzymes. A major cell separation enzyme, 
LytN, has the YSIRK-G/S motif, meaning that it is secreted at the cross wall (276). If its export is 
inhibited when lytD or lyrA is inactivated, it may explain the defect in cell separation we 
observed via TEM.  
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Figure 25. Hypothetical model for LyrA and LytD roles in cell separation. New wall teichoic 
acids are synthesized at the septum (1). TarO and teichoic acids are required for proper 
localization of PBP4 and Atl to the cell septum, and they may recruit other PG synthesis and cell 
division factors as well, including LyrA and LytD (2). The secretory machinery exports YSIRK-
G/S proteins at the cell septum. LyrA may activate LytD to cut glycan strands. Perhaps long 
glycan strands inhibit surface protein secretion and/or attachment to the cell wall. LytN is an 
example YSIRK-G/S-containing protein, which is essential for proper cell separation (3). The 
proper secretion of LytN allows for successful cell separation (4).  
 
Another major outstanding question is how inhibition of PBP4 in combination with lyrA or 
lytD confers an increase in fitness compared to inhibition of PBP4 alone. These results suggest 
that when PBP4 is inactivated by cefoxitin, the presence of active LyrA and LytD confers a 
fitness defect. PBP4 is required for highly crosslinked peptidoglycan, and when inactivated, the 
cell wall is weakened (Figure 26A and B) (231). In the absence of LytD, the glycan strands are 
longer (Figure 26C) (197). Perhaps longer glycan strands inhibit protein export, but perhaps 
they can restore some of the cell wall’s strength when PBP4 is inactivated (Figure 26C and D). 
This could explain why inactivation of genes required for proper LytD activity can result in an 
increase in number of reads (increased fitness) in the presence of cefoxitin. This model (Figures 
25 and 26) has allowed us to develop hypotheses for further experimentation. 
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Figure 26. Cefoxitin and LytD affect the structure of the cell wall. A model of peptidoglycan 
in different strains/conditions is shown. Glycan strands are shown as black hexagons while 
crosslinking is shown as red lines between glycan strands. (A) In a WT cell, LytD controls 
glycan strand length and PBP4 creates highly-crosslinked peptidoglycan. (B) When inactivated 
by cefoxitin, PBP4 can not create highly-crosslinked peptidoglycan, weakening the cell wall 
(231). (C) LytD controls glycan strand length (197), and when inactivated by a transposon, the 
glycan strands will be longer. (D) Perhaps these longer glycan strands can make up for the 
decreased crosslinking resulting from cefoxitin treatment, restoring the strength of the cell wall.  
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Future Directions 
Currently, other members of the lab (Katie Coe and Kaitline Schaefer) are studying 
LytD’s enzymatic activity in the presence and absence of LyrA, to see whether LyrA has an 
effect on LytD activity. It is known at PBP4, TarO, and LyrA localize to the cell septum, but in 
order to confirm the model above, we need to show that LytD does as well, which can be done 
using fluorescence microscopy. We also need more evidence to prove that these proteins 
interact. Furthermore, we have done co-immunoprecipitation using LyrA, but perhaps co-
immunoprecipitations using LytD would identify more proteins that interact with this complex.  
Conclusion 
 In conclusion, we were able to show that the method described in Chapter 2 for making 
and sequencing transposon libraries (132) can be applied to other strains of S. aureus, including 
multiple MRSA strains. We showed that knocking out a restriction system from MW2 increases 
the transposition efficiency when transducing from a different clonal complex, but does not 
affect oxacillin resistance factors. Therefore, this strain is a suitable background for transposon 
library generation. Using cefoxitin, a PBP4-selective β-lactam, as a probe, we identified a 
possible interaction between LytD and LyrA, and crosslinking experiments confirmed that these 
proteins physically interact. Both proteins appear to be important for sortase-anchored surface 
protein export. More work is needed to understand this interaction, but the work so far has 
allowed us to build a model from which we can design experiments. Finally, we have outlined 
the beginning of a method for predicting the function of hypothetical genes. By sequencing 
transposon libraries treated with a wider variety of antibiotics and computationally automating 
the way similar resistance and sensitization patterns are predicted, we may be able to predict 
functions, pathways, and even physical interactions for any hypothetical gene. 
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Chapter 4. Tn-Seq as a tool for studying antibiotics and antibiotic-resistance 
 
We anticipate that contents of this chapter will be published in a journal prior to the publication 
of this dissertation. 
This work was done in collaboration with Mithila Rajagopal and Melissa Martin. 
 
4.1 Introduction 
 
Antibiotic-resistance 
Antibiotic-resistant bacterial infections have recently become a global public health 
crisis, but antibiotic resistance was observed in the clinic only a few years after the first antibiotic 
was introduced (4). This is due to the fact that in the early years of antibiotic discovery, 
pharmaceutical companies developed many new antibiotics. The golden age of antibiotic 
discovery lasted from about 1950 to 1960, and in fact, about half of the antibiotics in use today 
were discovered during this time (22). Since then, however, development of new antimicrobials 
has slowed, while bacteria have developed resistance to every clinically available antibiotic 
(277).  
Different antibiotics target different cellular processes by interfering with the function of 
an essential gene or cellular structure. Some of the cellular processes that are commonly 
inhibited by antibiotics include cell wall biosynthesis, protein synthesis, DNA/RNA synthesis, 
and the cell membrane. Inhibition of these processes normally causes cell death, but bacteria 
have been able to evolve and/or acquire new strategies to increase their resistance to 
antibiotics. Furthermore, bacteria often have innate mechanisms for up- or down-regulating 
genes that help defend against antibiotic treatment.  
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Tn-seq for studying intrinsic resistance factors 
S. aureus is a gram-positive pathogen whose ability to evade both antibiotics and the 
human immune system contributes to the intractability of its infections. Many factors, both 
internal and acquired, contribute to its ability to survive stressful conditions. S. aureus can 
become resistant to antibiotics by acquiring resistance factors from other species via horizontal 
gene transfer. For example, VRSA strains have acquired the VanA gene cluster from 
Enterococcus faecalis, which provides vancomycin-resistance to S. aureus. In contranst, there 
can be internal factors, called intrinsic resistance factors, that play a role in the normal 
physiology of the bacterium as well as contributing to antibiotic resistance. These factors are 
usually common to both MRSA and MSSA strains. 
 Individual studies have highlighted the importance of specific intrinsic factors to certain 
antibiotics. For instance, MprF, a protein that catalyzes the synthesis and subsequent flipping of 
lysl-phosphatidylglycerol, is a well-studied intrinsic factor, that contributes to resistance to 
cationic antimicrobial peptides, daptomycin, and some aminoglycosides (206, 278, 279).  Also, 
in MRSA strains, effective pharmacological inhibition of TarO, the first step in wall teichoic acid 
biosynthesis, with tunicamycin restores full sensitivity to β-lactams even though the β-lactam 
resistance gene, pbp2a, is present (189, 265). These examples show that there are 
opportunities to mitigate antibiotic resistance by targeting intrinsic resistance factors. Therefore, 
it is important to identify the full repertoire of intrinsic factors that affect susceptibility to different 
classes of antibiotics. 
Many intrinsic resistance factors in S. aureus have been identified by screening mutant 
libraries for increased susceptibility to a specific antibiotic (51, 280), but there has yet to be a 
systematic analysis of genes that can confer resistance to multiple classes of antibiotics in S. 
aureus. A global view of all intrinsic resistance factors in S. aureus and their effects on 
antibiotics of various classes will enable further understanding of the bacterial stress response. 
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A better understanding of these factors will allow for the nomination of candidates for potentiator 
development, which is particularly important in this "post-antibiotic era".  
Recent advances in next-generation sequencing (NGS) have made possible systems-
level approaches to identify genes that confer protection to various stresses (89, 132). In this 
work, we use such an approach to identify intrinsic resistance factors that are important for 
resistance to six clinically relevant antibiotics having different modes of action. We highlight 
those that are important across multiple classes of antibiotics and also note factors that confer 
resistance to certain antibiotics but sensitivity to others. Furthermore, we have characterized 
two new intrinsic resistance factors for multiple antibiotics which may be important for the 
cellular response to envelope stress.  
Tn-Seq for predicting mechanism of action 
We expanded the panel of antibiotics tested to twenty-five antibiotics to use Tn-Seq for 
predicting mechanism of action of a new antibiotic. Antibiotics target essential cell systems, but 
not all essential genes make good targets. Even though a gene may be essential, resistance 
may evolve quickly or it may be difficult for the antibiotic to gain access to the target because of 
intrinsic efflux genes or membrane permeability issues (281-283). Furthermore, if the antibiotic 
targets a gene with homology to the human version of that gene, off-target effects in the human 
body may be a problem. Therefore, before an antibiotic can go in to the clinic, it is helpful to 
know the mechanism by which it kills the cell. To do this, researchers must figure out the target 
of the antibiotic. This process can be very lengthy and complex, adding to the cost of developing 
new antibiotics.  
 There are a variety of tools that scientists can use to predict mechanism of action. These 
include, but are not limited to, cytological profiling (284), macromolecular radiolabeling (285), 
gene expression profiling (286), and proteomics analyses (287). Furthermore, with the advent of 
next-generation sequencing and the increasing utility of applying machine learning algorithms to 
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biology, computational approaches for mechanism of action prediction are becoming more 
common. One method uses an artificial neural network and an antimicrobial peptide’s predicted 
physicochemical properties to predict that peptide’s mechanism of action (288). However, this 
prediction algorithm only works for antimicrobial peptides. Another method, the Antibioticome, 
utilizes a retrobiosynthetic algorithm along with whole genome analysis to predict a natural 
product’s mechanism of action, but this method would not work with a synthetically-derived 
antibiotic (289). Finally, another method was recently published that uses a random-forest 
classifier with a Bayesian learner to predict the mechanism of action of drugs against 
pathogenic Saccharomyces cerevisiae based on their chemical-genetic interactions (290). In 
addition, this method can predict whether combinations of drugs would synergize or antagonize. 
This method is powerful, but unless your drug is active in yeast (many antibiotics are not), you 
cannot use it to predict mechanism of action. Therefore, a computational method that can be 
used with any class of antibiotic to predict the mechanism of action in bacteria could be very 
useful for antibiotic development. 
Here, we use our high-efficiency phage-based transposon library sequencing platform 
(132) to develop a two-pronged approach for mechanism of action determination in S. aureus. 
S. aureus and its methicillin-resistant relative, MRSA, are dangerous pathogens found as both 
nosocomial and community-acquired infections (136). We have created ultra-high density 
transposon libraries in S. aureus that have the ability to upregulate as well as inactivate any 
gene in the genome (See Chapter 2) (132, 133). In order to develop a method for predicting 
antibiotic mechanism of action in this strain, we have treated a transposon library made in a 
methicillin-sensitive (MSSA) strain with twenty-five different compounds, including clinically-
used antibiotics, agricultural antibiotics, and validated chemical probes, and sequenced the 
transposon insertion sites using Tn-Seq. The phage-based transposition system utilized here is 
highly-efficient, allowing us to multiplex different transposon constructs together as described in 
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Chapter 2. These transposon constructs contain outward-facing promoters of different 
strengths, and depending on the location and orientation of transposon insertion, they have the 
ability to constitutively upregulate nearby genes. This is useful to us because target-
upregulation is a common mechanism of antibiotic resistance (135). The first method of target-
prediction relies on the outward-facing promoters present in our platform to identify upregulated 
genes. The second method utilizes a machine learning algorithm that compares the mutations 
conferring resistance and sensitivity to a new antibiotic with the mutations conferring resistance 
and sensitivity to a panel of 25 known antibiotics. Antibiotics with similar mechanisms have 
similar resistance factors, so by identifying a known antibiotic with similar resistance factors, we 
are able to predict the new antibiotic’s mechanism of action. This strategy has allowed us to 
identify and validate both known and novel antibiotic targets and other resistance mechanisms.  
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4.2 Identification and validation of intrinsic resistance factors 
 
Treatment of the transposon libraries with antibiotics 
 First, we used a small panel of antibiotics to investigate the intrinsic resistance factors of 
S. aureus. These experiments were conducted in collaboration with Michael Gilmore’s lab at 
Massachusetts General Hospital. We used both our transposon library system (132) as well as 
data obtained by their lab using a transposon library created using a plasmid-based system (90) 
and sequenced using the DNA shearing method (291). These experiments were done in 
different ways (different growth media, growth volumes, and number of generations grown). 
Therefore, any genes that are identified as hits in both of these methods are more likely to be 
important for resistance regardless of the conditions in which the cells are grown. Combining 
these two approaches allows for a more robust dataset that should identify relevant resistance 
factors to any antibiotic tested. Specific differences between these transposon libraries as well 
as differences in antibiotic treatment protocols are described in Methods (Appendix A).  
The two libraries were treated with sub-minimum inhibitory concentrations (MICs) of 
antibiotics. These antibiotics - ciprofloxacin, linezolid, gentamycin, oxacillin, vancomycin 
daptomycin - were chosen for their clinical relevance and selected as representatives of 
antibiotics that target major pathways: DNA synthesis, protein synthesis, cell wall synthesis, and 
membrane stability (Figure 27 A-B) (11, 16-19, 292, 293). After treatment, the library DNA was 
extracted, and Tn-Seq was performed in order to sequence the location of the transposon 
insertions (Figure 27C).  
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Figure 27. Intrinsic antibiotic resistance factors can be identified using Tn-Seq. The 
structures of the six different antibiotics (A) and their targets (B) used in the Tn-Seq 
experiments are shown. (C) A pooled transposon insertion library is grown with or without 
antibiotic and subjected to Tn-Seq to quantify the number of sequence reads that map to each 
insertion location (black lines). Here, the red gene has a similar number of reads in both 
conditions. The orange gene has a lower number of reads in the treated sample than in the 
untreated control due to a decreased fitness of those transposon mutants in the presence of the 
tested antibiotic. Genes of this type are known as intrinsic resistance factors. Finally, the blue 
gene has a greater number of reads in the treated sample than in the untreated control signaling 
that inactivation of this gene increases bacterial fitness in the presence of the test antibiotic. 
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Data analysis 
Data was analyzed as previously described with one additional step (132). Before 
comparing the number of reads/gene using the Mann-Whitney U test, the experimental 
condition (antibiotic treatment) was normalized to the untreated control using simulation-based 
re-sampling to minimize differences between the two conditions (104, 107). After analyzing all 
experiments for both libraries separately, the results (ratios and p-values) for all antibiotic 
treatments were combined. P-values were combined using Fisher’s method and the ratio of 
number of reads in the experiment to the control (hereafter referred to as fold change) was 
combined by calculating the geometric mean of the fold changes. 
Normally, we set one cutoff for statistical significance (p-value) and one cutoff for 
practical significance (fold change). However, we could not set a single practical significance 
cutoff for all antibiotics because it would have resulted in different numbers of hits. Different 
antibiotics seem to exert a different selective pressure on the transposon mutant libraries, even 
when used at the same fraction of MIC. This results in some datasets where there are large fold 
changes for a large fraction of the genes, while others had smaller fold changes in fewer genes. 
Therefore, setting a single cut-off based on the fold-change would result in different numbers of 
hits for the different antibiotics.  
To solve this problem, we set different practical significance cutoffs for each antibiotic, 
We first identified the subset of genes having p-values < 0.05, and then adjusted the fold 
change cutoff such that a maximum of 20 genes remained. This value was different for each 
antibiotic, and the cutoffs ranged from a ten-fold increase/decrease in number of reads (10x and 
0.1x) for ciprofloxacin to a 55-fold increase/decrease for oxacillin (55x and 0.018x). Then we 
manually filtered out those genes where all the reads map to only one transposon insertion site 
as these are likely to be artifacts. It should be noted that this list of top 20 or fewer genes for 
each antibiotic includes genes with fewer reads in the treated sample compared to the control 
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as well as genes with more reads (Table 6). The former represent intrinsic resistance factors as 
disrupting those results in decreased fitness in the presence of an antibiotic, but the latter are 
also of interest as they provide information on how antibiotic resistance can arise via gene 
inactivation. 
Intrinsic factors that decrease or increase susceptibility to antibiotics 
We compared the top hits for each condition and identified 80 unique hits as some 
genes are found to be hits for more than one antibiotic (Table 6). Twenty-one genes were hits 
with more than one antibiotic. Fourteen genes were important for resistance to at least two 
antibiotics, and no gene was a resistance factor for all six antibiotics. These 80 hits include 
genes involved in almost every major aspect of cell function including cell envelope 
homeostasis (14 genes), DNA/RNA/protein synthesis (6 genes), protein modification and 
transport (4 genes), oxidative phosphorylation (11 genes), metabolism/metabolic transporters 
(11 genes), transcriptional regulators (10 genes), and multicomponent sensory systems (11 
genes), Additionally, we have identified thirteen hypothetical genes that are important for 
resistance. 
Whereas the top twenty gene list for most of the six antibiotics included few genes with 
more reads mapping to them under the treatment condition than the control, half of the genes in 
the list for gentamycin belonged in this category (Figure 28). All these genes were in the 
oxidative phosphorylation pathway. It is known that gentamycin and other aminoglycosides rely 
on the membrane potential to gain entry into cells (294, 295). Disrupting genes in the oxidative 
phosphorylation pathway therefore limits cellular penetration.  
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Figure 28 (See page 94). Inactivation of the oxidative phosphorylation pathway confers 
resistance to gentamicin.  (A) Schematic of the oxidative phosphorylation pathway is depicted 
here. Reads were enriched in the eleven genes named in the figure when treated with 
gentamicin. A subset of genes in the oxidative phosphorylation pathway were tested to 
determine if inactivation confers resistance to gentamycin. (B) The fold change in reads/gene in 
the gentamycin-treated sample compared to the control for each of these genes is shown. (C) 
Fitness compared to WT of mutant strains in which the indicated genes were inactivated was 
assessed using spot dilutions of WT and mutant strains plated on gentamycin (photo on left). 
Fitness was calculated as the ratio of the highest dilution that allowed growth of WT relative to 
the mutant (plot on right). 
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Figure 28 (Continued). 
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Our fitness analysis also identified many other genes previously known to affect 
antibiotic resistance. For example, sigB was among the hits with oxacillin treatment. Reads 
mapping to this gene, and the other components involved in the alternative sigma factor 
pathway, rsbV and rsbW, were significantly depleted. It has been shown that over-expressing 
SigB results in cells with thicker cell walls, increased transcript levels of penicillin binding 
proteins, and elevated MICs to β-lactams (296). Similarly, reads in all three genes of the vraRST 
operon were substantially depleted in the presence of vancomycin. vraRST encodes a multi-
component-sensing system (MCS) that regulates the cell wall stress stimulon (50, 143, 297). 
Reads mapping to pbp4, a PBP involved in synthesis of highly-crosslinked peptidoglycan and β-
lactam resistance (174, 231, 247), were also found to be depleted under oxacillin treatment. 
Finally, norA, which encodes an efflux pump that is known to be involved in ciprofloxacin 
resistance (7, 298), was identified as an important factor under ciprofloxacin treatment in our 
analysis. In addition to these and other known intrinsic resistance factors, we have identified 13 
hypothetical genes that are important for resistance (Table 6). 
Intrinsic resistance factors to multiple classes of antibiotics 
Of the twenty-one genes that were hits with more than one antibiotic, eight of these were 
hits with more than two antibiotics (Table 6). These 8 genes include previously characterized 
genes - mprF, ndh, and components of the graRS/vraFG multi-component system, as well as 
two genes of unknown function: SAOUHSC_01025 and SAOUHSC_01050. We were 
encouraged by the fact that we found many previously-identified resistance factors considering 
the substantial differences between testing an antibiotic against a single mutant and testing it 
against a huge pooled mutant collection. To provide additional validation of our approach, we 
tested the fitness of selected mutants (ndh, fmtA, and mprF) against all six antibiotics using a 
spot dilution assay (Figure 29). Briefly, this assay works by serially diluting a strain by 10 fold 
each time, and spotting each dilution on plates containing the antibiotic of interest. A strain more 
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resistant to the antibiotic than WT will grow at higher dilutions than WT; while WT will grow at 
higher dilutions than the test strain if the test strain is sensitive to the antibiotic. These three 
genes were identified as hits with more than one antibiotic treatment. Ndh (NADH 
dehydrogenase) is involved in the electron transport chain (299), fmtA is a cell surface protein of 
uncertain function (300-302), and mprF catalyzes formation of lyslyphosphatidylglycerol, a 
membrane modification that confers protection to cationic antibiotics (51, 190). In general, the 
agreement between mutant fitness as determined on plate assays is excellent (Figure 29). 
Notably, the mutants used in the plate assays were made in a different genetic background from 
the transposon libraries used in the Tn-Seq experiments (ndh and graR mutants in 
USA300:FPR3757(130) and mprF mutants in Newman while the library was created in HG003 
(132)), making the agreement between the fitness values all the more remarkable. 
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Figure 29 (See page 98). Tn-Seq results were validated by testing mutant fitness in spot 
dilution assays. (A)Tn-Seq results and validation for selected genes are shown. ndh encodes 
an NADH dehydrogenase involved in oxidative phosphorylation (299); fmtA is a cell surface 
protein of undetermined function (300-302); graR is a member of a multicomponent sensing 
system (MCS) (303); mprF and dltA are members of this MCS's regulon (304). Top panel: Bar 
graph depicting fold change relative to the untreated control for each of the six antibiotics. 
*There are very few insertions in dltA control so changes in fitness are not detectable. Bottom 
panel: Bar graph depicting fitness compared to WT of mutant strains in which the indicated 
genes are inactivated. (B) Fitness was assessed by spotting ten-fold dilutions of WT and mutant 
strains on antibiotic plates and comparing the highest dilutions that resulted in growth. An 
example of the plate dilution spotting assays is shown. The left plate has serial dilutions of WT, 
∆dltA, ∆graR, and ∆mprF strains spotted on TSA with no antibiotic. On the right, the same 
strains are spotted on 1µg/ml vancomycin. While growth of WT is unchanged at this 
concentration of vancomycin, the ∆dltA and ∆graR strains have severe fitness defects. ∆mprF 
has a more modest fitness defect.  
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Figure 29 (Continued). 
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graRS/vraFG is a very important multi-component sensing system  
Multi-component sensory/regulatory systems (MCS) allow bacteria to sense and 
respond to their environments. These systems typically include a membrane-anchored 
extracellular sensory domain fused to an intracellular kinase domain and a separate, cytosolic 
response regulator, but they can also include additional elements, such as ABC-transporter-like 
and other membrane proteins.  A stimulus sensed by the sensory domain results in a change in 
phosphorylation of the response regulator, which then modulates the expression of downstream 
targets (305). S. aureus contains many multi-component sensing systems, and we identified 
multiple components of three of these systems, agrABCD, vraTSR, and graRS/vraFG, as top 
hits under treatment with at least one antibiotic (Table 3). 
The agr locus controls quorum sensing as well as the expression of virulence factors 
and autolysins (306-308). We found that reads mapping to agrA, agrB, and agrD were depleted 
under treatment with oxacillin and daptomycin. This suggests that this MCS could be playing a 
role in the response to these antibiotics, possibly due to its functions in regulating the autolysin 
lytM and the PBPs (144, 309, 310). While agrC was also depleted under these treatments, it did 
not meet our cut offs.  
The vraTSR system is known for its crucial role in withstanding vancomycin treatment 
(143), and all three components of vraTSR were among the top twenty genes identified as 
important under vancomycin treatment. This sensing system regulates expression of cell wall 
biosynthetic genes and has also been implicated in β-lactam resistance (50, 144, 297). Although 
reads mapping to these genes were also depleted under oxacillin treatment, they did not meet 
our cut offs for top 20 most important genes. 
The single most important MCS across all the six antibiotics tested was found to be 
graXRS/vraFG. Four components of this system made our cut offs under gentamycin, 
daptomycin and vancomycin treatment . Moreover, compared to wildtype, we found the fitness 
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of a ΔgraR mutant to be reduced by four to five orders of magnitude when plated on these 
antibiotics (Figure 29).It was also sensitive to ciprofloxacin, although less so. The graRS/vraFG 
reguon was characterized and found to have links to other global regulatory systems such as 
agr and walKR as well as many stress-response and virulence genes (304), but it is most well-
known for modulating the charge of the cell envelope through modulating the expression of 
mprF and the dlt operon. MprF attaches lysine to phosphatidylglycerol (190, 311) while the dlt 
operon attaches D-alanine to lipo- and wall-teichoic acids (312). These pathways confer 
protection to cationic antimicrobial peptides, aminoglycosides, and other positively-charged 
antibiotics (313). Whereas mprF was identified as a top hit under several treatment conditions, 
transposon insertions in the dlt genes were poorly represented in the control libraries because 
dlt mutants have substantial fitness defects and do not compete well with other strains. The fact 
that this system as well as a member of its regulon is so prevalent among the top hits was 
surprising, and it suggests that this system may be more important for antibiotic resistance than 
previously appreciated.  
We next asked whether the sensitization observed when knocking out graRS/vraFG is 
due to misregulation of the expression of mprF or dltA. We found the fitness of a dltA mutant to 
be greatly reduced compared to wildtype when plated on four of the six tested antibiotics (Figure 
29). Three of these, vancomycin, gentamicin, and ciprofloxacin, contain at least one net positive 
charge. The fitness of the graR mutant was also reduced on these antibiotics, but there was not 
a strong correlation between the number of positive charges and the fitness of the dltA mutant 
across different classes of antibiotics. For aminoglycoside antibiotics it was previously shown 
that the number of charges correlates with activity against the dltA mutant (105). D-alanylation 
serves different roles in the cell envelope (313-315), and so the fitness of the dltA mutant in the 
presence of different antibiotics may reflect these various roles. Similarly, the data suggest that 
MprF does not function simply to modulate cell membrane charge (51) as the mprF mutant is 
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most sensitive to daptomycin (Figure 21), which does not contain a net positive charge. Notably, 
the graR mutant was also sensitive to daptomycin, but the dltA mutant was not (Figure 29). It 
seems that depending on the type of stress this MCS senses, it may modulate the expression of 
many different genes including, but not limited to, dltA and mprF. 
Identification of two new resistance factors important in envelope stress 
 Of all the hits, thirteen are uncharacterized hypothetical genes. Two of these genes, 
SAOUHSC_01025 and SAOUHSC_01050, were predicted to be resistance factors for the cell-
envelope-targeting antibiotics oxacillin, vancomycin, and daptomycin. These genes are 
conserved in S. aureus and are both predicted to be conserved polytopic membrane proteins. 
According to the TMHMM Server v. 2.0 which predicts transmembrane helices in proteins, 
SAOUHSC_01025 is predicted to have six transmembrane helices, a 93 amino acid 
extracellular domain, and four more transmembrane helices. SAOUHSC_01050 is predicted to 
have three transmembrane helices and a large 191 amino acid extracellular domain. A BLAST 
search with SAOUHSC_01025 resulted in no homology to any characterized protein (all were 
annotated as hypothetical). So, a PSI-BLAST search against NCTC_8325, which is designed to 
detect distant sequence similarities was performed. This search reveals that SAOUHSC_01025 
has low (26%) identity with ComGB. In Streptococcus mutans and in B. subtilis, ComGB is a 
protein required for DNA uptake as well as biofilm formation (316), but its role in S. aureus has 
not been studied. PSI-BLAST was also used to identify S. aureus genes with homology to 
SAOUHSC_01050. We found that this protein has high homology (99% identity) with S. aureus 
proteins annotated as chitinases (Figure 30). Chitinases in bacteria are not well studied, but 
they have been shown to degrade colloidal chitin and peptidoglycan (317). Gene and protein 
annotations in S. aureus are not always accurate, but the similarity of SAOUHSC_01050 to a 
class of enzymes that has activity on peptidoglycan suggests an important role for this gene in 
cell envelope homeostasis.  
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Figure 30. SAOUHSC_01050 has high homology with S. aureus chitinases. PSI-BLAST 
was used to identify S. aureus proteins with homology to SAOUHSC-01050 (highlighted in 
yellow). Four of the top ten proteins identified were annotated as chitinases, which 
SAOUHSC_01050 has 99% homology with. We aligned three of these chitinases to 
SAOUHSC_01050 using Clustal Omega, and we confirmed that these are likely the same 
protein because there are differences in only three amino acids. These three amino acids are 
shown with colons instead of asterisks.  
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 We were able to mine the Tn-Seq data to try to better understand which pathways 
SAOUHSC_01025 and SAOUHSC_01050 are involved in. Our strategy here was based on the 
observations that we made in Chapter 3 where we identified at least two physically-interacting 
genes by identifying genes with the same resistance and sensitization patterns across a panel 
of β-lactams. In these experiments, we observed that inactivation of genes in the same pathway 
conferred a similar level of sensitization to each antibiotic. For example, every component of the 
graRS/vraFG MCS were resistance factors to the same subset of antibiotics: gentamicin, 
daptomycin, and vancomycin. Therefore, we hypothesized that we could nominate pathways for 
genes of unknown function by identifying known genes with very similar patterns of sensitization 
to these six antibiotics.  
One way to identify similar patterns in an unbiased way is to take advantage of machine 
learning algorithms (Figure 31A. We optimized a K-nearest neighbors machine learning 
algorithm using the Sci-kit learn Python library (318) to find genes that have the most similar 
resistance patterns to our gene of interest. To do this, we calculated the “fitness value” (See 
Methods) for each gene in each of the antibiotic treatments. In short, this value is based on the 
change in number of reads mapping to a gene, but it also normalizes for gene length and for 
insignificant changes when few reads map to the gene in the untreated condition.  We validated 
our algorithm by using the components of graXRS/vraFG as test cases, to see if the other 
components could be identified among the top 5 nearest neighbors (top 5 most genes with 
similar patterns) when we searched all the non-essential genes in the genome (2549 genes) 
(Figure 31A). We found that for each of these genes, at least two of the other components of the 
system were among the five closest genes in the genome, with the exception of graR (Table 7). 
GraR does not identify other components of this MCS because it often has a different fitness 
value than the other member of the MCS (Table 7, Figure 31B). With daptomycin, gentamicin, 
oxacillin, and vancomycin treatment, the fitness value for graR is approximately 10 fold higher 
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than for the other components of the system. Therefore, it makes sense that this algorithm 
would not identify other components of this MCS when searching with graR. GraR may have a 
slightly different fitness profile than the other components of this MCS because it is the 
transcriptional regulator of the system. If graS, vraF, or vraG are knocked out, the cell envelope 
stress sensing portion of the MCS, all of which resides in the membrane, may be somewhat 
defective, but graR could still retain some activity. If graR is knocked out, there is no way this 
system can modulate the expression of members of its regulon.  
 
Figure 31. The K-nearest neighbors algorithm can be used to identify genes with similar 
resistance patterns. (A) Schematic depicting the fitness of a subset of genes upon treatment 
with different antibiotics. Each column represents an antibiotic and each row represents a gene.  
Genes having related functions, such as the components of the GraRS/VraFG MCS, have 
similar fitness profiles across a panel of antibiotics. For any given test gene, we can identify 
genes with the most similar fitness profiles. These genes likely have functions that are related to 
the function of the test gene. (B) Each component of the graXRS/vraFG MCS was put through 
this analysis to identify the top five genes with the most similar pattern of resistance and 
sensitivity to these six antibiotics. With the exception of graR, every component identified at 
least two other components of the MCS. Continued page 105. 
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Figure 31 Continued. The fitness values for graXRS/vraFG were plotted. With daptomycin, 
gentamicin, oxacillin, and vancomycin, graS, vraF, vraG, and sometimes graX had very low 
fitness values. In contrast the fitness value of graR was on average 10 fold higher.  
 
 
 
Next, we applied this machine learning algorithm to our unknown genes of interest 
SAOUHSC_01025 and SAOUHSC_01050. The five genes most similar to SAOUHSC_01025 
were graR, graS, mprF, cvfC, and SAOUHSC_01050, while the five most similar to 
SAOUHSC_01050 were graS, mprF, cvfC, vraG, and SAOUHSC_01025 (Table 7). CvfC 
(conserved virulence factor C) was identified as a gene required for virulence in a silk worm 
model of S. aureus infection (319). The function of cvfC is not known, but when this non-
essential gene is deleted, it confers attenuated virulence in mice and decreased hemolysin 
production (319, 320). The presence of graS, mprF, and vraG in the results of this analysis 
suggests that they have functions related to maintaining membrane integrity and withstanding 
envelope stress. 
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Characterization of SAOUHSC_01025 and SAOUHSC-01050 
Using spot dilution testing, we tested the fitness of mutants with inactivating transposon 
insertions in SAOUHSC_01025 (tn::1025) and SAOUHSC_01050 (tn::1050) against a panel of 
twelve antibiotics with different targets (Figure 32). In addition to the six antibiotics originally 
used to probe the transposon libraries, we tested moenomycin, targocil, bacitracin, fosfomycin, 
mupirocin and rifampicin (Figure 32). Moenomycin and bacitracin inhibit peptidoglycan synthesis 
by interacting with extracellular targets (321, 322), whereas fosfomycin inhibits peptidoglycan 
synthesis by interacting with an intracellular target (323). Targocil inhibits wall-teichoic acid 
biosynthesis, resulting in depletion of peptidoglycan precursors and, therefore, inhibition of 
peptidoglycan synthesis (324). Mupirocin inhibits protein translation by targeting an acyl-tRNA 
synthetase (325), and rifampicin inhibits RNA polymerase (326). With one exception, both 
mutants showed moderate and similar reductions in fitness when plated on non-cell wall related 
antibiotics. The exception was that tn::1050 was far more sensitive to gentamycin than tn::1025, 
an unusual pattern not observed with any other antibiotic. Gentamicin enters the cell through the 
membrane. As a membrane protein, 1050 may play a role in gentamicin’s entrance to the cell, 
such that when it is inactivated, gentamicin can enter the cell more easily. Against cell wall 
active antibiotics, both tn::1025 and tn::1050 showed large reductions in fitness, with tn::1025 
often found to be more susceptible than tn::1050. Moenomycin provides a striking example of 
this as the fitness of the tn::1025 mutant decreased by four orders of magnitude while the 
fitness of the tn::1050 mutants did not change. In general, however, both mutants showed 
reduced fitness compared to the wild type strain. The decreased fitness of both mutants when 
plated on cell wall active antibiotics compared with other antibiotics is consistent with an 
important role in cell envelope integrity (Figure 32).  
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Figure 32. Two genes encoding polytopic membrane proteins are important for 
resistance to cell envelope targeting antibiotics. The K-nearest neighbors algorithm 
predicted that SAOUHSC_01025 and SAOUHSC_01050 were most similar to one another and 
also shared three of four other identified neighbors.  As these neighbors play an important role 
in protecting S. aureus from certain classes of antibiotics, we predict that SAOUHSC_01025 
and SAOUHSC_01050 are important for cell envelope integrity. Spot dilution assays showing 
fitness compared to WT of inactivation mutants in SAOUHSC_01025 and SAOUHSC_01050 
upon plating on the indicated antibiotics. Continued page 108.  
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Figure 32 continued. The first five antibiotics (moenomycin, vancomycin, targocil, bacitracin, 
and oxacillin) target the cell envelope and at least one of the two mutant strains is highly 
sensitive at an antibiotic concentration that permits growth of WT at all dilutions. With the 
exception of fosfomycin and daptomycin, the rest of the antibiotics have non-cell envelope 
targets, and we observe either little effect on these mutants (fosfomycin and daptomycin), or we 
observe an effect only at concentrations where the WT strain is also inhibited (mupirocin, 
linezolid, rifampicin, and ciprofloxacin). The last antibiotic is gentamicin, which inhibits protein 
synthesis but enters the cell using the membrane potential. Transposon insertions in 
SAOUHSC_01050 sensitize to this antibiotic.   
 
These mutants did not show a significant increase in sensitivity to lysis by triton X-100 
(Figure 33), but they showed a slight reduction in growth rate at 37°C. The doubling times for 
WT, tn::1025 and tn::1050 were 22.0, 25.4, and 26.5 minutes respectively, suggesting that 
these mutants have some fitness defects. Though a three or four minute increase in doubling 
time, may seem unsubstantial, in the context of a transposon library in liquid culture, where all 
the mutants are competing against each other for nutrients, it is easy for a small fitness defect to 
become amplified over successive generations.  
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Figure 33. Inactivation of SAOUHSC_01025 or SAOUHSC_01050 do not have an effect on 
TritonX-100 induced lysis. Lysis curves of WT, tn::1025 and tn::1050 with or without triton X-
100 show that WT and mutants lyse at similar rates. OD600 values were normalized to the initial 
starting OD of each sample. 
 
 Because the antibiotic resistance and sensitization patters of 1025 and 1050 were found 
to be similar to cvfC (319, 320), we tested whether there was any change in hemolysin 
production and activity by streaking WT, tn::1025 and tn::1050 on Columbia Blood Agar plates. 
In contrast to the cvfC mutant, which shows reduced hemolysin production, these mutants had 
greater hemolysin production than the WT strain (Figure 34). S. aureus encodes four 
hemolysins, α-, β-, γ-, and δ-hemolysin (34). Expression of the hemolysins is tightly regulated by 
the two component system SaeRS and the Agr system (327-331). In the presence of heme, α- 
and β-hemolysin expression is down-regulated to protect the cell from the toxic byproducts of 
heme degradation (327), while in blood, γ-hemolysin expression is upregulated (332). Because 
the tn::1025 and tn::1050 mutants increase hemolysin expression, it is possible that they 
function to negatively regulate their expression or activity. Though inactivating these genes 
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upregulates hemolysin production and cvfC knockouts have less hemolysin production, it still 
makes sense that we could identify cvfC as having a similar antibiotic resistance and sensitivity 
pattern. Depending on the type of cell stress, different transcriptional regulators can up- or 
down-regulate the expression of different sets of genes. Therefore, under cell envelope stress 
due to antibiotic treatment, inactivation may confer a similar phenotype, while in the presence of 
blood, the phenotype could be different. The different phenotype could also be related to which 
hemolysins are being produced by the different strains. The mechanism of heme toxicity in 
bacteria is not very well understood (333), but S. aureus is known to store exogeneously-
acquired heme in the cell membrane (334). As membrane proteins, SAOUHSC_01025 and 
SAOUHSC_01050 could play a role in the regulation of hemolysin production in response to the 
stores of heme in the membrane.  
 
Figure 34. tn::1025 and tn::1050 mutants have increased hemolysin production. WT, 
tn::1025, and tn::1050 strains were streaked onto Columbia Blood Agar plates to assess 
whether they have any kind of hemolysis phenotype. The mutants appeared to secrete more 
hemolysins than WT as can be seen by the black areas surrounding each colony.  
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4.3 Expansion of the antibiotic panel and identifying upregulated genes 
 
Advantages of Tn-Seq for predicting mechanism of action  
For these experiments, we used the same phage-based transposition system described 
in the previous chapters (132) with an expanded panel of twenty-five antibiotics in order to 
develop a method for predicting the mechanism of action of a new antibiotic using Tn-Seq. The 
phage-based transposition method was originally developed by Meredith and co-workers at 
Merck Research Labs for the purpose of predicting mechanism of action of new compounds. 
They showed that they were able to identify the target for many compounds (133, 134). 
However, this method relied on plating the transposon library on agar plates containing 
compound at two or three times the MIC and then sequencing the colonies that were able to 
survive and grow. This method works well, but suffers from two major drawbacks (Figure 35). 
First, sequencing individual colonies does not give a complete picture of which genes are 
involved in resistance across the entire genome. Without the significance gained from the 
millions of reads obtained using NGS, it may be difficult to prioritize and categorize the genes to 
follow up on. Secondly, many of the new antibiotics we study, especially natural products, are 
not available in large quantities. The amount of compound needed for use at high 
concentrations in multiple large agar plates would seriously deplete our supply for most of these 
compounds and make it impossible to perform many required follow up validation experiments 
(Figure 35).  
Adapting this transposition system for NGS has solved both of these problems. We can 
treat the transposon library with antibiotic in small (2 milliliter) cultures, which uses only a small 
amount of compound. Furthermore, because these experiments require very little compound, 
we can test a few concentrations of the compound to obtain more information about its 
mechanism of action. It is useful to test multiple concentrations because at lower 
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concentrations, we can identify the mutants that are more sensitive to the compound, while at 
higher concentrations, we can identify the mutants that are best able to survive the treatment. 
Tn-Seq enables the study of compound mechanism of actiomn using a more global, systems-
level approach where we can look at transposon insertions in every non-essential gene to 
determine that gene’s relevance to an antibiotic’s mechanism of action (Figure 35).  
 
Figure 35. Two approaches for mechanism of action prediction using transposon 
libraries. (A) The first method relies on selection of a transposon library on an agar plate 
containing a high concentration of antibiotic. Then, transposon insertion sites are sequenced 
one colony at a time. Potential targets can be nominated by identifying genes upregulated by 
the outward-facing promoter of the transposon. This approach has been very successful, but 
requires a lot of compound and sequencing individual colonies can be time intensive. (B) With 
NGS, the transposon library can be grown in small (2mL) culture volumes and transposon 
insertion sites can be sequenced using NGS. This allows us to simultaneously assess the 
fitness of every gene in the genome. A small culture volume allows us to do more experiments 
with different compound concentrations to identify resistance factors as well as upregulated 
genes.  
 
 
 
 113 
 
Treatment of the transposon library with antibiotic 
We have treated the HG003 transposon library (described in Chapters 2) with at least 
two different concentrations of 25 different antibiotics in 2 milliliters of cation-adjusted TSB 
(oxacillin and bacitracin were treated in MHB). These antibiotics included many different 
functional and chemical classes, and a full list can be viewed in Table 8. Concentrations were 
chosen by identifying at least one antibiotic concentration that caused a moderate delay 
(approximately three to five hour) and at least one concentration that resulted in an extreme 
delay (approximately twenty hour) in the time it took for the transposon library to reach 
stationary phase. Then we collected the cells, extracted the DNA, and prepared the DNA for 
NGS as previously-described (132). Lower concentrations allow us to identify transposon 
mutations that sensitize the cell to the antibiotic. At high concentrations, the delay in growth is 
due to the fact that few mutants are able to grow. This allows us to identify mutants that confer 
an increase in resistance to the antibiotic.  
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Method for identifying genes upregulated by transposon insertion 
 Because the phage-based transposon method is highly-efficient, it allows for the 
multiplexing of multiple transposon donor constructs together when creating the transposon 
library (See Chapter 2) (132, 133). We have taken advantage of this by creating transposon 
constructs containing outward-facing promoters of different strengths. These regulatory 
elements allow us to upregulate as well as inactivate any gene in the genome, and this function 
is very useful for studying a new antibiotic (Figure 36). Not only will we be able to identify 
resistance mechanisms due to upregulation of genes, but because target-upregulation is a 
common mechanism of antibiotic resistance, we may also be able to determine the target of a 
new antibiotic.  
 We developed a method for identifying genes that, when upregulated, increase 
resistance to antibiotics. The transposon library was treated with antibiotics and prepared for 
sequencing as previously described. However, the procedure for data analysis of the 
sequencing data differs. The goal of this analysis is to identify not only regions of the genome 
where there is a significant increase in number of reads, but also to identify regions of the 
genome where there is a preference for orientation of the transposon insertion. Transposons 
can insert into a TA site with the outward-facing promoter facing either direction, and if 
upregulation of a gene causes an increase in fitness, there should be a preference for insertion 
in one direction over the other where the preferential direction corresponds with the same 
direction as the native promoter of that gene (Figure 36).  
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Figure 36. Different transposon constructs can confer different phenotypes. (A) This 
transposon library has six transposon constructs multiplexed together (132). These include 
(from top to bottom): Blunt construct with no outward facing promoter, Dual construct with Ppen 
promoter and no transcriptional terminator after the erythromycin resistance gene, Cap 
construct with Pcap promoter, Erm construct which is the same as the Blunt construct except 
without the transcriptional terminator after the erythromycin resistance gene, Pen construct with 
Ppen promoter, and Tuf construct with Ptuf promoter. These outward facing promoters drive the 
expression of proximal genes to different extents; in order of increasing strength, Perm, Ppen, Pcap, 
and Ptuf. (B) We can identify different kinds of phenotypes using these constructs. If a 
transposon inserts into the middle of a gene, it inactivates that gene. That may have no effect 
on the fitness of the mutant, or depending on the condition of interest, the transposon mutant 
may confer a fitness defect (fewer number of reads mapping to the gene) or a fitness advantage 
(greater number of reads mapping to the gene). Continued page 117.  
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Figure 36 continued. (C) If a transposon construct with an outward-facing promoter inserts 
ahead of a gene, depending on the orientation of insertion, it may upregulate the proximal or 
another nearby gene. If the upregulation confers an increase in fitness, more reads will map to 
that area and there will be a preference for the orientation of transposon insertion. Furthermore, 
if upregulation of a gene confers a fitness advantage, there will also be few to no reads mapping 
within that gene because inactivation of that gene usually confers a fitness defect in that 
condition. 
 
 The automated analysis we have developed performs the following operations (Figure 
37): 1. It separates the sequencing data into reads mapping to the plus and minus strands for 
both the control and the antibiotic treatment conditions; 2. it normalizes the data using the 
simulation based sampling, with the plus strand reads for the treatment condition normalized to 
the plus strand reads for the control, and the minus strand reads for the treatment normalized to 
the minus strand reads for the control; 3. because we care about insertions in non-coding 
regions as well as genes, data is classified into 270bp “windows,” with each given a unique 
numerical name (this window size was chosen because it is ~1/10000th of the length of the 
genome and should on average contain ~27 TA sites, a window large enough to identify 
changes due to mutations affecting fitness and small enough to get a fine-grained view of 
fitness across the genome); 4. it identifies the mean and standard deviation of the number of 
reads per TA site and the ratio of plus strand to minus strand reads for each TA site across the 
genome; 5. it identifies TA sites where the number of reads is X standard deviations away from 
the mean in antibiotic treatment but not the control to identify TA sites where transposon 
insertion confers a fitness advantage; 6. it identifies TA sites where the number of reads in one 
strand is X standard deviations away from the mean but not in the other, suggesting that there is 
a preference for orientation of transposon insertion. X can be increased or decreased until 100-
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200 TA-sites remain, depending on how stringent of an analysis is desired. In our experience, 
increasing the stringency to approximately 100 TA sites allows us to be much more confident in 
our results. Decreasing the stringency can make analysis difficult because distinguishing truly 
upregulated genes from the background noise becomes more challenging. Here, we have used 
relatively stringent cutoffs.  
 The rest of the analysis is best done manually in order to retain all interesting genes 
(Figure 37). We identify windows where there are three or more TA sites that meet the cutoffs 
described above. Then, we determine where in the genome that window is and which direction 
the outward-facing transposon promoter is facing. Based on this information, we can nominate 
candidate genes that could be upregulated by the transposon insertions in this window. These 
promoters have the ability to act on genes not immediately proximal to the transposon insertion 
(133), so for this work, we looked for a gene within 2kb facing the appropriate direction. Then, 
we returned to the raw reads per TA site data to confirm that the candidate gene is upregulated. 
A gene whose upregulation increases the cell’s fitness with antibiotic treatment should have few 
or no reads mapping to it because inactivating the gene is likely to cause a decrease in fitness 
in that condition. Furthermore, in non-coding regions and in non-essential genes ahead of the 
candidate gene, we should see an increase in number of reads and a strong preference for 
transposon orientation (Figure 37).  
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Figure 37. (See page 120) Automated upregulation analysis indentifies signatures of 
upregulation and nominates candidate upregulated genes. 0. The starting point for this 
analysis uses the raw reads per transposon insertion site data (red bars). 1. The analysis begins 
by separating the sequencing data into reads mapping to the plus (purple bars) and minus (blue 
bars) strands for both the control and the antibiotic treatment conditions. 2. Then, it normalizes 
the data using the simulation based sampling. 3. Each read is then mapped to unique 270bp 
“windows” (numbered boxes below chart) with a unique numerical identifier. 4. Next, the mean 
number of reads per TA site and the standard deviation of that value across the genome is 
calculated. We also calculate the mean and standard deviation of the ratio of plus strand to 
minus strand reads for each TA site. 5. We identify the TA sites with an increase in reads 
compared to the average (X standard deviations from the mean, where X is empirically-
determined). Here, TA sites with such an increase are marked with an asterisk. 6. Then, of 
those TA sites with an increase in reads, we identify those with a preference for orientation of 
transposon insertion, by identifying an increase or decrease in the ratio of plus to minus strand 
reads compared to the average (X standard deviations away from the mean, whre X is 
empirically-determined). These TA sites are shown with a large red asterisk in contrast to the 
small black ones. 7. To identify signatures of upregulation, we identify windows where there are 
three or more TA sites that meet the cutoffs described above or adjacent windows with at least 
one TA site meeting the described cutoff. 8. Finally, we map the hit window back to the genome, 
and nominate candidate genes based on the location of the signature of upregulation and the 
orientation of that signature. In this example, the green Gene 2 is immediately proximal to the 
signature of upregulation and has no reads mapping to it, suggesting that it is essential in this 
condition and making it a likely candidate for upregulation.  Continued page 120. 
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Continued. This analysis can, in an unbiased way, distinguish between an increase in fitness 
due to upregulation of a gene (Gene 2) and an increase in reads that is due to inactivation of a 
gene (Gene 2). Continued page 121.  
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Figure 37 Continued.  
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Genes upregulated by transposon insertion 
 We have validated this method by performing it with every concentration of every 
antibiotic in Table 8. This method generally works better when the antibiotic concentration is 
close to or above the MIC. At high antibiotic concentrations, more transposon mutants are 
sensitive, so the background level of reads per transposon insertion site is low and it is easy to 
identify regions where transposon insertion may be upregulating genes.  
We identified upregulated genes for 11 of the 25 antibiotics, with 18 total genes 
upregulated (Table 9), including both essential and non-essential genes (Figure 38). Of these 
18 genes, half were target upregulation or target-modifying genes, three were hypothetical 
genes, and the rest were other annotated genes that, when upregulated, confer resistance 
through both known and unknown mechanisms (Table 9). The types of known resistance 
mechanisms included upregulation of efflux pumps (ex: norA with ciprofloxacin treatment (298)), 
antibiotic modification genes (ex: fosB with fosfomycin treatment (8)), target modification genes 
(ex: uppP with bacitracin treatment (335)), other clinical resistance mechanisms (ex: mprF with 
daptomycin treatment (52, 55, 279, 336)), and target upregulation (ex: alr and ddl with 
cycloserine treatment (337)) (Table 9). Of the novel resistance mechanisms we identified, some 
were known resistance mechanisms to other antibiotics but had never been seen for this 
antibiotic (ex: uppP with moenomycin treatment), some were known genes, but they had never 
been shown to confer resistance when upregulated (ex: recO with moxifloxacin treatment 
(324)), and some were completely hypothetical genes that have never been studied before (ex: 
SAOUHSC_02149 with daptomycin treatment) (Table 9).   
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Figure 38. Both essential and non-essential genes are found to be upregulated by 
transposon insertion. We manually confirm that our method for identifying these genes is 
functioning correctly by plotting the number of reads/TA site mapping to each strand for both the 
control and antibiotic-treated data. Here, we show the results for an essential gene, murJ, and a 
non-essential hypothetical gene, SAOUHSC_02149 using the construct carrying the Ptuf 
promoter. In the untreated control datasets, reads map to both strands of the genome meaning 
that transposons insert with the outward-facing promoter facing both toward and away from the 
gene. No reads map to murJ itself because it is essential (338). However, when you treat with 
an antibiotic, not only is there a 100-1000 fold increase in number of reads that map to the 
promoter region, but there is a complete preference for the orientation of the transposon such 
that the Ptuf promoter faces toward the gene.  
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There are several possible explanations why we were not able to identify upregulated 
genes for every antibiotic.  First of all, five of the antibiotics tested (vancomycin, ramoplanin, 
bacitracin, daptomycin, and polymixin) do not bind to and inhibit enzymes (15, 18, 19, 339-341), 
making identification of target upregulation for these antibiotics impossible. Secondly, this 
method relies on growing the library in liquid culture instead of on plates. Growing in liquid 
culture results in more competition between every mutant in the library. On a plate, a mutant 
may confer an increase in resistance, but if it does not also confer a high level of fitness 
compared to every other mutant in the library, when grown in liquid culture, it may be out-
competed by another mutant with a higher fitness. Some genes (often encoding membrane 
proteins) are known to have a fitness defect when upregulated (342, 343), and occasionally, 
upregulation of a target can actually sensitize the cell to antibiotic treatment (135). Therefore, it 
may be difficult to identify upregulated genes conferring an increase in resistance to an 
antibiotic using this method unless those genes also do not confer any kind of fitness defect.  
Validation of novel mechanisms of resistance 
 We validated a selection of the known and novel mechanisms of resistance. To do this, 
we placed the candidate gene of interest on the pLOW plasmid under the control of a strong 
constitutive promoter in the HG003 strain. We compared the growth of this strain with WT as 
well as a strain that has a transposon insertion inactivating the gene of interest. This strain was 
obtained from the Nebraska transposon library (130) and transduced into the HG003 
background. We chose to validate some of the novel genes identified above: uppP for 
moenomycin and the three hypothetical genes for daptomycin: SAOUHSC_00969, 
SAOUHSC_02149, and SAOUHSC_02164. We used uppP in our validation strategy because 
its known resistance activity with bacitracin will be a control for this validation strategy, and we 
chose to validate the novel genes identified with daptomycin because daptomycin is a relatively 
new antibiotic with a significant amount of success in the clinic. SAOUHSC_00969, 
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SAOUHSC_02149, and SAOUHSC_02164 are all very small with 107, 175, and 60 amino 
acids, respectively. Only SAOUHSC_02149 has any conserved domains, with a predicted 
bacterial Pleckstrin homology (bPH) domain at its N-terminus. These domains in eukaryotes 
bind phosphatidylinositol and are involved in recruiting proteins to membrane regions. All three 
of these proteins are predicted to have membrane spanning regions. The membrane spanning 
regions for SAOUHSC_00969 and SAOUHSC_02149 are near the N-terminus, while the 
membrane spanning region for SAOUHSC_02164 is in the C-terminal half. Other small peptides 
have been shown to be upregulated during cell wall stress (344), suggesting that daptomycin 
may be inducing cell wall stress along with membrane damage. However, these genes were not 
identified as hits with any other cell envelope targeting antibiotic, and upregulation of 
SAOUHSC_02149 did not confer an increase in resistance to any other antibiotic (Figure 39), 
suggesting that this phenotype is specific to daptomycin for at least one of these genes.  
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Figure 39. Upregulation of SAOUHSC_02149 only protects from daptomycin. WT, the 
transposon inactivation mutant of SAOUHSC_02149 (tn::02149), and a constitutively-
upregulated version in the pLOW plasmid (pLOW-02149) were grown without antibiotic and with 
daptomycin, bacitracin, moenomycin, vancomycin, targocil, oxacillin, and ramoplanin in a 96 
well plate to see if upregulating this gene protected from any other type of cell wall stress. All of 
these antibiotics inhibit cell wall synthesis. There was no significant change in growth compared 
to WT for pLOW-02149 in the presence of bacitracin, moenomycin, or oxacillin. Continued 
page 128. 
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Figure 39 continued. At 0.5µg/ml vancomycin, it seemed that pLOW-02149 might have better 
growth than WT, while tn::02149 had poorer growth, but at the next higher concentration tested, 
1µg/ml vancomycin, all strains were dead suggesting that SAOUHSC_02149 does not exert 
much of a protective effect. Furthermore, pLOW-02149 does not protect from targocil and 
ramoplanin treatment, and in fact, this strain may be slightly sensitive to these antibiotics. .  
 
Growth curves were used for validation of these unknown genes. Cells were grown in 
96-well plates for 16-18 hours at 37°C with and without antibiotics. Though there was no 
difference in fitness in the absence of antibiotic treatment, in the presence of antibiotics, the 
transposon mutants grew more slowly or did not grow at all, while the upregulated genes grew 
to stationary phase before the WT cells did (Figure 40). However, some upregulation constructs 
produced a higher increase in resistance than others. Upregulation of uppP increases 
resistance to bacitracin at least 32 fold while the other genes produce at most a more modest 2-
4 fold increase in MIC. All the results tested do validate to some extent, proving that this method 
works well for identifying genes that when upregulated by transposon insertion confer a fitness 
advantage.  
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Figure 40. Genes upregulated by transposon insertion confer increased antibiotic 
resistance. A selection of the validation performed is shown. We validated some of these hits 
by placing the gene of interest onto a plasmid that constitutively upregulates the gene. Then we 
compared the growth of these strains in the presence of antibiotic with both WT and a strain 
with the same gene knocked out. Here, we show a novel mechanism of resistance to 
daptomycin (upregulation of SAOUHSC_02149) and as a control, a known mechanism of 
resistance to bacitracin (upregulation of uppP) (335). As expected, the knockout is more 
sensitive to antibiotic treatment than WT, and the upregulated strain is more resistant than WT.  
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4.4 Applying machine learning algorithms to Tn-Seq data to predict antibiotic mechanism 
 
Strategy for predicting mechanism of action  
Though the method for identifying upregulated genes works well, we did not observe 
target upregulation for every antibiotic. Therefore, if we want to use this platform to determine 
antibiotic mechanism of action, we need to use another strategy. The strategy we have chosen 
to use takes advantage of an observation we made about vancomycin and ramoplanin. 
Vancomycin and ramoplanin have the same target, the peptidoglycan precursor, lipid II, but they 
bind to different parts of the molecule (16, 339). While vancomycin binds to the D-Ala-D-Ala 
moiety, ramoplanin binds to the sugar phosphate head. Because they have the same target 
molecule, the set of transposon mutants that can confer resistance and sensitivity to these 
antibiotics are very similar. If we look at every gene in the genome for each antibiotic and 
whether transposon insertions in that gene confer resistance of sensitivity, we can obtain a 
unique “resistance factor fingerprint” for each antibiotic. We noticed that the fingerprints for 
ramoplanin and vancomycin were almost identical, and we wondered whether this was true for 
the other antibiotics in our panel that had the same target or that targeted the same pathway. A 
cursory examination of the data revealed that this fingerprint is very similar for antibiotics with 
similar mechanisms of action such as trimethoprim and sulfamethoxazole, ciprofloxacin and 
moxifloxacin, as well as DMPI and CDFI.  
For a more quantitative comparison of the data, we used hierarchical clustering (Figure 
41). We chose to compare only one concentration for each antibiotic, always using sequencing 
data from the traditional “Blunt” transposon construct. We chose these concentrations by 
identifying the concentrations that had close to or greater than 1 million reads with a significant 
change in number of TA sites with insertions compared to the control. We looked for conditions 
where the antibiotic-treated condition only had about 40 - 60% of the TA insertion sites as the 
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control. Then, to compare data from different antibiotics tested, we had to put all the data on the 
same scale. We used the same method described earlier in this chapter to calculate a “fitness 
value” for each gene with each antibiotic treatment. Once we had the data on the same scale, 
we used hierarchical clustering to assess the similarities between antibiotics. This allows us to 
visualize the fingerprints and how similar they are for different antibiotics (Figure 41). Antibiotics 
with the same target such as vancomycin and ramoplanin (16, 339) or DMPI and CDFI (345) 
cluster together. In addition, there is a dramatic difference between some of the peptidoglycan 
synthesis inhibitors and all the others, highlighting the fact that the genes required for resistance 
to this class of antibiotics are very different than non-cell envelope targeting antibiotics.  
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Figure 41.  Some antibiotics cluster by mechanism of action using hierarchical 
clustering. Hierarchical clustering is a good way to help visualize the differences between 
antibiotic datasets. Here, we compare the fitness values for a subset of genes in the genome for 
a selection of antibiotic treatments. Bright red genes correspond to genes where transposon 
insertion confers a fitness defect, while bright green genes have a fitness advantage when 
inactivated with a transposon. The most obvious cluster is that consisting of cycloserine, 
oxacillin, moenomycin, fosfomycin, and cefaclor (all peptidoglycan synthesis inhibitors), but 
other compounds with the same target also happen to cluster together including 
ramoplanin/vancomycin, ciprofloxacin/moxifloxacin, and DMPI/CDFI. Continued page 133. 
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Figure 41 Continued. Though this method for classifying antibiotics can not be used to predict 
the mechanism of action of a new antibiotic, it allows us to visualize some of the similarities and 
differences in resistance factors between different antibiotic treatments.  
 
Using the K-nearest neighbors algorithm as an antibiotic classifier 
 We can observe differences in patterns with the heatmap output by hierarchical 
clustering, but we needed a better method for predicting mechanism of action using the 
resistance factor fingerprint of a new antibiotic with an unknown mechanism of action. Earlier in 
this chapter, we took advantage of the utility of machine learning algorithms to identify genes 
that when inactivated had the same pattern of resistance and sensitivity across a small panel of 
antibiotics, which helped us predict the pathways a hypothetical gene may be a part of. We can 
use a similar approach for predicting the mechanism of an unknown antibiotic. Using machine 
learning classifier algorithms, we can take advantage of information we already know about the 
mechanisms of action of our large panel of antibiotics in order to predict the target of a new 
antibiotic. After much experimentation with different classifiers, we again chose the K-nearest 
neighbors algorithm as implemented by the sci-kit learn Python library (318), the same algorithm 
earlier used to learn more about hypothetical genes. We can use our panel of antibiotics as the 
training data for this algorithm, telling the algorithm which class of antibiotics each known 
antibiotic belongs to. Then, when testing a new antibiotic, we can determine which class of 
antibiotics, a new antibiotic is most similar to (Figure 42).  
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Figure 42. Machine learning strategy for mechanism of action prediction. (A) We observed 
that the transposon mutations conferring resistance and sensitivity to antibiotics were very 
similar for antibiotics with the same target or with a target in the same pathway. We wanted to 
use this resistance factor fingerprint to predict the mechanism for a new antibiotic with an 
unknown target by comparing the resistance factor fingerprint of the new antibiotic to a curated 
panel of antibiotics with known mechanisms of action. (B) To do this, we use the K-nearest 
neighbors classifyin algorithm. A hypothetical example of the supervised K-nearest neighbors 
classifier (318) is shown using only three genes. This algorithm works by using a training 
dataset of antibiotics with known classes. Then, it takes an unknown antibiotic and uses the 
distance of that antibiotic to its closest X-number of neighbors to predict which class that 
antibiotic belongs to. In this case, the novel antibiotic is most similar to class A antibiotics 
suggesting that it may bind to Lipid II as vancomycin and ramoplanin do.  
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Additionally, this algorithm gives us the option of performing either supervised or 
unsupervised learning, depending on the goals of the analysis. Unsupervised learning takes the 
data for each antibiotic, and tries its best to compare them without any input from the user. In 
that sense, it is similar to hierarchical clustering, and as expected, the data from performing 
unsupervised learning resembles the results from the hierarchical clustering. When we use this 
algorithm for performing supervised clustering, we can tell it which class of antibiotics each 
antibiotic dataset belongs to. Then, when we predict the mechanism of a new antibiotic, the 
algorithm outputs which class of antibiotics the new one is most similar to, in contrast with 
unsupervised learning, which returns the most similar antibiotics.  
The next question was how to classify the antibiotics used in the training set. The most 
general classifier would be one that distinguished between cell-envelope targeting and non-cell 
envelope targeting antibiotics. However, this is not very useful for predicting the target of an 
antibiotic. On the other hand, going too detailed with our classifier and classifying by target itself 
would also not work well for a dataset of our size because our training set would only consist of 
one or two antibiotics per category. With a larger training set consisting of many antibiotics for 
each target of interest, we would likely be able to more precisely classify these antibiotics, but 
as a proof of principle project, we chose somewhat broader classes which reflect our smaller 
dataset (Table 10). These classes were chosen by examining the results of the hierarchical 
clustering and unsupervised learning analyses. For some classes of antibiotics where we had 
multiple antibiotics with the same target in our panel, we were able to go down to the target level 
as a classifier (ex: vancomycin and ramoplanin can be reliably classified as lipid II binding 
antibiotics). However, for others, it was more difficult to identify a group with similarities, so other 
antibiotics are classified into broader categories (ex: rifamycin and mupirocin were classified 
together as non-cell envelope targeting antibiotics). Unfortunately, a few antibiotics were tested 
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at too low of a concentration, and so those antibiotics were not able to be accurately placed into 
a classifier (Table 10).  
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Training the classifier algorithm 
 Various parameters were modified for optimizing this algorithm including the number of 
nearest neighbors, the distance metric, and the number of S. aureus genes included in the 
analysis. To assess the progress of the optimization, we used the unsupervised learning 
algorithm and four different metrics utilizing some of our known antibiotics as “test unknowns”. 
These four metrics are described in order of increasing stringency. 1) One antibiotic at one 
concentration should be most similar to the same antibiotic at a different concentration. 
For this, we used the 0.16ug/ml Moenomycin concentration which should be most similar to the 
0.32ug/ml Moenomycin sample. We want this method to be somewhat insensitive to the 
concentration at which the library is treated. Of course, if the concentration is too low or too 
high, no amount of normalization or training will be able to classify an antibiotic correctly, but we 
would like this algorithm to be able to tolerate small changes in antibiotic concentration. 2) One 
compound of a specific chemical class should be most similar to another compound of 
the same chemical class if they have the same target. For this metric we used CDFI, 
predicting it would be most similar to DMPI. These are two antibiotics of the same compound 
class whose target is the lipid II flippase, MurJ (345). 3) Two antibiotics of different chemical 
classes, but with the same target should also be most similar to each other. Depending on 
an antibiotic’s structure, charge, and method of entering the cell, it may elicit different stress 
responses, causing different transposon mutants to be differentially sensitive between the two 
antibiotics. However, we would still like to classify antibiotics by their mechanism as opposed to 
their chemical class. For this comparison, we used targocil and WTI-11, two compounds which 
target the wall teichoic transporter, TarGH, but kill the cell by depleting the lipid tether also used 
by peptidoglycan (PG) biosynthesis (324, 346). We found in early testing that the lower 
concentration of WTI-11 has a similar set of resistance factors as targocil, but the higher 
concentration appears more similar to peptidoglycan biosynthesis inhibitors. This makes sense 
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because the highest concentration at which we treated the library with targocil did not exert 
much selective pressure, and few significant hits were obtained. Therefore, it is not surprising 
that only the lower WTI-11 concentration matches targocil. The lower concentration of WTI-11 
was used here, but the higher one was used for the final clustering. These differences highlight 
the importance of testing different antibiotic concentrations.  4) Our most stringent metric for 
training this algorithm was using two antibiotics of different chemical classes with 
different targets, but whose targets are in the same pathway. We hoped that we could 
classify inhibitors into pathways, which would drastically decrease the number of possible 
targets compared to all the genes in the genome, or even all the genes involved in the cell 
envelope. For this, we used trimethoprim and sulfamethoxazole which both target different 
enzymes in the folate pathway (10, 347). We optimized the algorithm such that all four metrics 
were satisfied. In the end, we chose to use the Minkowsky distance metric, 2 nearest neighbors, 
and we found that the best classification resulted from only using a subset of genes. For each 
antibiotic, we identified the top 25% and bottom 25% with the biggest change in fitness values, 
and we used the unique set of these genes for this analysis, a total of 1614 genes. 
Validation of the method 
 In order to validate the method, instead of only using four antibiotics as we did in the 
optimization, we used all 25 antibiotics as “test unknowns”, and classified them with our 
optimized algorithm using all the other 24 antibiotics as the training set. The categories we used 
for this analysis are shown in Table 10. Unclassifiable antibiotics do not cluster well with drugs 
that are similar to them, likely because the concentration tested was too low. 
The results of our validation are shown in Table 11. We defined success in two ways: by 
whether or not the antibiotic was classified to the correct category and by whether or not we 
were able to learn about the antibiotic’s mechanism of action based on its categorization. The 
difference between these two is whether or not it was categorized into the “Unclassified” 
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category.  Overall, this algorithm classifies the antibiotics as we expected it to 80% of the time. 
There is some debate over the mechanism of action of daptomycin, which disrupts the 
membrane but also delocalizes some of the PG synthetic enzymes (18, 19). We observe that 
the transposon mutations conferring resistance and sensitization to daptomycin more closely 
match that of peptidoglycan biosynthesis inhibitors than other membrane disruptors such as 
polymixin. This result suggests that its mechanism of killing may be due to its PG synthesis 
inhibitory activity as opposed to its membrane disrupting characteristics. If we include 
daptomycin in our results as correct, then, we predict mechanism of action accurately 72% of 
the time. This is as good or better than other published computational mechanism prediction 
methods. The method most similar to ours was published in 2015 by Wildenhain and coworkers. 
This method also takes advantage of machine learning to identify similar patterns of chemical-
genetic interactions to identify the target of a drug in yeast (290). Their algorithm, SONARG, 
correctly predicts the target or a target related gene among the top six gene hits for 16 out of 27 
of the compounds tested (290). This corresponds to a 59% success rate.  It is likely that with a 
larger training data set, our classifier would be able to more accurate identify the mechanism, 
and with more training data per antibiotic target, we would be able to more reliably predict the 
target of the antibiotic.  
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Table 11. Mechanism of action predicted by machine learning analysis. Column 1 shows 
the target pathways for the antibiotics in Column 2. Column 3 shows the predicted mechanism 
of action using our machine learning approach. Cells are colored green (correct prediction), 
yellow (correct unclassified prediction), and red (incorrect classification).  
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4.5 Application of this approach to predict the mechanism of action of a new antibiotic 
 
The WAP antibiotics 
 Next we wanted to test this algorithm using a new compound with an unknown 
mechanism of action. We have access to a series of compounds extracted from Myxococcal 
fungi that we are working on in collaboration with Rolf Muller’s lab. I chose to concentrate on 
attempting to predict the mechanism of the WAP compound series (WAP1, WAP2, and WAP3) 
because we may be able to learn more about the target from a series of related compounds 
than if we just tested one antibiotic . In essence, it gives us more chances to guess the correct 
mechanism. Furthermore, as a set of related compounds, they should have the same or similar 
targets. If we see the same mechanism of action as a hit for more than one of the WAP 
compounds, we can be more confident in the results of that prediction. The WAP compounds 
are peptide-based antibiotics whose mechanism is unknown. One related compound WAP-
8294A2 was in phase I/II clinical trials as of 2011 (348, 349). The mechanism of this related 
compound is also not known. However, it is known that cardiolipin and phosphatidylglycerol 
antagonizes its effect (350). Wonsik Lee, a post doc in our lab, has shown that our WAP 
compound series is bactericidal, causing rapid lysis of gram positive bacteria, including S. 
aureus.  
We treated the transposon library with these compounds at two different concentrations 
and performed Tn-Seq on the extracted DNA. Then we put the resulting data through both the 
data pipelines described above. The upregulation analysis did not reveal any hits for any of the 
WAP antibiotics at any combinations. This could be because the concentrations at which the 
transposon library was treated were too low, and there was not enough selective to distinguish a 
hit from the background noise. On the other hand, we may not identify upregulated genes 
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because the most robust mechanisms of resistance are due to inactivation of other genes in the 
genome.  
Next, we put the data through the mechanism prediction algorithm. Both concentrations 
of WAP1 were predicted to be a PG synthesis inhibitor. The lower concentrations of WAP2 and 
WAP3 were unable to be classified, likely because the concentration used to treat the library 
was too low. However, the higher concentrations of WAP2 and WAP3 are predicted to bind to 
Lipid II to inhibit PG synthesis (Table 12). The fact that all of the WAP compounds are predicted 
to inhibit PG synthesis in one way or another suggests that this could be the mechanism by 
which this compound series acts. We have validated this prediction using the macromolecular 
radiolabeling assay (Figure 43). The next steps will be to narrow down the target from the list of 
many that are part of peptidoglycan biosynthesis. It will also be important to remember that 
other related pathways can be inhibited, but that the cell still dies due to the inhibition of PG 
synthesis (ex: daptomycin, bacitracin, and targocil/WTI-11). In either case, these preliminary 
results suggest that our analysis is working and that we can predict the mechanism of action of 
antibiotics using Tn-Seq. More experiments are needed to validate this hypothesis.  
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Figure 43. Macromolecular labeling predicts that the WAP compounds kill the cell by 
inhibiting cell wall synthesis. Macromolecular labeling assays were performed as described 
(285). Radiolabeled cells were treated with two concentrations of one of the WAP compounds. 
Though the amount of radiolabel incorporation increased for the radiolabels reporting on DNA 
synthesis, RNA synthesis, and protein synthesis, the radiolabel reporting on cell wall synthesis 
decreased at the higher concentration, suggesting that these compounds can inhibit cell wall 
synthesis. To assist with the comparison, the yellow lines mark the starting level of the 
radiolabel.  
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4.6 Discussion 
 
Intrinsic resistance factors of S. aureus 
 In this work, we identified 80 genes that when inactivated can increase or decrease S. 
aureus sensitivity to six different antibiotics. We chose to validate a selection of the hits that 
were found in more than one antibiotic treatment: ndh, fmtA, and mprF. Though they all 
sensitize to different antibiotics, the mechanism of sensitization could be different. mprF 
modifies characteristics of the cell envelope by modifying the charge which can affect how well 
the antibiotics enter the cell (51). On the other hand, genes like ndh are part of global systems 
that regulate cellular metabolism such as oxidative phosphorylation (299). When these are 
inactivated, the cell is forced to switch to alternative modes of growth (218) which could 
sensitize the cell to some antibiotics, or simply slow down growth enough, that the mutant is out-
competed by other mutants in the library. Finally, these resistance factors may represent actual 
synthetic lethal interactions with the target of the antibiotic (189). At sub-MIC antibiotic 
concentrations, the target of the antibiotic will be partially inhibited. During this partial inhibition, 
other genes will become essential. These conditionally-essential genes could be redundant 
genes, genes in parallel pathways, or even genes that interact with the antibiotic’s target. 
Though this analysis does not identify why the resistance factors promote resistance to each 
antibiotic, we are able to reliably confirm our sequencing results with these experiments.  
Global systems as resistance factors 
This method also confirms that global systems are very common resistance factors. 
When components of these systems are inactivated, resistance to antibiotics can increase or 
decrease. We confirmed that the agr system and the sigB locus as important resistance factors 
for oxacillin (and daptomycin for agr). The agr system is S. aureus’s quorum sensing system, 
but it also regulates genes involved in virulence and antibiotic resistance (306-308). It is 
 145 
 
possible that misregulation of some autolysins could lead to the sensitization affect we see with 
oxacillin and daptomycin. The sigB locus consists of sigB (the sigma factor), rsbW (the anti-
sigma factor), and rsbV (the anti-anti-sigma factor) (351, 352). All three genes are sensitive to 
oxacillin treatment. This locus is involved in regulation of growth phase, the heat shock 
response, and expression of virulence factors (353) (354). SigB has been implicated in 
resistance to cell-wall targeting antibiotics, and when over-expressed it causes a thickening of 
the cell wall (296, 355). Likely, it regulates the expression of genes that can modify the cell 
envelope to defend the cell from oxacillin-induced cell wall stress. Therefore, when sigB is 
inactivated, the cell cannot effectively respond to cell wall stress.  
 We only identified one global system that can increase resistance when inactivated. Ten 
genes in the oxidative phosphorylation pathway conferred resistance to gentamicin when 
knocked out by a transposon insertion. When these genes are interrupted, the cell switches to 
anaerobic growth, which not only slows down the growth rate of the cell, but also decreases the 
membrane potential. Without the membrane potential, gentamicin cannot enter the cell, and 
therefore cannot inhibit its target, the ribosome (294). It seemed remarkable that a set of 
mutants that slow growth had such a fitness advantage in the presence of an antibiotic that they 
outcompeted the majority of the other mutants in the library (Table 13). These mutants often 
cause highly persistent antibiotic-resistant infections with the characteristic small colony variant 
(SCV) phenotype (218). Our results agree with others that suggest that SCV strains can be 
induced by gentamicin treatment (356).  
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Role of multi-component sensory systems  
MCSs in S. aureus mediate responses to many types of conditions including quorum 
sensing, osmolarity, nutrient availability, and antibiotic treatment(305). Our data suggest that the 
graRS/vraFG MCS is very important for antibiotic resistance. This MCS is known to be 
important for a variety of cell functions (303, 304), but especially for regulating the charge of the 
cell envelope through the expression of dltA and mprF. Only three of the six antibiotics tested 
(vancomycin, gentamicin, and ciprofloxacin) contain at least one positive charge, but we did not 
observe a correlation between the number of charges on the antibiotic and the fitness of these 
strains. Furthermore, in the case of daptomycin, mprF inactivation sensitizes the cell, but 
inactivation of graR and dltA does not. If the only role of this MCS was only in modifying the 
charge of the cell envelope in response to positivitely charged antibiotics, we would not expect 
mprF inactivation to cause such a dramatic sensitization. Our results implicate graRS/vraFG in 
having important roles outside of simply modifying the charge of the cell envelope, and it seems 
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likely that the sensitization observed when this MCS is interrupted is due to a variety of factors 
including dltA and mprF.   
Machine learning can predict pathways 
We used the K-nearest neighbors machine learning algorithm to identify genes that had 
similar patterns of resistance as the two hypothetical genes we were interested in, 
SAOUHSC_01025 and SAOUHSC_01050. We hypothesized that this method could help us 
learn more about the function of hypothetical genes because we previously showed in Chapter 
3 that we were able to predict physical interactions by identifying genes with similar resistance 
and sensitivity patterns across different antibiotics. Using this algorithm, we found components 
of the graRS/vraFG MCS as well as a member of its regulon, mprF, suggesting that these 
genes are important for resistance to cell envelope stresses. There are a few ways that these 
genes could function that could produce the same resistance pattern as graRS/vraFG. If they 
physically interacted with the graRS/vraFG complex, they would have the same pattern as those 
genes. Also, if it were part of the graRS/vraFG regulon, it could have a similar pattern, as we 
see with mprF. The regulon of this system has been well-studied (304), and these genes have 
not been identified as part of it, so this explanation seems unlikely. Finally, these genes could 
be part of a parallel and complementary system which, in a semi-redundant manner, protects 
from cell envelope stress. Though this method cannot predict exactly which pathways these 
genes are part of, it does help us nominate targets and formulate hypotheses that can be tested 
with other experiments such as the ones that were done here. Furthermore, more data from 
different antibiotics with a wider variety of targets should allow us to more accurately predict the 
function of hypothetical genes.  
Tn-Seq and identification of upregulated genes 
 The analysis for identification of genes upregulated due to transposon insertion did not 
identify upregulated genes every time. This could be due to the fact that not all the antibiotics 
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were tested at a high enough concentration where there was not enough selective pressure 
which makes it difficult to pick out the signal for upregulation from the background level of 
transposon reads. However, it could also be due to the fact that there is an inactivation mutant 
that is more fit under antibiotic treatment than the upregulation mutant, so that the upregulation 
mutant gets outcompeted. It is possible that treating and sequencing the libraries at different 
antibiotic concentrations may yield better results. Moreover, the cutoffs used here were 
relatively stringent. It is possible that by decreasing the cutoffs, we may be better able to identify 
upregulated genes. However, this would also lead to more false positives as we get closer to 
the background level of transposon reads, and it will be more time intensive to identify true hits. 
Furthermore, as it stands, every gene we have tested has validated, so we can be confident in 
our other results. If we were to decrease the cutoffs, it would be vital to validate any candidate 
genes before proceeding with other experiments to predict the target. Though this method 
works, the method of plating the transposon library on agar plates does seem to more reliably 
reveal the target of the antibiotic. It should be possible to plate this transposon library on agar 
plates containing an antibiotic as was done previously (133, 134). Then the cells could be 
collected and the location of transposon insertions sequencing using NGS following the 
protocols described here. This will allow one to have access to the convenience of Tn-Seq (as 
opposed to sequencing single colonies) without the downsides apparent when growing the cells 
in liquid culture. We did not choose to perform the experiments this way because we have very 
little of our unknown compounds. Therefore, if amount of compound is not a limiting factor, this 
library can still be used in this way to identify upregulated genes and possibly predict the target. 
Upregulation of small peptides increases daptomycin resistance 
 With daptomycin treatment, we identified three small proteins (SAOUHSC_00969, 
SAOUHSC_02149, and SAOUHSC_02164) that when upregulated increase resistance to 
daptomycin. The products these genes code for are very small: 107, 175, and 60 amino acids 
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long respectively. Of these, only SAOUHSC_02149 has any predicted domains. According to 
the NCBI gene website, the N-terminal region has homology to a bacterial Pleckstrin-homology 
(bPH) domain. Little is known of the function of prokaryotic versions of this gene (357), but 
eukaryotic proteins with this domain are known for binding phosphatidylinositol and for targeting 
other proteins to membranes (358, 359). S. aureus membranes do not contain 
phosphatidylinositol, but they do contain phosphatidylglycerol (360). In fact, 
phosphatidylglycerol is required for daptomycin action (278), and depletion of 
phosphatidylglycerol results in daptomycin resistance in B. subtilis (361). Based on this, the 
simplest explanation for the reason upregulation of this gene causes resistance is that it is 
sequestering phosphatidylglycerol away from daptomycin, and without available 
phosphatidylglycerol, the antibiotic can not enter and disrupt the membrane. Without a predicted 
domain, it is difficult to hypothesize a mechanism of action for the other two genes. However, in 
previous experiments, upregulation of other small peptides such as these has been observed in 
response to cell envelope stress (344). Perhaps they function to stabilize the membrane or 
recruit other factors to specific parts of the cell to combat the stress induced by daptomycin 
treatment.   
Comparison with other computational methods 
We correctly predict the mechanism of action for known antibiotics with a success rate of 
72%. This rate is as good or better than other recently-published methods for computationally 
predicting mechanism of action that have been recently published. In 2015, Wildenhain et al. 
published research where they used a program called SONARG to predict the mechanism of 
action of 27 compounds in yeast (290). They report that their algorithm correctly predicted the 
known targets or an associated target pathway for only 16 of the 27 compounds they tested 
which translates to a success rate of 59%. Another method published by Johnston et al. in 2016 
uses a computational retrobiosynthetic analysis in combination with whole genome sequencing 
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to predict the mechanism of natural products (289). Not only is this analysis more time-intensive 
than ours, but they do not publish the rate at which they correctly predict mechanism of action. 
Predicting the mechanism for a new antibiotic 
 Here, we have described two complementary techniques for learning about the 
mechanism of action for a new antibiotic. Neither technique alone is perfect, but used in unison, 
they are able to correct for each other. In a best case scenario, these techniques will allow one 
to predict the target of an antibiotic, but even if it doesn’t, it will still lead to new information on 
potential resistance mechanisms that may occur during further testing or in the clinic which 
makes the analytical techniques described here very valuable.  
 As a proof of concept, these approaches work well, but there are many things that could 
be done to improve the results. For the antibiotics where we were unable to identify upregulated 
genes, we could try treating the transposon library at a slightly different antibiotic concentration. 
At a slightly higher concentration, there may be enough selective pressure to decrease the 
number of genes that we map reads to, which would allow us to more easily identify regions 
containing the signature of upregulation. In addition, treating at a slightly lower concentration 
could also help, as perhaps at a concentration close to that of the MIC, upregulated genes may 
have a higher fitness than some of the inactivation mutants that take over the library at higher 
concentrations. Unfortunately, as of yet, there is no way to predict what antibiotic concentration 
will result in the data that best produces upregulated genes. The machine learning approach is 
similar to other “big data” approaches in that these techniques improve quite a bit as more data 
is added to the training set. Currently, we have only sequenced one or two antibiotics per target. 
With more antibiotics per target, we could have a robust training data set that would allow us to 
more accurately predict the activity of a new antibiotic. Unfortunately, for some targets and even 
some mechanisms of action, there are not very many antibiotics available.  
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We are attempting to use this platform to identify the target of a series of related 
compounds, WAP1-3. Our approach predicts that these compounds inhibit a step in 
peptidoglycan biosynthesis, and preliminary biochemical experiments support this hypothesis. 
The next steps include testing whether these drugs bind some precursor in PG biosynthesis or 
whether they act more like daptomycin, inhibiting PG biosynthesis by binding to and disrupting 
the membrane (19). Wonsik Lee, a post doc in our lab, is currently performing these 
experiments.  
Conclusions 
 We have shown that our functional genomics approach to better understanding intrinsic 
antibiotic resistance can identify known and novel resistance factors. We have validated a 
number of both the known genes as well as the two hypothetical genes, SAOUHSC_01025 and 
SAOUHSC_01050. We also propose and utilize a method for predicting the function of 
hypothetical genes using machine learning to identify known genes with a similar resistance 
pattern. We have validated this method for these two genes and show that they are sensitive to 
cell envelope-targeting antibiotics. Any of these validated intrinsic resistance factors are 
potential targets for the development of potentiating compounds. These hypothetical drugs 
could be given in combination with currently FDA-approved antibiotics to sensitize S. aureus 
strains. Moreover, this approach can be applied to any antibiotic, and could be useful for not 
only better understanding the intrinsic resistance factors for that antibiotic, but also for predicting 
mechanisms of resistance due to gene inactivation. Applying this method to any compound is a 
robust way to predict intrinsic resistance factors for that compound as well as to learn more 
about bacterial physiology.  
 Furthermore, we have also developed two complementary approaches for learning more 
about antibiotic mechanism of action using Tn-Seq. The advantages of this approach are that 
with one simple experiment which uses very little compound, it allows anyone to develop 
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hypotheses about a comopund’s mechanism of action that can then be tested with biochemical 
experiments. This has the potential to speed up and decrease the cost of identifying the target 
of a new antibiotic. Moreover, we not only learn about the possible targets of the compound, but 
we learn about possible modes of resistance that could be observed in the clinic due to both 
inactivation and upregulation of genes. This could allow researchers to begin to address 
concerns regarding resistance mechanisms early on in the process of developing the antibiotic.  
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Chapter 5. Summary and Conclusions 
 
Development of new genomics tools for S. aureus 
 Transposon libraries are extremely useful and valuable technologies for better 
understanding bacterial physiology (89). The methods that existed for making transposon 
libraries in S. aureus were not very reliable, and included a high-temperature plasmid curing 
step which killed any temperature-sensitive mutant (125). The phage-based high-frequency of 
transposition platform described here solves these problems (133). We have adapted this 
system so that we can make a transposon library in any strain of S. aureus transducible by Φ11 
phage. Furthermore, we modified the standard DNA preparation procedure such that we can 
now analyze the results of experiments using NGS (132).  
The ability to assess and compare the fitness of mutations in every gene in the genome 
at once gives us a reliable and unbiased method for identifying the most important genes for 
survival in any condition. To do this, we figured out how to de-multiplex each transposon 
construct to analyze each one separately. Our analyses allow us to not only identify genes with 
a statistically-significant change in number of reads which map to them, but we can also identify 
genes that when upregulated by transposon insertion, confer an increase in fitness. This is 
especially-interesting because upregulation of genes is a common mechanism of antibiotic 
resistance. We have validated this platform by identifying the essential genes and comparing 
them to two other published lists of essential genes (90, 146). Furthermore, we identify 
temperature-sensitive genes that had previously been annotated as essential (132). Finally, we 
have also created transposon libraries in other S. aureus strains, such as the two community-
acquired MRSA strains, MW2 and USA300. This platform has the potential to be very useful for 
many experiments in the future including but not limited to identification of virulence factors, 
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factors essential for co-infection with another bacterium, and for comparative genomics studies 
between different strains of S. aureus.  
Discovery of new biology 
 Though the focus of this work was not to answer any particular biological question, in the 
process of validating the platform and optimizing the analyses, we identified many interesting 
genes that could begin to explain S. aureus’s success as a pathogen. During our temperature 
experiments, we identified transposon insertions into the menaquinone biosynthetic pathway 
that were better able to survive high-temperature stress than other mutants in the library. 
Furthermore, while studying the profiles of genes involved in β-lactam resistance in MRSA 
strains, we identified a set of genes that appear to be involved in sortase-anchored surface 
protein secretion. This allowed us to predict a function for a lytD that at that point had been 
completely unstudied (now, its enzymatic activity has been confirmed (197)). We treated 
transposon libraries with 25 different antibiotics, and for six of them, we have identified the most 
important intrinsic resistant factors. We were able to identify resistance factors across different 
classes of antibiotics which could potentially be targets for the development of potentiators to 
currently-used antibiotics, allowing them to be used even if the bacterium is resistant to the 
antibiotic alone. Moreover, some of these resistance factors were unstudied genes. We are 
beginning to characterize some of these genes, SAOUHSC_01025 and SAOUHSC_01050, and 
a better understanding of their function will lead to a deeper understanding of the actual 
processes and genes involved in the stress responses to treatment with different antibiotics. 
Now that this platform for treating and sequencing transposon libraries is up and running in our 
lab, and we show that it can uncover new biology, we hope that many questions about antibiotic 
resistance and S. aureus physiology will be answered. This could lead to novel strategies and 
methods for treating antibiotic-resistant infections caused by this dangerous pathogen.  
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New prediction methods 
 The success of this system thus far has allowed us to obtain an incredibly large and rich 
dataset full of potential projects. One major advantage of “big data” is the ability to make 
predictions based on patterns in a dataset. We devised an approach based on observations we 
made in Chapter 3, where two genes, lyrA and lytD, which had very similar resistance and 
sensitization patterns to three β-lactams, were found to physically interact. In Chapter 4, we 
have expanded and automated this approach by utilizing machine learning to make predictions. 
The first method we describe uses six different antibiotics to predict the function of hypothetical 
genes. With this smaller dataset, we are not able to accurately predict the function of a new 
gene or its interacting partners, but we can broadly identify which pathways it may be involved 
in. With a larger dataset, we may be able to more precisely identify a new gene’s function. We 
use a similar approach for predicting antibiotic mechanism of action. We use the resistance and 
sensitivity fingerprints of the 25 different antibiotics to train the machine learning dataset. This 
allows us to take a new antibiotic of unknown mechanism and predict which class of antibiotics 
it is most similar to. Currently, this method classifies antibiotics accurately with an 80% success 
rate. We expect that with a larger training set consisting of more antibiotics per target, this rate 
will only improve. Mechanism of action prediction is known to be difficult, and this tool will allow 
us to begin to nominate targets for an antibiotic that can be validated with follow-up biochemical 
experiments. Furthermore, antibiotics with novel mechanisms and targets are in high demand. It 
is possible that this method could identify these novel mechanisms if a new antibiotic is not 
similar to any antibiotic in our reference dataset.  
The future 
 These approaches are useful for answering not only specific biological questions, but 
also taking a more systems-level approach to understand bacterial physiology and antibiotic 
resistance. If we are going to be able to combat dangerous infections, we will need to make use 
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of novel strategies and new approaches. . Big datasets such as the ones obtained here are 
incredibly rich, and it would be difficult for one lab can fully make use of them. If this data could 
be shared with other researchers and other institutions, others viewing it with different eyes may 
be able to make connections that we never will. I have designed a website where this data can 
be easily accessed and viewed, and a software developer has assisted me with putting it online. 
Currently, this is only available for members of the Walker lab, but I have high hopes for a more 
open-access day in the future when we can make these data public, because only by sharing 
data and working together will we be able to solve the problem of antibiotic resistance.  
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Appendices  
A. Methods 
 
Strains and plasmids (Chapter 2-5) 
Table of strains and plasmids used can be found in Appendix B. Original strains and 
plasmids for the phage-based transposition system were obtained from Merck Research 
Laboratories. Plasmids were first introduced into the restriction negative S. aureus strain 
RN4220 and then moved into restriction competent HG003 strains by electroporation. Gene 
deletion strains were made using the E. coli-S. aureus shuttle vector pKFC. Stellar competent 
cells, pUC19, and the In-Fusion cloning kit were purchased from Clontech. Cultures of S. 
aureus were routinely grown in tryptic soy broth (TSB) at the indicated temperature, with 
erythromycin (5 or 10 μg/mL), chloramphenicol (10 μg/mL), or kanamycin/neomycin (25 μg/mL 
each) when required. Phage lysates were prepared in TSB top agar and titered as has been 
previously described. Overexpression strains were made by cloning the gene of interest into the 
pLOW plasmid. Mutants from the Nebraska transposon library were validated using PCR of the 
gene of interest and were transduced into the parent strain before experimentation.   
 
Creation of the transposon library (Chapter 2 and 3) 
To create the transposon library, phage lysates were made using the six donor strains 
harboring plasmids encoding transposon cassettes (pTM239-pTM244), where one in three 
progeny phage carries the transposon plasmid. Recipient strains (TM231 and the negative 
control TM232) were grown to late exponential phase, and resuspended in supplemented 
glucose minimal media (SGMM) (10 mM glucose, 2 mM MgCl2, 3.5 mM CaCl2, 0.1% CAS 
amino acids, 0.5% NaCl, 10 mM MES, pH 6.8). For each transposon construct, phage lysate 
was mixed with 25 ml recipient strain in SGMM (multiplicity of infection = 5). Solutions were 
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incubated at room temperature overnight. The next day, cells were pelleted and washed three 
times with an equal volume of TSB before being allowed to recover with shaking for two hours 
at 30°C. Approximately 108-109 cfu were spread per 150 × 15 mm petri dish containing TSB 
agar with 5 μg/ml erythromycin to select for transposon insertion mutants. The number of 
spontaneously ermR colonies was less than 1% in the control strain TM232 that does not 
express functional transposase. Plates were incubated at 30°C for two days, before being 
scraped (1-2 million total colonies) and pooled into a single 100 mL suspension. Cells were 
pelleted and washed three times with an equal volume of TSB, before being resuspended in 
TSB-glycerol (12.5% v/v), aliquoted, and stored at 80°C. Additional details for the preparation 
and sequencing of the transposon library can be found in Appendix C. 
 
Assessment of next-generation sequencing library composition (Chapter 2) 
A linearized pUC19 vector was made by inverse PCR using primers (Tm179-Tm180) 
containing 5’-overhangs homologous to the termini of the P5 and P7 Illumina sequences. The 
2.6 kb PCR product was agarose gel purified, ligated to an aliquot of the NGS insert library 
using the Clontech In-Fusion system as directed by the manufacturer, transformed into 
chemically competent E. coli cells, and selected on LB carbenicillin (100 μg/mL) plates. 
Plasmids were isolated from 2 mL cultures of separate colonies and the DNA inserts 
sequenced. At least 10 colonies were sequenced to confirm insert sequence diversity and lack 
of plasmid-transposon junction DNA. 
 
Next-generation sequencing Galaxy analysis (Chapter 2-5) 
The DNA concentration was determined using the Quant-IT™ PicoGreen kit from 
Invitrogen, and the sample was diluted to 10 nM in Buffer EB. Six samples with different 
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indexing barcodes were multiplexed together, and samples were sequenced on a Hi-Seq2000 
or Hi-Seq2500 for 100 cycles with 40% ΦX174 spiked in to the sequencing reaction. 
Sequencing data were uploaded to the Tufts Galaxy Service hosted by TUCF Genomics 
(http://tucf-genomics.tufts.edu/). The first four base pairs of the 8 bp indexing barcode were 
deleted since these data were occasionally of low quality. Multiplexed sample data was 
separated by the remaining 4 bp of the indexing barcode, and then again by the 3 bp 
transposon cassette barcode. Read ends were trimmed to leave the 16 bp of genomic 
sequence immediately flanking the TA dinucleotide insertion site and filtered to keep high-
quality reads (>90% of bases with quality score >20). Remaining reads were mapped to the S. 
aureus NCTC8325 genome using Bowtie. Hopcounts (the number of reads that map to a given 
site in the genome) were determined and these files were downloaded for subsequent statistical 
analysis. For details on custom analyses, see Appendix H 
 
Growth curves (Chapter 2 - 4) 
Growth curves were performed by diluting overnight cultures to an OD600 of 0.01 in 25 
mL Tryptic Soy Broth. Strains were grown with shaking in a 43°C or 30°C water bath. The OD of 
the cultures was measured every 10 (43°C) or every 20 (30°C) minutes in an Ultrospec 10 cell 
density meter until stationary phase.  
 
96-well growth curves (Chapter 3 and 5) 
Overnight cultures, were diluted to an OD600 = 0.001. 150µl of diluted culture was mixed 
with 1.5µl of antibiotic at 100X final concentration and mixed in a well of the 96 well plate. 
Growth curves were performed in 96 well plates at 37°C with shaking, measuring the OD600 
every 15 or 20min.. A Molecular devices plate reader was used for these experiments. 
 
 193 
 
Treatment of MRSA transposon libraries with β-lactams and sequencing (Chapter 3) 
 Transposon libraries were treated in 50mL cultures of TSB at 37°C. We inoculated with 
1,000,000 cfus of the transposon library and added the appropriate antibiotic. Then cultures 
were grown, shaking, until the cultures grew to OD between 1 and 2. Cells were spun down, 
and the DNA was isolated and prepared for Tn-Seq as described in Appendix C.  
 
Library 1 antibiotic treatment (Chapter 4) 
Library 1 was constructed by transformation of a temperature sensitive plasmid. A 100 μl 
aliquot of this initial S. aureus HG003 transposon library freezer stock, containing 108cfu, was 
used to inoculate 100 ml of MH cation adjusted broth and incubated for 15 h at 37°C with 
shaking at 200 rpm. A 10 μl aliquot (106cfu) of this input culture was then inoculated into a final 
volume of 200 μl in a 96-well plate broth microdilution format and incubated at 37°C for 8 h 
[approximately 5.5 generations (5 x 107cfu/200 μl)]. The 1/2x, 1/4x and 1/8x MIC wells for the 
library pool were determined based on the MIC of a small mutant pool (consisting of ten 
innocuous transposon mutants). This small pool was used to determine MICs in order to 
compensate for potential resistant mutants in the library pool. The chosen wells (1/2x, 1/4x and 
1/8x) were then subcultured (3 x 105cfu) into a second iteration of serial dilutions of antibiotics 
as described above and incubated for 15 h at 37°C [approximately 9 generations (2 x 
108cfu/200 μl)]. The 1/2x, 1/4x and 1/8x MIC wells were determined based on the small pool 
and these wells were transferred to 10 ml of BHI broth, incubated for 4 h at 37°C with shaking at 
200 rpm. Biological replicates were conducted for each growth condition. Genomic DNA was 
harvested using DNeasy Blood and Tissue kit (Qiagen, Valencia, CA) following the 
manufacturer’s instructions. Library1 was prepared using the shearing method. Illumina 
sequencing was completed by Harvard Biopolymers Facility or Tufts Genomic DNA sequencing 
core facility. 
 194 
 
Library 2 antibiotic treatment (Chapter 4 and 5) 
Library 2 was constructed using phage-based transposition and six different transposon 
constructs as previously described. TSB supplemented with 25mg/L Ca2+ and 12.5mg/L Mg2+ 
was used for all antibiotics except for oxacillin, which was tested using cation-adjusted Mueller-
Hinton Broth. For all antibiotics, an untreated control was prepared in the same media as was 
used for the tested antibiotic. A stock of the complete library was thawed and diluted to 0.2 
OD600 and grown to an OD 600 of ~0.4 to allow for a minimal stimulation of growth prior to 
treatment. The culture was then diluted to 4 x 105cfu/mL and added to 1mL of media with 2x the 
desired concentration of the antibiotic, to give a final starting inoculum of 2x105cfu/mL in 2mL 
culture volumes. Samples were grown at 37°C and harvested when they reached stationary 
phase. The concentrations of antibiotic tested were 2x, 1x, 0.5x and 0.25 x the MIC of the 
antibiotic. Samples were prepared for NGS as described in Appendix C.  
 
Plate dilution spotting (Chapter 3) 
Agar plates were prepared with TSB and the desired concentration of the 
compound/antibiotic of interest. Overnight cultures of mutants as well as WT strains were 
diluted 1:100 in fresh TSB and grown to an OD of 0.5. They were then diluted serially by 10-fold, 
spotted on to agar plate and incubated at 37°C overnight. Photos of plates were taken 18-36 
hours after plating.  
 
Plate dilution spotting (Chapter 4) 
Identified hits ndh, fmtA, SAOUHSC_01025 and SAOUHSC_01050 were validated using 
transposon mutants from the Nebraska library in background USA300_FPR3757.Deletion 
mutants in dltA,graR, and mprF were tested in MSSA strain Newman. Agar plates were 
prepared with TSB supplemented with Ca2+ (25mg/L) and Mg2+ (12.5mg/L) and a sub-MIC 
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concentration of the 6 antibiotics. Overnight cultures of mutants were diluted 1:100 in fresh TSB 
and grown to an OD of 1. They were then diluted serially by 10fold, spotted on to agar plate and 
incubated at 37°C overnight. The concentration of the antibiotic at which WT was severely 
inhibited showing growth in only the highest 1 or 2 dilutions on agar plates under these 
conditions was determined. This was considered to be the MIC under this condition. The spot 
dilution assays were then set up using three different antibiotic concentrations. The 
concentration closest to the MIC at which WT was at most 3 logs more depleted than non-
antibiotic control was used to calculate fitness. This concentration was used so that reduced 
fitness of any mutants could be observed. The exception to this was when the MIC 
concentration for gentamicin was used to evaluate the resistance of inactivation mutants in the 
oxidative phosphorylation pathway. Controls plates with no antibiotic were set up for all strains 
assayed and under these conditions, mutants and WT showed equal levels of growth (not 
shown). Fitness was assessed by determining the highest dilution for which growth was 
observed for a mutant and the WT strain. The highest dilution showing full growth for the mutant 
was then divided by the highest dilution showing full growth for the WT to calculate its fitness 
compared to WT.  These were plotted on a log scale. Those spots that showed hazy growth 
indicative of cell lysis, those that showed mixed populations of colonies of different sizes 
suggesting the possibility of suppressors and reduced fitness relative to spots with homogenous 
colonies, and those that had fewer than 10 individual colonies were not regarded as full growth.  
 
Co-immunoprecipitation  experiments using LyrA (Chapter 3) 
 Pull downs were performed by expressing LyrA linked to c-myc in a ΔlyrA. Cells were 
grown and then DSP crosslinking reagent was added. Cells were disrupted and membrane 
proteins solubilized. Then, the solubilized membrane proteins were run over a column with the 
tag receptor. Tagged LyrA as well as anything it is interacting with binds to the column. All other 
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proteins are washed away, and then LyrA and anything it is interaction with is eluted. These 
proteins are boiled, run on SDS-PAGE gels. Bands are cut out and digested with Trypsin. The 
identity of these peptides is determined using LC-MS.  
 
Transmission electron microscopy (Chapter 3) 
 Overnight cultures of the strains of interest were diluted to an OD=0.05 in 2mL TSB and 
grown to early exponential phase (OD~0.3). Cells were spun down 8000g 5min and 
resuspended in 100µl water and 100µl glutaraldehyde-formaledyle in sodium cacodylate buffer 
pH7.4 fixative provided by the Harvard Electron Microscopy core facility who also embedded the 
samples in resins. Samples were viewed using the JEOL 1200EX – 80kV electron microscope.  
 
Transmission electron microscopy with gold nanoparticles(Chapter 3) 
 Overnight cultures of cells were dilution to an OD=0.5 in 4mL of TSB, and grown to early 
exponential phase (OD~0.3). Cells were aliquoted into 2 x 2mL and  spun down 8000g 5min 
and washed twice with 1mL PBS pH 7.4. Cells were resuspended in 1mL PBS + 0.2mg/ml 
trypsin and incubated at 37C for 1 hour to remove proteins attached to the cell surface. Cells 
were spun down again and washed twice with 1mL PBS pH 7.4. One set of tubes was kept 
aside as a control, while the other was resuspended in 2mL TSB + 1mM PMSF (a protease 
inhibitor), transferred to a 15mL culture tube, and grown at 37°C, shaking for 10min to allow 
surface protein synthesis and export again. After this, the cells are spun down and washed 
twice with PBS pH 7.4 again. Then, they were resuspended in 1mL PBS + 1:2000 goat anti-
protein A and incubated at 37°C for 20 minutes. After another cycle of spinning down and 
washing with PBS pH 7.4, cells were resuspend in 50µl + 1:20 rabbit anti-goat antibody 
conjugated to 10nm gold nanobeads, incubated at room temperature for 20 minutes, and spun 
down. After washing twice with PBS pH 7.4, they were resuspended in 50µl PBS. 50µl of the 
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same fixative described above was added, the Harvard Electron Microscopy Core embedded 
the samples in resins, and the samples were viewed using the JEOL 1200EX – 80kV electron 
microscope. Antibodies were purchased from Abcam, product numbers ab181627 (Anti-protein 
A) and ab27245 (Rabbit anti-goat Gold).  
 
Identification of antibiotic resistance factors (Chapter 4) 
We identified datasets from Library 2 where reads mapped to 25-40%of the TA sites hit in the 
untreated control (with the exception of vancomycin treatment which hit 67% of the TA sites hit 
in the untreated control). These were processed for further analysis. This percent decrease was 
chosen such that we could identify genes with an increase and decrease in number of reads 
mapping to them. Library 2 contains transposon constructs with outward-facing promoters that 
can upregulate proximal genes in addition to the traditional construct which can only insert into 
and inactivate genes. For these experiments, we only considered data from the inactivation 
constructs. Data from biological replicates was combined, and before comparing the number of 
reads/gene using the Mann-Whitney U test, the experimental data was normalized to the control 
using simulation-based resampling. Then, data for each antibiotic treatment from each of the 
Library 1 experiments was combined with the data from the Library 2 experiments using the 
geometric mean of the ratios and Fisher’s method for combining corrected p-values. Top hits 
were identified by first filtering for genes with a p-value less than 0.05, then by increasing the 
ratio cut-off by integers until less than or equal to 20 genes were left.  See Appendix H for 
scripts.  
 
Triton X-100 induced lysis assay (Chapter 4) 
 Overnight cultures of WT and mutants were diluted 1:100 in fresh TSB and grown to an 
OD of 0.6. The cultures were harvested, washed with cold, sterile water and re-suspended in 
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0.05M Tris-HCl, pH 7.2, with or without 0.05% Triton X-100. Samples were incubated at 37°C 
and OD600 was measured every 20min for 3 hours. OD was normalized to the initial 
measurement for each sample. Error bars were obtained from two separate biological 
replicates.  
 
Machine learning algorithm optimization for predicting gene function (Chapter 4) 
We used the machine learning algorithm, k-nearest nearest neighbors to, in an 
unsupervised manner, identify other genes with similar resistance and sensitization patterns 
using the scikit-learn Python library (318). However, because of the different selective pressures 
exerted by each antibiotic, we cannot use the ratio of reads in the experiment versus the control 
that map to each gene as the metric for classification. In addition, we wanted to distinguish 
between the two following conditions: 1) A ratio change of 0.1 due to 100 reads in the control 
and 10 reads in the experiment and 2) A ratio change of 0.1 due to 1000 reads in the control 
and 100 reads in the experiment. If both genes are the same length, option 1 will be much less 
relevant than option 2 because 100 reads/gene and 10 reads/gene both correspond to a gene 
with a significant fitness defect while a change from 1000 reads/gene to 100 reads/gene is more 
likely to be a significant change. Therefore, we converted the ratios into a more appropriate 
value. This value, representing fitness under the antibiotic treatment is calculated by multiplying 
the converted ratio above by the number of reads mapping to that gene in the treatment 
condition, and normalizing to the length of the gene. Then, genes were ordered from smallest to 
largest “fitness”. To place all the samples on the same scale, the gene with the smallest “fitness” 
was given a value of 0, and the gene with the highest “fitness” was given a value of 1. All other 
genes were placed in order between these values, in increments that increase by 1/(total 
number of genes). This final value, which we call the “normalized fitness value”, is the value we 
use for the machine learning analysis. Finally, essential genes were removed from the dataset, 
 199 
 
and the K-nearest neighbors algorithm was further optimized by adjusting the Minkowski 
distance metric to output the genes with the most similar resistance/sensitization pattern to the 
test gene. We identified the five genes (the five nearest neighbors) having the most similar 
pattern of “normalized fitness values”.  
 
Identification of upregulated genes (Chapter 5) 
 To identify genes upregulated by transposon insertion, the untreated and antibiotic-
treated data is separated by type of transposon construct. Then, we separate the data by reads 
mapping to the plus strand and the minus strand of the genome. This lets us distinguish 
between the two different directions the outward-facing promoter may be facing. We then map 
this data to 270bp sections of the genome or windows. Each treated dataset from each strand is 
normalized to the control using simulation based resampling. Then, we identify the mean and 
standard deviation of reads that map to each TA site for each strand in the control. Then we 
look for TA sites in the experiment that are 4-6 standard deviations from the mean of the control. 
These are potential hits. If there are at least two potential hits in a window or a few windows in a 
row with hits, we investigate whether there are any genes nearby (within a few kb) that could be 
upregulated by these transposon insertions. Potential upregulated genes are then investigated 
to make sure that no reads map to them (if upregulation increases fitness, we would expect that 
inactivation would decrease the fitness) by mapping the reads/TA site as bar charts in Excel. 
This chart also allows us to check whether the majority of TA sites in the promoter region of the 
gene of interest contain transposons with promoters facing the same direction as the gene of 
interest. For scripts, see Appendix H.  
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Hierarchical Clustering (Chapter 5) 
 Hierarchical clustering was performed using the statistical programming language, R, 
and visualized using the gplots library. The spearman method was used to measure correlation 
and complete-linkage clustering to measure distance. We used the unique set of genes which 
had the largest 99th percentile of the data and smallest changes 1st percentile compared to the 
control to decrease the amount of noise in the data, and we used the “fitness value” described 
above for each gene to perform the comparison.  
 
K-Nearest Neighbors Algorithm for predicting mechanism of action (Chapter 5) 
 The sci-kit learn Python library was used for this analysis which came along with the 
anaconda distribution of the Python language. I wrote Python scripts that convert the raw read 
count data into fitness values for each antibiotic. This data is then fed into the K-nearest 
neighbors algorithm in an unsupervised way (where I identify each antibiotic as a unique class) 
or in a supervised way (where I classify the antibiotics by their mechanism of action) as a 
training set. We use the minkowski distance metric, a step size = 0.2, and each antibiotic was 
weighted uniformly. Two neighbors were used to predict the mechanism of an unknown 
antibiotic. With a larger training data set, this value could be increased which could result in 
more accurate predictions. 
 
 
 
 
 
 
 
 201 
 
B. Strains and Plasmids 
 
Strain Genotype/Phenotype Source (if other than here) 
RN4220 S. aureus subsp. aureus NCTC8325 MSSA; 
r− m+; partial agr defect 
Kreiswirth et al. Nature. 1983 
HG003 S. aureus subsp. aureus NCTC8325 MSSA ; 
Φ11 Φ12 Φ113, r+ m+; agr+ 
Herbert et al. Infect Immun. 
2010 
TM51 RN4220 attB::Orf5 (pTM378) Wang et al. Nat Chem Biol. 2011 
TM53 RN4220 attB::Orf5 (pTM381) Wang et al. Nat Chem Biol. 2011 
TM174 RN4220 (pOrf5 Tnp+) KmR 
 
TM175 RN4220 (pOrf5 Tnp-) KmR 
 
TM176 HG003 (pOrf5 Tnp+) KmR 
 
TM177 HG003 (pOrf5 Tnp-) KmR 
 
TM222 HG003 attLint::FRT attR::FRT 
 
TM226 HG003 Φ11::FRT 
 
TM231 TM226 (pOrf5 Tnp+) 
 
TM232 TM226 (pOrf5 Tnp-) 
 
∆lyrA HG003 lyrA::KmR 
 
∆mprF HG003 mprF::KmR 
 
MW2 S. aureus subsp. aureus Community acquired MRSA: ATCC BAA-1707 ermS, kanS Baba et al. Lancet. 2002 
USA300 
S. aureus subsp. aureus Community acquired 
MRSA strain USA300_TCH1516: ATCC BAA-
1717 ermR, kanR, catS 
Highlander et al. BMC 
Microbiol. 2007 
TM258 MW2 ∆hsdR - restriction system knocked out, parent strain for making transposon libraries  
TM262 TM258 with pWV01-Tnpase+-ORF5 
 
 202 
 
TM263 TM258 with pWV01-Tnpase damaged-ORF5 
 
TM283 
USA300 ∆pUSA300HOUMR ermS, kanS, 
catS, parent strain for making transposon 
libraries  
TM284 TM283 with pWV01-Tnpase+-ORF5 
 
TM285 TM283 with pWV01-Tnpase damaged-ORF5 
 
MW2 ∆pbp3 MW2 unmarked pbp3 deletion strain Memmi et al. Antimicrob Agents Chemother. 2008 
MW2 ∆pbp4 MW2 unmarked pbp4 deletion strain Memmi et al. Antimicrob Agents Chemother. 2008 
tn::pbp3 Nebraska Transposon library mutant NE420 transduced into TM283 
transduced from strain from 
Fey et al. MBio. 2013  
tn::pbp4 Nebraska Transposon library mutant NE679 transduced into TM283 
transduced from strain from 
Fey et al. MBio. 2013  
SHM161 HG003 ∆lyrA pTM63-lyrA-cmyc (integrated into genome), camR  
tn::lytD Nebraska Transposon library mutant NE1909 transduced into TM283 
transduced from strain from 
Fey et al. MBio. 2013  
USA300-pLOW-
lytD pLOW-lytD electroporated into TM283  
USA300 ∆lyrA ∆lyrA (kanR marked) transduced into TM283 
 
∆lyrA-pLOW-lytD pLOW-lytD electroporated into USA300 ∆lyrA 
 
JE2 
WT USA300_FPR3757, parent background 
fro Nebraska transposon mutant library, 
ATCC BAA-1556 
Fey et al. MBio. 2013  
tn::ndh Nebraska Transposon library mutant NE1884 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
tn::qoxB Nebraska Transposon library mutant NE732 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
tn::qoxA Nebraska Transposon library mutant NE92 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
tn::fmtA Nebraska Transposon library mutant NE1022 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
Newman MSSA strain Newman, ATCC 25904 Hawiger et al. J Lab Clin Med. 1970 
Newman ∆graR unmarked graR deletion in Newman Santa Maria et al. PNAS. 2014 
Newman ∆mprF unmarked mprF deletion in Newman  transduced from strain from Ting Pang, Bernhardt Lab 
Newman ∆dltA unmarked dltA deletion in Newman Santa Maria et al. PNAS. 2014 
tn::1025 Nebraska Transposon library mutant NE1044 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
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tn::1050 Nebraska Transposon library mutant NE1420 transduced into JE2 
transduced from strain from 
Fey et al. MBio. 2013  
tn::02149 Nebraska Transposon library mutant NE1894 transduced into HG003 
transduced from strain from 
Fey et al. MBio. 2013  
tn::00969 Nebraska Transposon library mutant NE50 transduced into HG003 
transduced from strain from 
Fey et al. MBio. 2013  
tn::uppP Nebraska Transposon library mutant NE480 transduced into HG003 
transduced from strain from 
Fey et al. MBio. 2013  
HG003 pLOW-
02149 
HG003 expressing SAOUHSC_02149 from 
pLOW plasmid  
HG003 pLOW-
00969 
HG003 expressing SAOUHSC_00969 from 
pLOW plasmid  
HG003 pLOW-
02164 
HG003 expressing SAOUHSC_02164 from 
pLOW plasmid  
HG003 pLOW-
uppP 
HG003 expressing SAOUHSC_00691 (uppP) 
from pLOW plasmid  
 
Plasmids Genotype/Phenotype Source (if other than here) 
pKFC 
temperature-sensitive shuttle vector; Ampr in 
E. coli, Cmr in S aureus 
Kate and Sugai. J Microbiol 
Methods. 2011 
pUC19 
pMB1 ori lacZ’ ApR Clontech pTM402 pT181 
repC- cop Clontech 
pTM402 
pT181 repC- cop 623 ori sso; 1-kb DNA Φ 11 
fragment; mini-Tnp cassette with ermB of 
Tn551 and outward facing Ppen promoter; 
Em R 
Wang et al. Nat Chem Biol. 
2011 
pTM378 
pWV01ts ori aphA-3 Gram+ RBS HMAR1 C9 
transposase ; KmR 
Wang et al. Nat Chem Biol. 
2011 
pTM381 
pWV01ts ori aphA-3 Gram+ RBS ΔHMAR1 
C9 truncated transposase ; KmR 
Wang et al. Nat Chem Biol. 
2011 
pCP20 
Vector containing the S. cervesiae FLP 
recombinase 
Cerepanov and Wackernagel. 
Gene. 1995 
pMS182 
E. coli/S. aureus shuttle vector Cmr pLI50 
with Ppen GFP-mut2 
Swoboda et al. ACS Chem 
Biol. 2009 
pORF5 Tnp+ 
pTM378 with the cI-like repressor ORF5 from 
Φ11 
 
pORF5 Tnp- 
pTM381 with the cI-like repressor ORF5 from 
Φ11 
 
pTM239 (Blunt) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gGTAa) - 
EmR 
 
pTM240 (Ppen) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gAATa) 
and outward facing Ppen promoter- EmR 
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pTM241 (Pcap) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gTGGa) 
for outward facing Pcap promoter- EmR 
 
pTM242 (Ptuf) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gGATa) 
for outward facing Ptuf promoter- EmR 
 
pTM243 (Perm) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gGCAa) 
for outward facing Perm promoter- EmR 
 
pTM244 (Pdual) 
pTM402 modified with NotI-P7 annealing site-
ITR2::MmeI-NotI with DNA barcode (gATTa) 
for outward facing PDual promoter- EmR 
 
pTM204attLint 
pKFC vector with 1-kb DNA homology regions 
flanking attLint on each side of FRT 
recombination sequence 
 
pTM204attR 
pKFC vector with 1-kb DNA homology regions 
flanking attR on each side of FRT 
recombination sequence 
 
pTM195 
pLI50- Ppen-FLP recombinase of 
Saccharomyces cervesiae 
 
(pKFC-lyrA) 
pKFC vector with 1-kb DNA homology regions 
flanking lyrA on each side of the kanamycin 
resistance cassette 
Santa Maria et al. PNAS. 
2014 
(pKFC-mprF) 
pKFC vector with 1-kb DNA homology regions 
flanking mprF on each side of the kanamycin 
resistance cassette 
 pKFC-hsdR 
(MW016) 
pKFC vector for in fame knockout of hsdR 
using Clontech assembly 
 
pTM283 
pKFC vector with in frame deletion of ermR 
allele 
 
pTP63 
vector for single copy integration of 
gene/construct into genome Ting Pang, Bernhardt lab 
pTP44 
same as pRAB14, encodes integrase for 
integration of pTP63 into S. aureus genome Ting Pang, Bernhardt lab 
pLOW-lytD 
USA300HOU_1765 cloned into pLOW 
plasmid (constitutive upregulation), ermR 
 
pLOW-02149 
SAOUHSC_02149 cloned into pLOW plasmid 
(constitutive upregulation), ermR 
 
pLOW-02164 
SAOUHSC_02164 cloned into pLOW plasmid 
(constitutive upregulation), ermR 
 
pLOW-00969 
SAOUHSC_00969 cloned into pLOW plasmid 
(constitutive upregulation), ermR 
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pLOW-uppP 
uppP (SAOUHSC_00691) cloned into pLOW 
plasmid (constitutive upregulation), ermR 
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C. Detailed protocol for the preparation of transposon library DNA for NGS 
 
Unless otherwise described, reactions are mixed and incubated in 1.5 mL Eppendorf 
LoBind tubes. DNA was stored at -20°C overnight, and at -80°C long term. At least 10 μg of 
high molecular weight genomic DNA was purified. 10 μg of genomic DNA was digested with 50-
100 U NotI in a 600 μl reaction in NEB Buffer #3 supplemented with BSA. The reaction was 
vortexed gently, mixed by inversion, spun down, and incubated at 37°C for seven hours (mixing 
and spinning down once halfway through). NotI was inactivated at 70°C for 20 minutes, and 
cooled to room temperature (5 minutes).  
Next, the transposon-plasmid junctions were removed through a size-selective 
precipitation. The 4x Precipitation buffer contains 32% PEG8000, 2.2M NaCl (autoclaved), 
40mM Na2PO4 or K2PO4 pH 7.5 (autoclaved), and brought to volume with autoclaved ddH2O. 
200μl of 4x precipitation buffer was added to the 600μl digest reaction and vortexed and 
inverted (not pipetted) to mix. This reaction was incubated in an ice water bath in a 4°C cold 
room for 12-16 hours. After incubation, the reaction was spun down in a tabletop centrifuge at 
maximum speed for 20 minutes at 4°C. Then, the supernatant was removed, and the 
precipitated DNA was washed once with cold 1x Precipitation buffer, spinning down the DNA at 
maximum speed for 10 minutes at 4°C. To further purify the DNA, pellets were washed twice 
with room temperature 70% ethanol, spinning down the DNA at maximum speed for 5 minutes 
at room temperature between washes. The final DNA pellet was dried and resuspended in 50- 
100μl standard elution buffer (10mM Tris, pH 8.5) by pipetting.  
A PCR check was performed on one sample (undigested and NotI digested) to confirm 
that the DNA was sufficiently digested using primers that anneal to the transposon on either 
side of a NotI site. As a control, other primers were also used that anneal to a genomic fragment 
inside the tarK gene. Seven reactions were set up for each primer set for both undigested and 
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digested DNA. The 25μl PCR reaction consisted of 2.5μl 10x KOD Hot Start Buffer, 5 μl 5x CES 
mix, 1.5μl 25mM MgSO4, 2.5 μl 2mM dNTPs, 0.25 μl of each primer (experimental or control), 
0.25 μl KOD Hot Start Polymerase, 25 ng of DNA (digested or undigested), and autoclaved 
ddH2O to bring the reaction to 25 μl. Reactions were incubated in a thermocycler at 95°C for 2 
minutes; with 30 cycles of 95°C for 20 seconds, 55°C for 20 seconds, and 70°C for 30 seconds; 
and 12°C for storage. CES buffer consists of 2.7M betaine, 6.7mM DTT, 6.7% DMSO, and 
55μg/ml BSA. Beginning at the end of 9 cycles, a tube from each category of reaction 
(undigested with experimental primers, digested with experimental primers, undigested with 
control primers, digested with control primers) was removed from the thermocycler every three 
cycles and quenched with DNA gel loading buffer supplemented with 0.1% SDS. Samples were 
stored at -20°C until all cycles were completed. The final tubes were removed at the end of the 
27th cycle. These reactions were run on a 1% agarose gel in TAE buffer. In a sample deemed 
sufficiently digested, a six cycle product detection threshold difference between the undigested 
and digested samples when using the experimental primers (785 bp) in comparison to the 
control primers (1298 bp) was required.  
Once we confirmed that the DNA had been sufficiently digested, the biotinylated 
adaptors were ligated. 50 μM of annealed adaptors were prepared by mixing 15 μl of 100 μM 
TM214 and 15 μl of 100 μM TM215 with 1.5 μl 1M NaCl. This reaction was incubated in a 
thermocycler at 95°C for 5 minutes followed by cooling to 4°C at a rate of 0.1°C/second. Each 
150μl ligation reaction consisted of 15 μl of 10x T4 ligase buffer, 8 μg digested DNA in 100 μl of 
ddH2O, 3 μl of T4 ligase enzyme, 4.5 μl of annealed adaptors diluted 1:10 to 5 μM in ice cold 1x 
T4 ligase buffer, and 27.5 μl autoclaved ddH2O. Reactions were incubated at 16°C overnight. 
Another size-selective precipitation was performed to remove un-ligated adaptors from genomic 
DNA. 50 μl of the same 4x PEG solution described above was added to the ligation reaction, 
and the tube mixed by vortexing, spun down, and incubated at 4°C or in the cold room for 12-16 
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hours. After incubation, the DNA is washed and dried in the same manner as described above 
after the NotI digest.  
Next, transposon-genome junctions were captured by digesting the DNA with MmeI 
which digests 20 bp 3’ from its asymmetric recognition site near the end of the transposon ITR. 
The M12 oligonucleotides were first annealed together as described above to create 50 μM 
double-stranded DNA. MmeI digests take place in 200μl reactions and require at least 5 μg of 
DNA from the previous step diluted to 50 μl in autoclaved ddH2O. MmeI reactions consist of 20 
μl 10x NEB CutSmart Buffer, 0.8 μl 32 mM SAM, 2 μl 50 μM annealed M12 oligos, 50 μl DNA, 2 
μl MmeI enzyme, and 125.2 μl autoclaved ddH2O. The reactions were incubated at 37°C for 
two hours.  
MmeI-digested DNA was ligated to streptavidin dynabeads via the biotinylated adaptor. 
This required three buffers. The 2x BandW Buffer consists of 2 M NaCl, 10 mM Tris, and 1 mM 
EDTA pH 7.5 with concentrated HCl [9]. LoTE Buffer consists of 3 mM Tris, 0.2 mM EDTA pH 
7.5 with concentrated HCl [9]. LoTE+Tween Buffer is the same as LoTE buffer, but 
supplemented with 0.05% Tween 20. 200 μl of 2x BandW buffer was added to each sample. 32 
μl/sample of Dynabeads® M-280 Streptavidin beads was added to a LoBind tube and placed in 
the magnetic particle collector (MPC). Then, the supernatant was removed, and the beads were 
washed three times with 1 mL of 1x BandW buffer. Finally, the sample was resuspended in 32 
μl/sample of 1x BandW buffer, and 32 μl of beads were added to each diluted MmeI digest 
sample. These were incubated at room temperature for one hour, resuspending by tapping and 
inversion every 10-15 minutes. At this point, all biotinylated DNA should be bound to the beads, 
so the beads were collected using the MPC, washed once with LoTE+Tween and twice with 
LoTE (no Tween). Finally, the beads were resuspended in 100μl of LoTE, and transferred to a 
PCR tube. Beads can be stored in LoTE buffer at 4°C overnight.  
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With one end of the DNA attached to beads, the other Illumina adaptors with index 
barcodes were ligated to the other end. We used six adaptors (LIB_AdaptT_1_long, 
LIB_AdaptB_1_long, LIB_AdaptT_2_long, LIB_AdaptB_2_long, LIB_AdaptT_3_long, 
LIB_AdaptB_3_long, LIB_AdaptT_4_long, LIB_AdaptB_4_long, LIB_AdaptT_5_long, 
LIB_AdaptB_5_long, LIB_AdaptT_6_long, LIB_AdaptB_6_long) annealed to each other (T to B) 
as described above. We would like to note that neither the barcodes in these adaptors nor the 
transposon construct-specific barcodes use an error-correcting barcode sequence. Without 
error correcting barcodes, it is possible that sequences could be mis-assigned to the wrong 
sample or wrong transposon construct due to errors in sequencing. However, because we only 
used sequences with a high quality score in our analysis, we assume that the fraction of mis-
assigned sequences is negligible. These double-stranded adaptors were diluted tenfold to 5 μM 
in ice cold T4 ligase buffer. The ligation mix consisted of 16.4 μl ddH2O and 2 μl 10x T4 ligase 
buffer per sample. Beads were collected in the MPC and resuspended in 18.4 μl ligation mix. 
0.6 μl of the double-stranded adaptor is added to each tube, a different adaptor to each tube. 
Then 1 μl of T4 ligase is added to each tube. The reaction is mixed by pipetting, and the 
reactions were incubated for 6-7 hours at 16°C in a thermocycler, mixing by tapping and 
pipetting every 15 minutes. After incubation, the beads were washed once with 150 μl 
LoTE+Tween and twice with 150 μl LoTE. Again, beads can be stored in LoTE buffer at 4°C 
overnight.  
The final PCR reaction amplifies the transposon-genome junction off of the beads and 
adds the adaptor sequences required for Illumina sequencing. Beads were collected in the MPC 
and resuspended in 50 μl of the final PCR reaction mix. This 50 μl PCR reaction consists of 5 μl 
10x KOD buffer, 3 μl 25 mM MgSO4, 5 μl 2 mM dNTPs, 35.5 μl autoclaved ddH2O, 0.5 μl 
100μM TM199, 0.5 μl 100 μM LIB-PCR_3, and 0.5 μl KOD Hot Start Polymerase per sample. 
The reaction was incubated in the thermocycler using the following program: 95°C for 2 
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minutes; 15- 18 cycles of 95°C for 20 seconds, 60°C for 20 seconds, 72°C for 20 seconds. The 
beads were collected, and the supernatant was transferred to new tubes where DNA loading 
buffer was added, and the samples were run on a 2% agarose gel in TAE at 130V for 20 
minutes. Bands of the expected size (161 bp) were extracted using the Qiagen gel extraction kit 
with a few minor modifications. The gel fragments were dissolved in Buffer QG at room 
temperature to prevent dissociation of the short strands of DNA. After the final Buffer PE wash, 
excess buffer was removed from the column by pipette. The DNA was eluted in 30 μl Buffer EB, 
and DNA concentration was determined using the Quant-ITTM PicoGreen kit from Invitrogen. 
The final TnSeq sample was diluted to 10 nM in Buffer EB, and six samples with different 
barcodes were typically multiplexed together in a single lane. Samples were sequenced on a Hi-
Seq2000 or HiSeq2500 for 100 cycles with 40% ΦX174 spiked in to the sequencing reaction. 
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D. Essential genes with different promoter constructs 
 
Blunt Erm Promoters 
Gene Locus Gene Locus Gene Locus 
SAOUHSC_00001-dnaA SAOUHSC_00001-dnaA SAOUHSC_00001-dnaA 
SAOUHSC_00005 SAOUHSC_00004-recF SAOUHSC_00004-recF 
SAOUHSC_00006 SAOUHSC_00005 SAOUHSC_00005 
SAOUHSC_00009 SAOUHSC_00006 SAOUHSC_00006 
SAOUHSC_00015 SAOUHSC_00009 SAOUHSC_00009 
SAOUHSC_00017-rplI SAOUHSC_00015 SAOUHSC_00015 
SAOUHSC_00018 SAOUHSC_00018 SAOUHSC_00018 
SAOUHSC_00021 SAOUHSC_00021 SAOUHSC_00021 
SAOUHSC_00226 SAOUHSC_00226 SAOUHSC_00226 
SAOUHSC_00349 SAOUHSC_00349 SAOUHSC_00349 
SAOUHSC_00350-rpsR SAOUHSC_00350-rpsR SAOUHSC_00350-rpsR 
SAOUHSC_00374 SAOUHSC_00375-guaA SAOUHSC_00374 
SAOUHSC_00375-guaA SAOUHSC_00413 SAOUHSC_00375-guaA 
SAOUHSC_00413 SAOUHSC_00442 SAOUHSC_00413 
SAOUHSC_00442 SAOUHSC_00444 SAOUHSC_00420 
SAOUHSC_00444 SAOUHSC_00451-tmk SAOUHSC_00442 
SAOUHSC_00445-recR SAOUHSC_00454 SAOUHSC_00451-tmk 
SAOUHSC_00451-tmk SAOUHSC_00461 SAOUHSC_00461 
SAOUHSC_00454 SAOUHSC_00471-glmU SAOUHSC_00471-glmU 
SAOUHSC_00461 SAOUHSC_00472 SAOUHSC_00482 
SAOUHSC_00471-glmU SAOUHSC_00482 SAOUHSC_00484 
SAOUHSC_00472 SAOUHSC_00484 SAOUHSC_00485 
SAOUHSC_00481 SAOUHSC_00485 SAOUHSC_00490 
SAOUHSC_00482 SAOUHSC_00490 SAOUHSC_00491 
SAOUHSC_00484 SAOUHSC_00491 SAOUHSC_00493-lysS 
SAOUHSC_00485 SAOUHSC_00493-lysS SAOUHSC_00511-cysS 
SAOUHSC_00486-ftsH SAOUHSC_00511-cysS SAOUHSC_00518-rplK 
SAOUHSC_00490 SAOUHSC_00518-rplK SAOUHSC_00519-rplA 
SAOUHSC_00491 SAOUHSC_00519-rplA SAOUHSC_00520-rplJ 
SAOUHSC_00493-lysS SAOUHSC_00520-rplJ SAOUHSC_00521-rplL 
SAOUHSC_00510 SAOUHSC_00521-rplL SAOUHSC_00524-rpoB 
SAOUHSC_00511-cysS SAOUHSC_00524-rpoB SAOUHSC_00525 
SAOUHSC_00518-rplK SAOUHSC_00525 SAOUHSC_00527-rpsL 
SAOUHSC_00519-rplA SAOUHSC_00526 SAOUHSC_00528 
SAOUHSC_00520-rplJ SAOUHSC_00527-rpsL SAOUHSC_00529-fusA 
SAOUHSC_00521-rplL SAOUHSC_00528 SAOUHSC_00530-tuf 
SAOUHSC_00524-rpoB SAOUHSC_00529-fusA SAOUHSC_00574-eutD 
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SAOUHSC_00525 SAOUHSC_00530-tuf SAOUHSC_00575 
SAOUHSC_00527-rpsL SAOUHSC_00575 SAOUHSC_00578 
SAOUHSC_00528 SAOUHSC_00578 SAOUHSC_00579 
SAOUHSC_00529-fusA SAOUHSC_00579 SAOUHSC_00611-argS 
SAOUHSC_00530-tuf SAOUHSC_00611-argS SAOUHSC_00641-tarB 
SAOUHSC_00574-eutD SAOUHSC_00641-tarB SAOUHSC_00643-tarH 
SAOUHSC_00575 SAOUHSC_00643-tarH SAOUHSC_00645-tarD 
SAOUHSC_00578 SAOUHSC_00645-tarD SAOUHSC_00742 
SAOUHSC_00579 SAOUHSC_00742 SAOUHSC_00743-nrdF 
SAOUHSC_00610 SAOUHSC_00743-nrdF SAOUHSC_00752-murB 
SAOUHSC_00611-argS SAOUHSC_00752-murB SAOUHSC_00771 
SAOUHSC_00641-tarB SAOUHSC_00771 SAOUHSC_00778 
SAOUHSC_00643-tarH SAOUHSC_00778 SAOUHSC_00785 
SAOUHSC_00645-tarD SAOUHSC_00785 SAOUHSC_00788 
SAOUHSC_00742 SAOUHSC_00788 SAOUHSC_00795 
SAOUHSC_00743-nrdF SAOUHSC_00789 SAOUHSC_00796-pgk 
SAOUHSC_00752-murB SAOUHSC_00795 SAOUHSC_00797-tpiA 
SAOUHSC_00769-secA SAOUHSC_00796-pgk SAOUHSC_00798 
SAOUHSC_00771 SAOUHSC_00797-tpiA SAOUHSC_00799-eno 
SAOUHSC_00778 SAOUHSC_00798 SAOUHSC_00804-smpB 
SAOUHSC_00785 SAOUHSC_00799-eno SAOUHSC_00832 
SAOUHSC_00788 SAOUHSC_00804-smpB SAOUHSC_00848 
SAOUHSC_00795 SAOUHSC_00832 SAOUHSC_00849 
SAOUHSC_00796-pgk SAOUHSC_00848 SAOUHSC_00850 
SAOUHSC_00797-tpiA SAOUHSC_00849 SAOUHSC_00851 
SAOUHSC_00798 SAOUHSC_00850 SAOUHSC_00868 
SAOUHSC_00799-eno SAOUHSC_00851 SAOUHSC_00869-dltA 
SAOUHSC_00804-smpB SAOUHSC_00868 SAOUHSC_00870-dltB 
SAOUHSC_00832 SAOUHSC_00869-dltA SAOUHSC_00871-dltC 
SAOUHSC_00848 SAOUHSC_00870-dltB SAOUHSC_00872-dltD 
SAOUHSC_00849 SAOUHSC_00871-dltC SAOUHSC_00884 
SAOUHSC_00850 SAOUHSC_00872-dltD SAOUHSC_00885 
SAOUHSC_00851 SAOUHSC_00884 SAOUHSC_00886 
SAOUHSC_00868 SAOUHSC_00885 SAOUHSC_00887 
SAOUHSC_00869-dltA SAOUHSC_00886 SAOUHSC_00888 
SAOUHSC_00870-dltB SAOUHSC_00887 SAOUHSC_00889 
SAOUHSC_00871-dltC SAOUHSC_00888 SAOUHSC_00900-pgi 
SAOUHSC_00872-dltD SAOUHSC_00889 SAOUHSC_00903 
SAOUHSC_00884 SAOUHSC_00900-pgi SAOUHSC_00904 
SAOUHSC_00885 SAOUHSC_00903 SAOUHSC_00905 
SAOUHSC_00886 SAOUHSC_00904 SAOUHSC_00921 
SAOUHSC_00887 SAOUHSC_00905 SAOUHSC_00933 
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SAOUHSC_00888 SAOUHSC_00921 SAOUHSC_00943-ppnK 
SAOUHSC_00889 SAOUHSC_00933 SAOUHSC_00953-ypfP 
SAOUHSC_00900-pgi SAOUHSC_00943-ppnK SAOUHSC_00980-menA 
SAOUHSC_00903 SAOUHSC_00947 SAOUHSC_00982-menF 
SAOUHSC_00904 SAOUHSC_00953-ypfP SAOUHSC_00983-menD 
SAOUHSC_00905 SAOUHSC_00980-menA SAOUHSC_00985 
SAOUHSC_00921 SAOUHSC_00981 SAOUHSC_01035 
SAOUHSC_00933 SAOUHSC_00982-menF SAOUHSC_01036 
SAOUHSC_00943-ppnK SAOUHSC_00983-menD SAOUHSC_01040 
SAOUHSC_00947 SAOUHSC_00984 SAOUHSC_01041 
SAOUHSC_00953-ypfP SAOUHSC_00985 SAOUHSC_01042 
SAOUHSC_00980-menA SAOUHSC_01000 SAOUHSC_01043 
SAOUHSC_00981 SAOUHSC_01035 SAOUHSC_01063-ftsW 
SAOUHSC_00982-menF SAOUHSC_01036 SAOUHSC_01075-coaD 
SAOUHSC_00983-menD SAOUHSC_01040 SAOUHSC_01093-pheT 
SAOUHSC_00985 SAOUHSC_01041 SAOUHSC_01144-ftsL 
SAOUHSC_01000 SAOUHSC_01042 SAOUHSC_01145 
SAOUHSC_01002 SAOUHSC_01043 SAOUHSC_01146-mraY 
SAOUHSC_01035 SAOUHSC_01063-ftsW SAOUHSC_01147-murD 
SAOUHSC_01036 SAOUHSC_01075-coaD SAOUHSC_01148-div1B 
SAOUHSC_01040 SAOUHSC_01078 SAOUHSC_01149 
SAOUHSC_01041 SAOUHSC_01093-pheT SAOUHSC_01150-ftsZ 
SAOUHSC_01042 SAOUHSC_01144-ftsL SAOUHSC_01159-ileS 
SAOUHSC_01043 SAOUHSC_01145 SAOUHSC_01163 
SAOUHSC_01063-ftsW SAOUHSC_01146-mraY SAOUHSC_01166-pyrB 
SAOUHSC_01075-coaD SAOUHSC_01147-murD SAOUHSC_01168-pyrC 
SAOUHSC_01077 SAOUHSC_01148-div1B SAOUHSC_01169 
SAOUHSC_01078 SAOUHSC_01149 SAOUHSC_01170-carB 
SAOUHSC_01092-pheS SAOUHSC_01150-ftsZ SAOUHSC_01172-pyrE 
SAOUHSC_01093-pheT SAOUHSC_01159-ileS SAOUHSC_01179 
SAOUHSC_01142 SAOUHSC_01163 SAOUHSC_01183 
SAOUHSC_01143-mraW SAOUHSC_01166-pyrB SAOUHSC_01189 
SAOUHSC_01144-ftsL SAOUHSC_01168-pyrC SAOUHSC_01190 
SAOUHSC_01145 SAOUHSC_01169 SAOUHSC_01194 
SAOUHSC_01146-mraY SAOUHSC_01170-carB SAOUHSC_01197 
SAOUHSC_01147-murD SAOUHSC_01171 SAOUHSC_01198 
SAOUHSC_01148-div1B SAOUHSC_01172-pyrE SAOUHSC_01199 
SAOUHSC_01149 SAOUHSC_01178 SAOUHSC_01201-acpP 
SAOUHSC_01150-ftsZ SAOUHSC_01179 SAOUHSC_01205 
SAOUHSC_01158 SAOUHSC_01183 SAOUHSC_01207 
SAOUHSC_01159-ileS SAOUHSC_01188 SAOUHSC_01210-trmD 
SAOUHSC_01163 SAOUHSC_01189 SAOUHSC_01211-rplS 
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SAOUHSC_01166-pyrB SAOUHSC_01190 SAOUHSC_01216-sucC 
SAOUHSC_01168-pyrC SAOUHSC_01194 SAOUHSC_01222 
SAOUHSC_01169 SAOUHSC_01197 SAOUHSC_01228-codY 
SAOUHSC_01170-carB SAOUHSC_01198 SAOUHSC_01233 
SAOUHSC_01171 SAOUHSC_01199 SAOUHSC_01234-tsf 
SAOUHSC_01172-pyrE SAOUHSC_01201-acpP SAOUHSC_01235-pyrH 
SAOUHSC_01178 SAOUHSC_01205 SAOUHSC_01236-frr 
SAOUHSC_01179 SAOUHSC_01207 SAOUHSC_01238 
SAOUHSC_01183 SAOUHSC_01210-trmD SAOUHSC_01240 
SAOUHSC_01188 SAOUHSC_01211-rplS SAOUHSC_01241-polC 
SAOUHSC_01189 SAOUHSC_01216-sucC SAOUHSC_01243-nusA 
SAOUHSC_01190 SAOUHSC_01218 SAOUHSC_01244 
SAOUHSC_01194 SAOUHSC_01222 SAOUHSC_01245 
SAOUHSC_01197 SAOUHSC_01228-codY SAOUHSC_01246-infB 
SAOUHSC_01198 SAOUHSC_01234-tsf SAOUHSC_01249 
SAOUHSC_01199 SAOUHSC_01235-pyrH SAOUHSC_01250-rpsO 
SAOUHSC_01200 SAOUHSC_01236-frr SAOUHSC_01252 
SAOUHSC_01201-acpP SAOUHSC_01238 SAOUHSC_01260 
SAOUHSC_01205 SAOUHSC_01240 SAOUHSC_01262-recA 
SAOUHSC_01207 SAOUHSC_01241-polC SAOUHSC_01287 
SAOUHSC_01209-rimM SAOUHSC_01243-nusA SAOUHSC_01337 
SAOUHSC_01210-trmD SAOUHSC_01244 SAOUHSC_01351 
SAOUHSC_01211-rplS SAOUHSC_01245 SAOUHSC_01352 
SAOUHSC_01216-sucC SAOUHSC_01246-infB SAOUHSC_01373 
SAOUHSC_01218 SAOUHSC_01249 SAOUHSC_01374 
SAOUHSC_01222 SAOUHSC_01250-rpsO SAOUHSC_01424-murG 
SAOUHSC_01228-codY SAOUHSC_01252 SAOUHSC_01434 
SAOUHSC_01230 SAOUHSC_01260 SAOUHSC_01467 
SAOUHSC_01234-tsf SAOUHSC_01262-recA SAOUHSC_01470 
SAOUHSC_01235-pyrH SAOUHSC_01287 SAOUHSC_01473 
SAOUHSC_01236-frr SAOUHSC_01337 SAOUHSC_01474 
SAOUHSC_01238 SAOUHSC_01351 SAOUHSC_01481 
SAOUHSC_01239 SAOUHSC_01352 SAOUHSC_01482-aroB 
SAOUHSC_01240 SAOUHSC_01373 SAOUHSC_01483-aroF 
SAOUHSC_01241-polC SAOUHSC_01374 SAOUHSC_01487-ubiE 
SAOUHSC_01243-nusA SAOUHSC_01424-murG SAOUHSC_01491-gpsA 
SAOUHSC_01244 SAOUHSC_01434 SAOUHSC_01492-engA 
SAOUHSC_01245 SAOUHSC_01467 SAOUHSC_01496-cmk 
SAOUHSC_01246-infB SAOUHSC_01470 SAOUHSC_01501 
SAOUHSC_01249 SAOUHSC_01473 SAOUHSC_01591 
SAOUHSC_01250-rpsO SAOUHSC_01474 SAOUHSC_01592-fur 
SAOUHSC_01252 SAOUHSC_01481 SAOUHSC_01598 
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SAOUHSC_01259 SAOUHSC_01482-aroB SAOUHSC_01612-bkdA2 
SAOUHSC_01260 SAOUHSC_01483-aroF SAOUHSC_01613-bkdA1 
SAOUHSC_01262-recA SAOUHSC_01487-ubiE SAOUHSC_01619 
SAOUHSC_01265 SAOUHSC_01492-engA SAOUHSC_01621-nusB 
SAOUHSC_01267 SAOUHSC_01501 SAOUHSC_01623 
SAOUHSC_01287 SAOUHSC_01550 SAOUHSC_01624 
SAOUHSC_01337 SAOUHSC_01553 SAOUHSC_01659 
SAOUHSC_01351 SAOUHSC_01555 SAOUHSC_01661 
SAOUHSC_01352 SAOUHSC_01556 SAOUHSC_01662 
SAOUHSC_01373 SAOUHSC_01567 SAOUHSC_01663 
SAOUHSC_01374 SAOUHSC_01575 SAOUHSC_01666 
SAOUHSC_01424-murG SAOUHSC_01591 SAOUHSC_01668-era 
SAOUHSC_01434 SAOUHSC_01592-fur SAOUHSC_01672 
SAOUHSC_01467 SAOUHSC_01598 SAOUHSC_01690-holA 
SAOUHSC_01470 SAOUHSC_01612-bkdA2 SAOUHSC_01697 
SAOUHSC_01473 SAOUHSC_01613-bkdA1 SAOUHSC_01698 
SAOUHSC_01474 SAOUHSC_01623 SAOUHSC_01700 
SAOUHSC_01481 SAOUHSC_01624 SAOUHSC_01701 
SAOUHSC_01482-aroB SAOUHSC_01659 SAOUHSC_01720 
SAOUHSC_01483-aroF SAOUHSC_01661 SAOUHSC_01721 
SAOUHSC_01487-ubiE SAOUHSC_01662 SAOUHSC_01722-alaS 
SAOUHSC_01488 SAOUHSC_01663 SAOUHSC_01727 
SAOUHSC_01491-gpsA SAOUHSC_01666 SAOUHSC_01738-hisS 
SAOUHSC_01492-engA SAOUHSC_01668-era SAOUHSC_01746 
SAOUHSC_01496-cmk SAOUHSC_01672 SAOUHSC_01753-obgE 
SAOUHSC_01501 SAOUHSC_01690-holA SAOUHSC_01756 
SAOUHSC_01591 SAOUHSC_01697 SAOUHSC_01757-rplU 
SAOUHSC_01592-fur SAOUHSC_01698 SAOUHSC_01766 
SAOUHSC_01598 SAOUHSC_01700 SAOUHSC_01767-valS 
SAOUHSC_01599 SAOUHSC_01701 SAOUHSC_01772 
SAOUHSC_01612-bkdA2 SAOUHSC_01702 SAOUHSC_01773 
SAOUHSC_01613-bkdA1 SAOUHSC_01720 SAOUHSC_01774-hemC 
SAOUHSC_01614 SAOUHSC_01721 SAOUHSC_01776-hemA 
SAOUHSC_01619 SAOUHSC_01722-alaS SAOUHSC_01782 
SAOUHSC_01623 SAOUHSC_01727 SAOUHSC_01784-rplT 
SAOUHSC_01624 SAOUHSC_01738-hisS SAOUHSC_01785-rpmI 
SAOUHSC_01635 SAOUHSC_01746 SAOUHSC_01786-infC 
SAOUHSC_01659 SAOUHSC_01753-obgE SAOUHSC_01787 
SAOUHSC_01661 SAOUHSC_01756 SAOUHSC_01791 
SAOUHSC_01662 SAOUHSC_01757-rplU SAOUHSC_01792 
SAOUHSC_01663 SAOUHSC_01766 SAOUHSC_01807 
SAOUHSC_01666 SAOUHSC_01767-valS SAOUHSC_01809 
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SAOUHSC_01668-era SAOUHSC_01772 SAOUHSC_01826 
SAOUHSC_01670 SAOUHSC_01773 SAOUHSC_01839 
SAOUHSC_01672 SAOUHSC_01774-hemC SAOUHSC_01865-trmB 
SAOUHSC_01690-holA SAOUHSC_01776-hemA SAOUHSC_01858 
SAOUHSC_01697 SAOUHSC_01784-rplT SAOUHSC_01866 
SAOUHSC_01698 SAOUHSC_01785-rpmI SAOUHSC_01871 
SAOUHSC_01699-aroE SAOUHSC_01786-infC SAOUHSC_01875-leuS 
SAOUHSC_01700 SAOUHSC_01787 SAOUHSC_01915-menC 
SAOUHSC_01701 SAOUHSC_01791 SAOUHSC_01916 
SAOUHSC_01720 SAOUHSC_01792 SAOUHSC_01961-hemH 
SAOUHSC_01721 SAOUHSC_01807 SAOUHSC_01962-hemE 
SAOUHSC_01722-alaS SAOUHSC_01809 SAOUHSC_01973 
SAOUHSC_01727 SAOUHSC_01811 SAOUHSC_02106 
SAOUHSC_01738-hisS SAOUHSC_01812 SAOUHSC_02107 
SAOUHSC_01741 SAOUHSC_01826 SAOUHSC_02114 
SAOUHSC_01746 SAOUHSC_01839 SAOUHSC_02116-gatB 
SAOUHSC_01750-ruvB SAOUHSC_01865-trmB SAOUHSC_02117-gatA 
SAOUHSC_01753-obgE SAOUHSC_01866 SAOUHSC_02118-gatC 
SAOUHSC_01756 SAOUHSC_01871 SAOUHSC_02122 
SAOUHSC_01757-rplU SAOUHSC_01875-leuS SAOUHSC_02123 
SAOUHSC_01766 SAOUHSC_01909 SAOUHSC_02133 
SAOUHSC_01767-valS SAOUHSC_01915-menC SAOUHSC_02140 
SAOUHSC_01772 SAOUHSC_01916 SAOUHSC_02143 
SAOUHSC_01773 SAOUHSC_01961-hemH SAOUHSC_02151 
SAOUHSC_01774-hemC SAOUHSC_01962-hemE SAOUHSC_02152 
SAOUHSC_01776-hemA SAOUHSC_01973 SAOUHSC_02228 
SAOUHSC_01778-clpX SAOUHSC_02106 SAOUHSC_02277-gcp 
SAOUHSC_01782 SAOUHSC_02107 SAOUHSC_02279 
SAOUHSC_01783 SAOUHSC_02114 SAOUHSC_02280 
SAOUHSC_01784-rplT SAOUHSC_02116-gatB SAOUHSC_02318-ddl 
SAOUHSC_01785-rpmI SAOUHSC_02117-gatA SAOUHSC_02336-fabZ 
SAOUHSC_01786-infC SAOUHSC_02118-gatC SAOUHSC_02357 
SAOUHSC_01787 SAOUHSC_02122 SAOUHSC_02359-prfA 
SAOUHSC_01789 SAOUHSC_02123 SAOUHSC_02369 
SAOUHSC_01791 SAOUHSC_02133 SAOUHSC_02400 
SAOUHSC_01792 SAOUHSC_02140 SAOUHSC_02409 
SAOUHSC_01793-nrdR SAOUHSC_02143 SAOUHSC_02480-truA 
SAOUHSC_01807 SAOUHSC_02151 SAOUHSC_02486 
SAOUHSC_01809 SAOUHSC_02152 SAOUHSC_02487-rpsM 
SAOUHSC_01811 SAOUHSC_02219 SAOUHSC_02488-rpmJ 
SAOUHSC_01828 SAOUHSC_02220 SAOUHSC_02489-infA 
SAOUHSC_01839 SAOUHSC_02227 SAOUHSC_02490-adk 
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SAOUHSC_01865-trmB SAOUHSC_02228 SAOUHSC_02491-secY 
SAOUHSC_01858 SAOUHSC_02233 SAOUHSC_02492-rplO 
SAOUHSC_01866 SAOUHSC_02255-groES SAOUHSC_02493-rpmD 
SAOUHSC_01871 SAOUHSC_02277-gcp SAOUHSC_02494-rpsE 
SAOUHSC_01875-leuS SAOUHSC_02279 SAOUHSC_02495-rplR 
SAOUHSC_01915-menC SAOUHSC_02280 SAOUHSC_02496-rplF 
SAOUHSC_01916 SAOUHSC_02318-ddl SAOUHSC_02498-rpsH 
SAOUHSC_01961-hemH SAOUHSC_02336-fabZ SAOUHSC_02499-rpsN 
SAOUHSC_01962-hemE SAOUHSC_02357 SAOUHSC_02500-rplE 
SAOUHSC_01973 SAOUHSC_02359-prfA SAOUHSC_02501-rplX 
SAOUHSC_02106 SAOUHSC_02369 SAOUHSC_02502-rplN 
SAOUHSC_02107 SAOUHSC_02400 SAOUHSC_02503-rpsQ 
SAOUHSC_02114 SAOUHSC_02409 SAOUHSC_02504 
SAOUHSC_02116-gatB SAOUHSC_02480-truA SAOUHSC_02505-rplP 
SAOUHSC_02117-gatA SAOUHSC_02486 SAOUHSC_02506-rpsC 
SAOUHSC_02118-gatC SAOUHSC_02487-rpsM SAOUHSC_02507-rplV 
SAOUHSC_02122 SAOUHSC_02488-rpmJ SAOUHSC_02508-rpsS 
SAOUHSC_02123 SAOUHSC_02489-infA SAOUHSC_02509-rplB 
SAOUHSC_02133 SAOUHSC_02490-adk SAOUHSC_02510-rplW 
SAOUHSC_02140 SAOUHSC_02491-secY SAOUHSC_02511-rplD 
SAOUHSC_02143 SAOUHSC_02492-rplO SAOUHSC_02512a 
SAOUHSC_02151 SAOUHSC_02493-rpmD SAOUHSC_02512-rplC 
SAOUHSC_02152 SAOUHSC_02494-rpsE SAOUHSC_02515 
SAOUHSC_02255-groES SAOUHSC_02495-rplR SAOUHSC_02528 
SAOUHSC_02277-gcp SAOUHSC_02496-rplF SAOUHSC_02612 
SAOUHSC_02278 SAOUHSC_02498-rpsH SAOUHSC_02623 
SAOUHSC_02279 SAOUHSC_02499-rpsN SAOUHSC_02793-pgcA 
SAOUHSC_02280 SAOUHSC_02500-rplE SAOUHSC_03053-trmE 
SAOUHSC_02318-ddl SAOUHSC_02501-rplX SAOUHSC_03054-rnpA 
SAOUHSC_02336-fabZ SAOUHSC_02502-rplN SAOUHSC_A01514 
SAOUHSC_02357 SAOUHSC_02503-rpsQ 
 SAOUHSC_02359-prfA SAOUHSC_02504 
 SAOUHSC_02369 SAOUHSC_02505-rplP 
 SAOUHSC_02400 SAOUHSC_02506-rpsC 
 SAOUHSC_02409 SAOUHSC_02507-rplV 
 SAOUHSC_02480-truA SAOUHSC_02508-rpsS 
 SAOUHSC_02483-cbiO SAOUHSC_02509-rplB 
 SAOUHSC_02486 SAOUHSC_02510-rplW 
 SAOUHSC_02487-rpsM SAOUHSC_02511-rplD 
 SAOUHSC_02488-rpmJ SAOUHSC_02512a 
 SAOUHSC_02489-infA SAOUHSC_02512-rplC 
 SAOUHSC_02490-adk SAOUHSC_02515 
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SAOUHSC_02491-secY SAOUHSC_02528 
 SAOUHSC_02492-rplO SAOUHSC_02612 
 SAOUHSC_02493-rpmD SAOUHSC_02623 
 SAOUHSC_02494-rpsE SAOUHSC_02805 
 SAOUHSC_02495-rplR SAOUHSC_03053-trmE 
 SAOUHSC_02496-rplF SAOUHSC_03054-rnpA 
 SAOUHSC_02498-rpsH 
  SAOUHSC_02499-rpsN 
  SAOUHSC_02500-rplE 
  SAOUHSC_02501-rplX 
  SAOUHSC_02502-rplN 
  SAOUHSC_02503-rpsQ 
  SAOUHSC_02504 
  SAOUHSC_02505-rplP 
  SAOUHSC_02506-rpsC 
  SAOUHSC_02507-rplV 
  SAOUHSC_02508-rpsS 
  SAOUHSC_02509-rplB 
  SAOUHSC_02510-rplW 
  SAOUHSC_02511-rplD 
  SAOUHSC_02512a 
  SAOUHSC_02512-rplC 
  SAOUHSC_02515 
  SAOUHSC_02528 
  SAOUHSC_02612 
  SAOUHSC_02623 
  SAOUHSC_02793-pgcA 
  SAOUHSC_03052 
  SAOUHSC_03053-trmE 
  SAOUHSC_03054-rnpA 
  SAOUHSC_03055-rpmH 
  SAOUHSC_A01514 
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E. Essential genes in three studies 
 
Valentino Essential Genes Chaudhuri Essential Genes Santiago Essential Genes 
SAOUHSC_00001 SAOUHSC_00001 SAOUHSC_00001 
SAOUHSC_00002 SAOUHSC_00002 SAOUHSC_00005 
SAOUHSC_00005 SAOUHSC_00003 SAOUHSC_00006 
SAOUHSC_00006 SAOUHSC_00005 SAOUHSC_00009 
SAOUHSC_00009 SAOUHSC_00006 SAOUHSC_00015 
SAOUHSC_00017 SAOUHSC_00015 SAOUHSC_00017 
SAOUHSC_00018 SAOUHSC_00018 SAOUHSC_00018 
SAOUHSC_00020 SAOUHSC_00020 SAOUHSC_00021 
SAOUHSC_00021 SAOUHSC_00021 SAOUHSC_00226 
SAOUHSC_00038 SAOUHSC_00226 SAOUHSC_00349 
SAOUHSC_00112 SAOUHSC_00336 SAOUHSC_00350 
SAOUHSC_00223 SAOUHSC_00345 SAOUHSC_00374 
SAOUHSC_00226 SAOUHSC_00349 SAOUHSC_00375 
SAOUHSC_00227 SAOUHSC_00350 SAOUHSC_00413 
SAOUHSC_00275 SAOUHSC_00375 SAOUHSC_00442 
SAOUHSC_00345 SAOUHSC_00442 SAOUHSC_00444 
SAOUHSC_00348 SAOUHSC_00444 SAOUHSC_00445 
SAOUHSC_00374 SAOUHSC_00454 SAOUHSC_00451 
SAOUHSC_00375 SAOUHSC_00461 SAOUHSC_00454 
SAOUHSC_00444 SAOUHSC_00474 SAOUHSC_00461 
SAOUHSC_00451 SAOUHSC_00475 SAOUHSC_00471 
SAOUHSC_00453 SAOUHSC_00482 SAOUHSC_00472 
SAOUHSC_00454 SAOUHSC_00484 SAOUHSC_00481 
SAOUHSC_00461 SAOUHSC_00489 SAOUHSC_00482 
SAOUHSC_00471 SAOUHSC_00490 SAOUHSC_00484 
SAOUHSC_00472 SAOUHSC_00491 SAOUHSC_00485 
SAOUHSC_00473 SAOUHSC_00493 SAOUHSC_00486 
SAOUHSC_00475 SAOUHSC_00509 SAOUHSC_00490 
SAOUHSC_00481 SAOUHSC_00510 SAOUHSC_00491 
SAOUHSC_00482 SAOUHSC_00511 SAOUHSC_00493 
SAOUHSC_00484 SAOUHSC_00516 SAOUHSC_00510 
SAOUHSC_00486 SAOUHSC_00518 SAOUHSC_00511 
SAOUHSC_00489 SAOUHSC_00519 SAOUHSC_00518 
SAOUHSC_00490 SAOUHSC_00520 SAOUHSC_00519 
SAOUHSC_00491 SAOUHSC_00521 SAOUHSC_00520 
SAOUHSC_00509 SAOUHSC_00525 SAOUHSC_00521 
SAOUHSC_00510 SAOUHSC_00527 SAOUHSC_00524 
SAOUHSC_00516 SAOUHSC_00529 SAOUHSC_00525 
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SAOUHSC_00518 SAOUHSC_00530 SAOUHSC_00527 
SAOUHSC_00519 SAOUHSC_00549 SAOUHSC_00528 
SAOUHSC_00521 SAOUHSC_00575 SAOUHSC_00529 
SAOUHSC_00524 SAOUHSC_00577 SAOUHSC_00530 
SAOUHSC_00525 SAOUHSC_00578 SAOUHSC_00574 
SAOUHSC_00526 SAOUHSC_00579 SAOUHSC_00575 
SAOUHSC_00527 SAOUHSC_00611 SAOUHSC_00578 
SAOUHSC_00529 SAOUHSC_00640 SAOUHSC_00579 
SAOUHSC_00549 SAOUHSC_00642 SAOUHSC_00610 
SAOUHSC_00573 SAOUHSC_00643 SAOUHSC_00611 
SAOUHSC_00574 SAOUHSC_00645 SAOUHSC_00641 
SAOUHSC_00578 SAOUHSC_00741 SAOUHSC_00643 
SAOUHSC_00579 SAOUHSC_00742 SAOUHSC_00645 
SAOUHSC_00611 SAOUHSC_00752 SAOUHSC_00742 
SAOUHSC_00640 SAOUHSC_00760 SAOUHSC_00743 
SAOUHSC_00641 SAOUHSC_00762 SAOUHSC_00752 
SAOUHSC_00642 SAOUHSC_00769 SAOUHSC_00769 
SAOUHSC_00643 SAOUHSC_00771 SAOUHSC_00771 
SAOUHSC_00680 SAOUHSC_00781 SAOUHSC_00778 
SAOUHSC_00728 SAOUHSC_00785 SAOUHSC_00785 
SAOUHSC_00735 SAOUHSC_00788 SAOUHSC_00788 
SAOUHSC_00741 SAOUHSC_00790 SAOUHSC_00795 
SAOUHSC_00778 SAOUHSC_00803 SAOUHSC_00796 
SAOUHSC_00790 SAOUHSC_00849 SAOUHSC_00797 
SAOUHSC_00794 SAOUHSC_00850 SAOUHSC_00798 
SAOUHSC_00795 SAOUHSC_00851 SAOUHSC_00799 
SAOUHSC_00796 SAOUHSC_00868 SAOUHSC_00804 
SAOUHSC_00799 SAOUHSC_00870 SAOUHSC_00832 
SAOUHSC_00851 SAOUHSC_00920 SAOUHSC_00848 
SAOUHSC_00857 SAOUHSC_00921 SAOUHSC_00849 
SAOUHSC_00871 SAOUHSC_00947 SAOUHSC_00850 
SAOUHSC_00872 SAOUHSC_00954 SAOUHSC_00851 
SAOUHSC_00886 SAOUHSC_00998 SAOUHSC_00868 
SAOUHSC_00887 SAOUHSC_01028 SAOUHSC_00869 
SAOUHSC_00896 SAOUHSC_01038 SAOUHSC_00870 
SAOUHSC_00900 SAOUHSC_01040 SAOUHSC_00871 
SAOUHSC_00920 SAOUHSC_01050 SAOUHSC_00872 
SAOUHSC_00921 SAOUHSC_01063 SAOUHSC_00884 
SAOUHSC_00933 SAOUHSC_01075 SAOUHSC_00885 
SAOUHSC_00934 SAOUHSC_01077 SAOUHSC_00886 
SAOUHSC_00938 SAOUHSC_01078 SAOUHSC_00887 
SAOUHSC_00943 SAOUHSC_01093 SAOUHSC_00888 
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SAOUHSC_01023 SAOUHSC_01148 SAOUHSC_00889 
SAOUHSC_01028 SAOUHSC_01149 SAOUHSC_00900 
SAOUHSC_01035 SAOUHSC_01150 SAOUHSC_00903 
SAOUHSC_01063 SAOUHSC_01159 SAOUHSC_00904 
SAOUHSC_01075 SAOUHSC_01176 SAOUHSC_00905 
SAOUHSC_01093 SAOUHSC_01179 SAOUHSC_00921 
SAOUHSC_01106 SAOUHSC_01183 SAOUHSC_00933 
SAOUHSC_01118 SAOUHSC_01188 SAOUHSC_00943 
SAOUHSC_01143 SAOUHSC_01190 SAOUHSC_00947 
SAOUHSC_01144 SAOUHSC_01191 SAOUHSC_00953 
SAOUHSC_01145 SAOUHSC_01197 SAOUHSC_00980 
SAOUHSC_01146 SAOUHSC_01198 SAOUHSC_00981 
SAOUHSC_01154 SAOUHSC_01208 SAOUHSC_00982 
SAOUHSC_01176 SAOUHSC_01211 SAOUHSC_00983 
SAOUHSC_01178 SAOUHSC_01214 SAOUHSC_00985 
SAOUHSC_01179 SAOUHSC_01216 SAOUHSC_01000 
SAOUHSC_01183 SAOUHSC_01222 SAOUHSC_01002 
SAOUHSC_01190 SAOUHSC_01234 SAOUHSC_01035 
SAOUHSC_01191 SAOUHSC_01235 SAOUHSC_01036 
SAOUHSC_01196 SAOUHSC_01236 SAOUHSC_01040 
SAOUHSC_01197 SAOUHSC_01237 SAOUHSC_01041 
SAOUHSC_01198 SAOUHSC_01238 SAOUHSC_01042 
SAOUHSC_01199 SAOUHSC_01240 SAOUHSC_01043 
SAOUHSC_01200 SAOUHSC_01241 SAOUHSC_01063 
SAOUHSC_01203 SAOUHSC_01244 SAOUHSC_01075 
SAOUHSC_01207 SAOUHSC_01246 SAOUHSC_01077 
SAOUHSC_01224 SAOUHSC_01260 SAOUHSC_01078 
SAOUHSC_01232 SAOUHSC_01287 SAOUHSC_01092 
SAOUHSC_01234 SAOUHSC_01337 SAOUHSC_01093 
SAOUHSC_01235 SAOUHSC_01350 SAOUHSC_01142 
SAOUHSC_01236 SAOUHSC_01351 SAOUHSC_01143 
SAOUHSC_01237 SAOUHSC_01352 SAOUHSC_01144 
SAOUHSC_01238 SAOUHSC_01359 SAOUHSC_01145 
SAOUHSC_01239 SAOUHSC_01361 SAOUHSC_01146 
SAOUHSC_01240 SAOUHSC_01362 SAOUHSC_01147 
SAOUHSC_01241 SAOUHSC_01373 SAOUHSC_01148 
SAOUHSC_01259 SAOUHSC_01467 SAOUHSC_01149 
SAOUHSC_01260 SAOUHSC_01470 SAOUHSC_01150 
SAOUHSC_01262 SAOUHSC_01473 SAOUHSC_01158 
SAOUHSC_01270 SAOUHSC_01477 SAOUHSC_01159 
SAOUHSC_01285 SAOUHSC_01490 SAOUHSC_01163 
SAOUHSC_01287 SAOUHSC_01492 SAOUHSC_01166 
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SAOUHSC_01338 SAOUHSC_01598 SAOUHSC_01168 
SAOUHSC_01350 SAOUHSC_01599 SAOUHSC_01169 
SAOUHSC_01374 SAOUHSC_01625 SAOUHSC_01170 
SAOUHSC_01390 SAOUHSC_01627 SAOUHSC_01171 
SAOUHSC_01409 SAOUHSC_01661 SAOUHSC_01172 
SAOUHSC_01434 SAOUHSC_01666 SAOUHSC_01178 
SAOUHSC_01435 SAOUHSC_01668 SAOUHSC_01179 
SAOUHSC_01441 SAOUHSC_01672 SAOUHSC_01183 
SAOUHSC_01473 SAOUHSC_01683 SAOUHSC_01188 
SAOUHSC_01474 SAOUHSC_01684 SAOUHSC_01189 
SAOUHSC_01487 SAOUHSC_01700 SAOUHSC_01190 
SAOUHSC_01490 SAOUHSC_01701 SAOUHSC_01194 
SAOUHSC_01492 SAOUHSC_01714 SAOUHSC_01197 
SAOUHSC_01496 SAOUHSC_01720 SAOUHSC_01198 
SAOUHSC_01501 SAOUHSC_01721 SAOUHSC_01199 
SAOUHSC_01550 SAOUHSC_01725 SAOUHSC_01200 
SAOUHSC_01551 SAOUHSC_01726 SAOUHSC_01201 
SAOUHSC_01554 SAOUHSC_01727 SAOUHSC_01205 
SAOUHSC_01555 SAOUHSC_01737 SAOUHSC_01207 
SAOUHSC_01573 SAOUHSC_01738 SAOUHSC_01209 
SAOUHSC_01619 SAOUHSC_01755 SAOUHSC_01210 
SAOUHSC_01623 SAOUHSC_01756 SAOUHSC_01211 
SAOUHSC_01624 SAOUHSC_01757 SAOUHSC_01216 
SAOUHSC_01625 SAOUHSC_01766 SAOUHSC_01218 
SAOUHSC_01662 SAOUHSC_01770 SAOUHSC_01222 
SAOUHSC_01663 SAOUHSC_01777 SAOUHSC_01228 
SAOUHSC_01669 SAOUHSC_01784 SAOUHSC_01230 
SAOUHSC_01672 SAOUHSC_01785 SAOUHSC_01234 
SAOUHSC_01682 SAOUHSC_01786 SAOUHSC_01235 
SAOUHSC_01683 SAOUHSC_01787 SAOUHSC_01236 
SAOUHSC_01684 SAOUHSC_01788 SAOUHSC_01238 
SAOUHSC_01687 SAOUHSC_01791 SAOUHSC_01239 
SAOUHSC_01698 SAOUHSC_01806 SAOUHSC_01240 
SAOUHSC_01700 SAOUHSC_01807 SAOUHSC_01241 
SAOUHSC_01727 SAOUHSC_01837 SAOUHSC_01243 
SAOUHSC_01737 SAOUHSC_01839 SAOUHSC_01244 
SAOUHSC_01738 SAOUHSC_01856 SAOUHSC_01245 
SAOUHSC_01741 SAOUHSC_01866 SAOUHSC_01246 
SAOUHSC_01746 SAOUHSC_01871 SAOUHSC_01249 
SAOUHSC_01753 SAOUHSC_01875 SAOUHSC_01250 
SAOUHSC_01755 SAOUHSC_01908 SAOUHSC_01252 
SAOUHSC_01756 SAOUHSC_01909 SAOUHSC_01259 
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SAOUHSC_01757 SAOUHSC_01928 SAOUHSC_01260 
SAOUHSC_01760 SAOUHSC_01930 SAOUHSC_01262 
SAOUHSC_01767 SAOUHSC_02102 SAOUHSC_01265 
SAOUHSC_01772 SAOUHSC_02106 SAOUHSC_01267 
SAOUHSC_01773 SAOUHSC_02107 SAOUHSC_01287 
SAOUHSC_01774 SAOUHSC_02114 SAOUHSC_01337 
SAOUHSC_01777 SAOUHSC_02117 SAOUHSC_01351 
SAOUHSC_01778 SAOUHSC_02118 SAOUHSC_01352 
SAOUHSC_01784 SAOUHSC_02122 SAOUHSC_01373 
SAOUHSC_01785 SAOUHSC_02123 SAOUHSC_01374 
SAOUHSC_01786 SAOUHSC_02132 SAOUHSC_01424 
SAOUHSC_01787 SAOUHSC_02133 SAOUHSC_01434 
SAOUHSC_01788 SAOUHSC_02140 SAOUHSC_01467 
SAOUHSC_01789 SAOUHSC_02151 SAOUHSC_01470 
SAOUHSC_01791 SAOUHSC_02152 SAOUHSC_01473 
SAOUHSC_01792 SAOUHSC_02254 SAOUHSC_01474 
SAOUHSC_01804 SAOUHSC_02260 SAOUHSC_01481 
SAOUHSC_01805 SAOUHSC_02277 SAOUHSC_01482 
SAOUHSC_01807 SAOUHSC_02279 SAOUHSC_01483 
SAOUHSC_01808 SAOUHSC_02280 SAOUHSC_01487 
SAOUHSC_01809 SAOUHSC_02306 SAOUHSC_01488 
SAOUHSC_01811 SAOUHSC_02317 SAOUHSC_01491 
SAOUHSC_01827 SAOUHSC_02318 SAOUHSC_01492 
SAOUHSC_01829 SAOUHSC_02327 SAOUHSC_01496 
SAOUHSC_01837 SAOUHSC_02336 SAOUHSC_01501 
SAOUHSC_01839 SAOUHSC_02337 SAOUHSC_01591 
SAOUHSC_01841 SAOUHSC_02357 SAOUHSC_01592 
SAOUHSC_01856 SAOUHSC_02359 SAOUHSC_01598 
SAOUHSC_01857 SAOUHSC_02361 SAOUHSC_01599 
SAOUHSC_01858 SAOUHSC_02366 SAOUHSC_01612 
SAOUHSC_01859 SAOUHSC_02368 SAOUHSC_01613 
SAOUHSC_01871 SAOUHSC_02371 SAOUHSC_01614 
SAOUHSC_01875 SAOUHSC_02399 SAOUHSC_01619 
SAOUHSC_01905 SAOUHSC_02405 SAOUHSC_01623 
SAOUHSC_01906 SAOUHSC_02407 SAOUHSC_01624 
SAOUHSC_01908 SAOUHSC_02477 SAOUHSC_01635 
SAOUHSC_01909 SAOUHSC_02478 SAOUHSC_01659 
SAOUHSC_01911 SAOUHSC_02484 SAOUHSC_01661 
SAOUHSC_01924 SAOUHSC_02485 SAOUHSC_01662 
SAOUHSC_01961 SAOUHSC_02486 SAOUHSC_01663 
SAOUHSC_01962 SAOUHSC_02487 SAOUHSC_01666 
SAOUHSC_01973 SAOUHSC_02488 SAOUHSC_01668 
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SAOUHSC_01977 SAOUHSC_02489 SAOUHSC_01670 
SAOUHSC_01993 SAOUHSC_02490 SAOUHSC_01672 
SAOUHSC_02084 SAOUHSC_02499 SAOUHSC_01690 
SAOUHSC_02102 SAOUHSC_02500 SAOUHSC_01697 
SAOUHSC_00015 SAOUHSC_00009 SAOUHSC_01698 
SAOUHSC_00022 SAOUHSC_00223 SAOUHSC_01699 
SAOUHSC_00023 SAOUHSC_00225 SAOUHSC_01700 
SAOUHSC_00100 SAOUHSC_00227 SAOUHSC_01701 
SAOUHSC_00225 SAOUHSC_00348 SAOUHSC_01720 
SAOUHSC_00349 SAOUHSC_00451 SAOUHSC_01721 
SAOUHSC_00396 SAOUHSC_00471 SAOUHSC_01722 
SAOUHSC_00442 SAOUHSC_00472 SAOUHSC_01727 
SAOUHSC_00493 SAOUHSC_00524 SAOUHSC_01738 
SAOUHSC_00511 SAOUHSC_00528 SAOUHSC_01741 
SAOUHSC_00520 SAOUHSC_00574 SAOUHSC_01746 
SAOUHSC_00528 SAOUHSC_00620 SAOUHSC_01750 
SAOUHSC_00530 SAOUHSC_00641 SAOUHSC_01753 
SAOUHSC_00577 SAOUHSC_00728 SAOUHSC_01756 
SAOUHSC_00610 SAOUHSC_00743 SAOUHSC_01757 
SAOUHSC_00742 SAOUHSC_00793 SAOUHSC_01766 
SAOUHSC_00743 SAOUHSC_00795 SAOUHSC_01767 
SAOUHSC_00752 SAOUHSC_00796 SAOUHSC_01772 
SAOUHSC_00762 SAOUHSC_00797 SAOUHSC_01773 
SAOUHSC_00769 SAOUHSC_00798 SAOUHSC_01774 
SAOUHSC_00771 SAOUHSC_00799 SAOUHSC_01776 
SAOUHSC_00781 SAOUHSC_00804 SAOUHSC_01778 
SAOUHSC_00785 SAOUHSC_00847 SAOUHSC_01782 
SAOUHSC_00786 SAOUHSC_00848 SAOUHSC_01783 
SAOUHSC_00797 SAOUHSC_00869 SAOUHSC_01784 
SAOUHSC_00804 SAOUHSC_00871 SAOUHSC_01785 
SAOUHSC_00819 SAOUHSC_00872 SAOUHSC_01786 
SAOUHSC_00847 SAOUHSC_00881 SAOUHSC_01787 
SAOUHSC_00848 SAOUHSC_00892 SAOUHSC_01789 
SAOUHSC_00849 SAOUHSC_00900 SAOUHSC_01791 
SAOUHSC_00850 SAOUHSC_00903 SAOUHSC_01792 
SAOUHSC_00867 SAOUHSC_00922 SAOUHSC_01793 
SAOUHSC_00868 SAOUHSC_00933 SAOUHSC_01807 
SAOUHSC_00869 SAOUHSC_00934 SAOUHSC_01809 
SAOUHSC_00870 SAOUHSC_00943 SAOUHSC_01811 
SAOUHSC_00884 SAOUHSC_00957 SAOUHSC_01829 
SAOUHSC_00885 SAOUHSC_00980 SAOUHSC_01839 
SAOUHSC_00888 SAOUHSC_01035 SAOUHSC_01856 
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SAOUHSC_00889 SAOUHSC_01036 SAOUHSC_01859 
SAOUHSC_00939 SAOUHSC_01092 SAOUHSC_01866 
SAOUHSC_00947 SAOUHSC_01100 SAOUHSC_01871 
SAOUHSC_00954 SAOUHSC_01106 SAOUHSC_01875 
SAOUHSC_00957 SAOUHSC_01119 SAOUHSC_01915 
SAOUHSC_00980 SAOUHSC_01144 SAOUHSC_01916 
SAOUHSC_00981 SAOUHSC_01145 SAOUHSC_01961 
SAOUHSC_00985 SAOUHSC_01146 SAOUHSC_01962 
SAOUHSC_01003 SAOUHSC_01147 SAOUHSC_01973 
SAOUHSC_01036 SAOUHSC_01154 SAOUHSC_02106 
SAOUHSC_01092 SAOUHSC_01178 SAOUHSC_02107 
SAOUHSC_01142 SAOUHSC_01189 SAOUHSC_02114 
SAOUHSC_01147 SAOUHSC_01199 SAOUHSC_02116 
SAOUHSC_01148 SAOUHSC_01201 SAOUHSC_02117 
SAOUHSC_01149 SAOUHSC_01205 SAOUHSC_02118 
SAOUHSC_01150 SAOUHSC_01207 SAOUHSC_02122 
SAOUHSC_01158 SAOUHSC_01209 SAOUHSC_02123 
SAOUHSC_01159 SAOUHSC_01210 SAOUHSC_02133 
SAOUHSC_01189 SAOUHSC_01232 SAOUHSC_02140 
SAOUHSC_01201 SAOUHSC_01243 SAOUHSC_02143 
SAOUHSC_01205 SAOUHSC_01245 SAOUHSC_02151 
SAOUHSC_01209 SAOUHSC_01249 SAOUHSC_02152 
SAOUHSC_01214 SAOUHSC_01250 SAOUHSC_02255 
SAOUHSC_01222 SAOUHSC_01252 SAOUHSC_02277 
SAOUHSC_01230 SAOUHSC_01285 SAOUHSC_02278 
SAOUHSC_01233 SAOUHSC_01333 SAOUHSC_02279 
SAOUHSC_01243 SAOUHSC_01374 SAOUHSC_02280 
SAOUHSC_01244 SAOUHSC_01424 SAOUHSC_02318 
SAOUHSC_01245 SAOUHSC_01434 SAOUHSC_02336 
SAOUHSC_01246 SAOUHSC_01435 SAOUHSC_02357 
SAOUHSC_01249 SAOUHSC_01462 SAOUHSC_02359 
SAOUHSC_01252 SAOUHSC_01466 SAOUHSC_02368 
SAOUHSC_01263 SAOUHSC_01474 SAOUHSC_02399 
SAOUHSC_01289 SAOUHSC_01496 SAOUHSC_02407 
SAOUHSC_01293 SAOUHSC_01501 SAOUHSC_02478 
SAOUHSC_01294 SAOUHSC_01504 SAOUHSC_02482 
SAOUHSC_01333 SAOUHSC_01592 SAOUHSC_02485 
SAOUHSC_01351 SAOUHSC_01605 SAOUHSC_02486 
SAOUHSC_01362 SAOUHSC_01623 SAOUHSC_02487 
SAOUHSC_01373 SAOUHSC_01624 SAOUHSC_02488 
SAOUHSC_01410 SAOUHSC_01662 SAOUHSC_02489 
SAOUHSC_01424 SAOUHSC_01663 SAOUHSC_02490 
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SAOUHSC_01467 SAOUHSC_01678 SAOUHSC_02491 
SAOUHSC_01470 SAOUHSC_01682 SAOUHSC_02492 
SAOUHSC_01477 SAOUHSC_01690 SAOUHSC_02493 
SAOUHSC_01483 SAOUHSC_01697 SAOUHSC_02494 
SAOUHSC_01544 SAOUHSC_01722 SAOUHSC_02495 
SAOUHSC_01578 SAOUHSC_01739 SAOUHSC_02496 
SAOUHSC_01579 SAOUHSC_01741 SAOUHSC_02498 
SAOUHSC_01580 SAOUHSC_01742 SAOUHSC_02499 
SAOUHSC_01592 SAOUHSC_01746 SAOUHSC_02500 
SAOUHSC_01598 SAOUHSC_01750 SAOUHSC_02501 
SAOUHSC_01599 SAOUHSC_01751 SAOUHSC_02502 
SAOUHSC_01605 SAOUHSC_01753 SAOUHSC_02503 
SAOUHSC_01627 SAOUHSC_01767 SAOUHSC_02504 
SAOUHSC_01666 SAOUHSC_01782 SAOUHSC_02505 
SAOUHSC_01690 SAOUHSC_01792 SAOUHSC_02506 
SAOUHSC_01697 SAOUHSC_01795 SAOUHSC_02507 
SAOUHSC_01701 SAOUHSC_01808 SAOUHSC_02508 
SAOUHSC_01714 SAOUHSC_01809 SAOUHSC_02509 
SAOUHSC_01722 SAOUHSC_01811 SAOUHSC_02510 
SAOUHSC_01725 SAOUHSC_01827 SAOUHSC_02511 
SAOUHSC_01726 SAOUHSC_01829 SAOUHSC_02512 
SAOUHSC_01766 SAOUHSC_01979 SAOUHSC_02512a 
SAOUHSC_01776 SAOUHSC_02116 SAOUHSC_02527 
SAOUHSC_01795 SAOUHSC_02255 SAOUHSC_02612 
SAOUHSC_02002 SAOUHSC_02491 SAOUHSC_02623 
SAOUHSC_02017 SAOUHSC_02492 SAOUHSC_02793 
SAOUHSC_02053 SAOUHSC_02493 SAOUHSC_03052 
SAOUHSC_02054 SAOUHSC_02494 SAOUHSC_03053 
SAOUHSC_02055 SAOUHSC_02495 SAOUHSC_03054 
SAOUHSC_02065 SAOUHSC_02496 SAOUHSC_03055 
SAOUHSC_02076 SAOUHSC_02498 SAOUHSC_A01514 
SAOUHSC_02106 SAOUHSC_02501 
 SAOUHSC_02107 SAOUHSC_02502 
 SAOUHSC_02114 SAOUHSC_02503 
 SAOUHSC_02116 SAOUHSC_02504 
 SAOUHSC_02117 SAOUHSC_02505 
 SAOUHSC_02118 SAOUHSC_02506 
 SAOUHSC_02122 SAOUHSC_02507 
 SAOUHSC_02123 SAOUHSC_02508 
 SAOUHSC_02132 SAOUHSC_02509 
 SAOUHSC_02133 SAOUHSC_02510 
 SAOUHSC_02140 SAOUHSC_02511 
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SAOUHSC_02151 SAOUHSC_02512 
 SAOUHSC_02152 SAOUHSC_02527 
 SAOUHSC_02154 SAOUHSC_02571 
 SAOUHSC_02164 SAOUHSC_02572 
 SAOUHSC_02175 SAOUHSC_02575 
 SAOUHSC_02183 SAOUHSC_02612 
 SAOUHSC_02209 SAOUHSC_02623 
 SAOUHSC_02214 SAOUHSC_02720 
 SAOUHSC_02215 SAOUHSC_02757 
 SAOUHSC_02219 SAOUHSC_02791 
 SAOUHSC_02224 SAOUHSC_02805 
 SAOUHSC_02235 SAOUHSC_02859 
 SAOUHSC_02237 SAOUHSC_02860 
 SAOUHSC_02238 SAOUHSC_03049 
 SAOUHSC_02254 SAOUHSC_03052 
 SAOUHSC_02255 SAOUHSC_03053 
 SAOUHSC_02277 SAOUHSC_03054 
 SAOUHSC_02279 SAOUHSC_03055 
 SAOUHSC_02280 
  SAOUHSC_02294 
  SAOUHSC_02306 
  SAOUHSC_02307 
  SAOUHSC_02317 
  SAOUHSC_02318 
  SAOUHSC_02325 
  SAOUHSC_02327 
  SAOUHSC_02332 
  SAOUHSC_02336 
  SAOUHSC_02357 
  SAOUHSC_02359 
  SAOUHSC_02361 
  SAOUHSC_02368 
  SAOUHSC_02371 
  SAOUHSC_02379 
  SAOUHSC_02383 
  SAOUHSC_02399 
  SAOUHSC_02405 
  SAOUHSC_02407 
  SAOUHSC_02410 
  SAOUHSC_02411 
  SAOUHSC_02412 
  SAOUHSC_02416 
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SAOUHSC_02437 
  SAOUHSC_02438 
  SAOUHSC_02440 
  SAOUHSC_02477 
  SAOUHSC_02478 
  SAOUHSC_02484 
  SAOUHSC_02485 
  SAOUHSC_02486 
  SAOUHSC_02487 
  SAOUHSC_02488 
  SAOUHSC_02489 
  SAOUHSC_02490 
  SAOUHSC_02491 
  SAOUHSC_02492 
  SAOUHSC_02493 
  SAOUHSC_02494 
  SAOUHSC_02495 
  SAOUHSC_02496 
  SAOUHSC_02498 
  SAOUHSC_02499 
  SAOUHSC_02500 
  SAOUHSC_02501 
  SAOUHSC_02502 
  SAOUHSC_02503 
  SAOUHSC_02504 
  SAOUHSC_02505 
  SAOUHSC_02506 
  SAOUHSC_02507 
  SAOUHSC_02508 
  SAOUHSC_02509 
  SAOUHSC_02510 
  SAOUHSC_02511 
  SAOUHSC_02512 
  SAOUHSC_02527 
  SAOUHSC_02534 
  SAOUHSC_02571 
  SAOUHSC_02623 
  SAOUHSC_02707 
  SAOUHSC_02720 
  SAOUHSC_02721 
  SAOUHSC_02745 
  SAOUHSC_02860 
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SAOUHSC_02872 
  SAOUHSC_03043 
  SAOUHSC_03054 
  SAOUHSC_03055 
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F. Genes important for S. aureus growth at different temperatures 
 
16°C blunt 
  
gene locus 
corrected p-
value 
ratio 
experiment/control 
SAOUHSC_01857 6.88E-05 6.06 
   23°C blunt 
  
gene locus 
corrected p-
value 
ratio 
experiment/control 
SAOUHSC_01857 1.69E-04 5.03 
   37°C blunt 
  
gene locus 
corrected p-
value 
ratio 
experiment/control 
SAOUHSC_00536-ilvE 6.18E-05 14.59 
SAOUHSC_01618-ispA 9.63E-04 12.82 
SAOUHSC_01613-
bkdA1 2.90E-03 8.00 
SAOUHSC_01611 2.03E-04 6.50 
SAOUHSC_00525 5.59E-03 6.40 
SAOUHSC_01612-
bkdA2 2.36E-02 6.18 
SAOUHSC_01153 5.05E-03 0.08 
SAOUHSC_01154-
sepF 3.55E-02 0.07 
   43°C blunt 
  
gene locus 
corrected p-
value 
ratio 
experiment/control 
SAOUHSC_00014 2.41E-03 22.85 
SAOUHSC_00015 1.60E-03 0.13 
SAOUHSC_00022-
yycH 2.20E-04 0.03 
SAOUHSC_00023-yycI 7.71E-05 0.03 
SAOUHSC_00290 1.27E-08 0.02 
SAOUHSC_00364 7.20E-06 0.07 
SAOUHSC_00373 4.35E-05 10.01 
SAOUHSC_00420 1.51E-05 10.69 
SAOUHSC_00455 1.81E-02 0.17 
SAOUHSC_00462 4.95E-03 6.42 
SAOUHSC_00464-
ksgA 8.11E-04 8.97 
SAOUHSC_00488 2.15E-04 0.04 
SAOUHSC_00504-yakI 4.53E-07 0.02 
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SAOUHSC_00505-clpC 5.43E-03 0.14 
SAOUHSC_00618 3.44E-03 0.07 
SAOUHSC_00646-
pbp4 2.64E-02 0.15 
SAOUHSC_00668-
vraG 2.89E-04 0.19 
SAOUHSC_00675 2.20E-02 0.16 
SAOUHSC_00678 1.29E-08 0.02 
SAOUHSC_00718-718 4.58E-03 0.06 
SAOUHSC_00755 1.67E-02 22.75 
SAOUHSC_00756 1.18E-09 0.02 
SAOUHSC_00760-
gdpS 1.66E-07 0.04 
SAOUHSC_00794 1.14E-03 0.02 
SAOUHSC_00803 7.71E-05 0.07 
SAOUHSC_00892 8.05E-03 0.11 
SAOUHSC_00935 1.02E-02 5.90 
SAOUHSC_00965-
CAAX 3.82E-02 5.04 
SAOUHSC_00982-
menF 1.59E-05 13.25 
SAOUHSC_00983-
menD 1.03E-09 9.73 
SAOUHSC_00996 1.92E-02 0.06 
SAOUHSC_00997-lcpB 2.60E-03 0.17 
SAOUHSC_01025-
1025 2.01E-09 0.04 
SAOUHSC_01039 4.45E-04 20.47 
SAOUHSC_01050-
1050 4.37E-09 0.03 
SAOUHSC_01095 4.91E-02 0.07 
SAOUHSC_01153 2.50E-05 0.04 
SAOUHSC_01154-
sepF 1.79E-02 0.10 
SAOUHSC_01165 2.23E-05 0.06 
SAOUHSC_01184 7.77E-04 0.12 
SAOUHSC_01186 1.60E-03 0.04 
SAOUHSC_01203-rnc 3.82E-02 0.16 
SAOUHSC_01265 9.22E-04 8.69 
SAOUHSC_01269 1.50E-07 0.03 
SAOUHSC_01271 1.93E-05 0.02 
SAOUHSC_01278 1.12E-10 15.60 
SAOUHSC_01346 6.44E-04 5.45 
SAOUHSC_01359-
mprF 1.10E-21 0.05 
SAOUHSC_01361-lcpA 6.76E-03 0.04 
SAOUHSC_01427 7.39E-10 25.24 
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SAOUHSC_01437 6.33E-04 0.10 
SAOUHSC_01462-
gpsB 2.03E-02 0.03 
SAOUHSC_01480 3.26E-04 10.79 
SAOUHSC_01481 3.71E-02 5.98 
SAOUHSC_01482-
aroB 2.57E-08 20.95 
SAOUHSC_01483-aroF 2.36E-03 8.05 
SAOUHSC_01497 2.16E-04 0.07 
SAOUHSC_01585 1.48E-06 8.10 
SAOUHSC_01586 7.43E-08 32.16 
SAOUHSC_01618-ispA 2.41E-04 20.18 
SAOUHSC_01627 6.59E-04 0.04 
SAOUHSC_01650 3.17E-03 0.06 
SAOUHSC_01652-
pbp3 1.10E-11 0.02 
SAOUHSC_01656 2.90E-07 12.64 
SAOUHSC_01657 7.87E-04 12.92 
SAOUHSC_01682-
dnaJ 2.40E-03 0.04 
SAOUHSC_01683-
dnaK 1.90E-09 0.02 
SAOUHSC_01685-hrcA 1.88E-08 0.02 
SAOUHSC_01696 1.11E-04 0.19 
SAOUHSC_01699-
aroE 9.58E-03 8.35 
SAOUHSC_01739 3.49E-02 0.09 
SAOUHSC_01758-
mreD 1.27E-05 0.02 
SAOUHSC_01759-
mreC 5.64E-07 0.02 
SAOUHSC_01779-tig 3.24E-05 16.96 
SAOUHSC_01803 7.76E-16 0.02 
SAOUHSC_01810 2.94E-04 0.06 
SAOUHSC_01821 3.24E-05 17.85 
SAOUHSC_01827-ezrA 1.15E-03 0.07 
SAOUHSC_01852-
aroA 3.55E-04 11.38 
SAOUHSC_01854 1.59E-05 0.04 
SAOUHSC_01857 2.98E-09 0.16 
SAOUHSC_01858 2.20E-04 0.02 
SAOUHSC_01895-lytD 3.18E-03 10.48 
SAOUHSC_01913 2.12E-02 0.04 
SAOUHSC_01960-
hemY 2.04E-05 9.79 
SAOUHSC_01975-
sbcD 4.58E-03 6.24 
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SAOUHSC_01979 4.06E-04 35.37 
SAOUHSC_01997 4.52E-02 0.10 
SAOUHSC_02004 7.92E-05 0.05 
SAOUHSC_02012-sgtB 4.58E-03 6.77 
SAOUHSC_02121 4.80E-05 0.06 
SAOUHSC_02131 3.71E-02 0.13 
SAOUHSC_02143 7.16E-05 19.13 
SAOUHSC_02264 9.53E-04 0.20 
SAOUHSC_02268 6.06E-03 0.15 
SAOUHSC_02305-alr1 6.74E-07 0.08 
SAOUHSC_02308 2.33E-07 0.03 
SAOUHSC_02309 9.60E-04 0.13 
SAOUHSC_02319-
rodA 1.32E-09 0.02 
SAOUHSC_02337-
murA 1.48E-06 0.02 
SAOUHSC_02341-F-
type 2.39E-04 0.07 
SAOUHSC_02345-F-
type 1.33E-05 0.05 
SAOUHSC_02347-F-
type 1.58E-02 0.17 
SAOUHSC_02350-F-
type 1.66E-02 0.06 
SAOUHSC_02351 1.79E-02 0.05 
SAOUHSC_02358 4.01E-03 23.16 
SAOUHSC_02366 3.31E-04 23.54 
SAOUHSC_02369 3.70E-02 11.09 
SAOUHSC_02372 1.26E-02 0.08 
SAOUHSC_02383 7.88E-13 0.02 
SAOUHSC_02481-cbiQ 5.09E-05 0.01 
SAOUHSC_02483-cbiO 1.59E-02 0.11 
SAOUHSC_02552 3.66E-05 0.06 
SAOUHSC_02571 8.02E-06 0.03 
SAOUHSC_02589 9.27E-03 5.47 
SAOUHSC_02611-lyrA 3.69E-05 24.09 
SAOUHSC_02664 3.30E-08 7.27 
SAOUHSC_02690 8.02E-03 11.85 
SAOUHSC_02885 5.76E-06 5.96 
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G. Tn-Seq hits with a panel of β-lactam antibiotics in MW2 and USA300 
 
USA300 0.1 ug/ml 
oxacillin ratio 
USA300 1 ug/ml 
oxacillin ratio 
USA300 10 ug/ml 
oxacillin ratio 
USA300HOU_0413 38.591 USA300HOU_0414 4364.00 USA300HOU_0413 7897.59 
USA300HOU_0504 37.224 USA300HOU_2045 2342.00 USA300HOU_0504 7415.57 
USA300HOU_1784 33.296 USA300HOU_0413 2129.04 USA300HOU_0414 3492.00 
USA300HOU_1197 32.898 USA300HOU_0504 2024.22 USA300HOU_0383 2303.80 
USA300HOU_0959 29.970 USA300HOU_0383 581.00 USA300HOU_1670 979.56 
USA300HOU_0505 26.869 USA300HOU_1666 170.09 USA300HOU_2045 674.50 
USA300HOU_2116 21.058 USA300HOU_1194 70.67 USA300HOU_1632 552.33 
USA300HOU_1823 17.964 USA300HOU_2515 34.03 USA300HOU_0275 40.56 
USA300HOU_0993 13.532 USA300HOU_0411 24.59 USA300HOU_1052 17.60 
USA300HOU_1727 12.620 USA300HOU_0275 12.78 
  USA300HOU_1403 12.402 USA300HOU_1667 12.25 
  USA300HOU_0990 12.370 
    USA300HOU_1539 11.124 
 
 
  USA300HOU_1404 10.499 
    USA300HOU_0136 0.099 
    USA300HOU_1385 0.099 
    USA300HOU_0035 0.097 
    USA300HOU_2368 0.092 
    USA300HOU_1293 0.091 
    USA300HOU_0693 0.090 
    USA300HOU_0703 0.089 
    USA300HOU_1856 0.089 
    USA300HOU_1765 0.088 
    USA300HOU_2655 0.087 
    USA300HOU_2130 0.085 
    USA300HOU_0718 0.085 
    USA300HOU_2503 0.085 
    USA300HOU_1729 0.067 
    USA300HOU_1728 0.064 
    USA300HOU_0498 0.063 
    USA300HOU_0351 0.062 
    USA300HOU_2302 0.058 
    USA300HOU_0681 0.056 
    USA300HOU_0769 0.056 
    USA300HOU_0662 0.053 
    USA300HOU_2109 0.053 
    USA300HOU_1350 0.052 
    USA300HOU_0682 0.043 
    USA300HOU_0683 0.024 
    USA300HOU_0794 0.023 
    USA300HOU_0031 0.023 
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MW2 WT 0.1µg/ml 
oxacillin ratio 
MW2 WT 1µg/ml 
oxacillin ratio 
MW2 WT 10µg/ml 
oxacillin ratio 
aroA 41.88 clpP 9297.33 relA 18665.86 
MW0926 14.68 MW2393 3058.90 MW0465 12952.65 
  
MW0465 3052.45 guaB 401.18 
  
relA 2661.21 clpP 156.33 
  
hemB 1359.00 hemB 118.00 
  
hemE 334.50 MW0177 69.80 
  
topB 173.81 pgk 33.27 
  
guaB 140.66 
  
  
aroA 134.63 
  
  
guaA 121.43 
  
  
hemH 70.87 
  
  
menE 59.88 
  
  
aroB 45.41 
  
  
aroC 36.04 
  
  
pyrC 34.52 
  
  
MW0765 16.10 
  
  
hemY 14.92 
  
  
MW1872 13.76 
  
  
MW0913 10.03 
  
 
 
 
MW2 ∆hsdR 0.1 
ug/ml oxacillin ratio 
MW2 ∆hsdR 1 
ug/ml oxacillin ratio 
MW2 10 ∆hsdR 
ug/ml oxacillin ratio 
MW2301 19.64 clpP 7491.25 relA 2188.66 
MW0883 14.12 srrA 1121.30 clpP 1029.00 
MW0926 14.11 fmt 1112.95 MW0465 943.76 
pbuX 10.06 relA 1028.63 guaB 115.70 
aapA 0.03 MW0465 425.69 MW2041 67.07 
  
guaB 194.70 
  
  
MW0883 54.23 
  
  
MW1145 32.00 
  
  
comEB 12.39 
  
  
MW0153 6.18 
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USA300 + 8µg/ml 
mecillinam 
 
USA300 + 0.2µg/ml 
cefoxitin 
 Locus ratio Locus ratio 
USA300HOU_0504 48.66 USA300HOU_1869 10.98 
USA300HOU_0413 48.04 USA300HOU_1841 10.95 
USA300HOU_2715 9.07 USA300HOU_1680 10.51 
USA300HOU_2714 8.81 USA300HOU_1403 10.35 
USA300HOU_1632 7.00 USA300HOU_1753 10.34 
USA300HOU_1667 5.50 USA300HOU_0014 10.31 
USA300HOU_1164 4.49 USA300HOU_1784 10.27 
USA300HOU_0505 4.26 USA300HOU_0836 10.09 
USA300HOU_1699 4.23 USA300HOU_1758 0.10 
USA300HOU_0021 4.17 USA300HOU_0995 0.10 
USA300HOU_0497 0.19 USA300HOU_1082 0.10 
USA300HOU_2302 0.18 USA300HOU_2694 0.10 
USA300HOU_1828 0.16 USA300HOU_2332 0.10 
USA300HOU_0693 0.15 USA300HOU_2126 0.10 
USA300HOU_0662 0.14 USA300HOU_1882 0.09 
USA300HOU_1559 0.13 USA300HOU_2702 0.09 
USA300HOU_0498 0.12 USA300HOU_1043 0.09 
USA300HOU_1022 0.11 USA300HOU_1497 0.09 
USA300HOU_0769 0.08 USA300HOU_1873 0.09 
USA300HOU_1224 0.07 USA300HOU_0790 0.09 
USA300HOU_0683 0.07 USA300HOU_1856 0.09 
USA300HOU_0794 0.07 USA300HOU_2598 0.09 
USA300HOU_1350 0.07 USA300HOU_1203 0.09 
USA300HOU_0681 0.06 USA300HOU_2276 0.09 
USA300HOU_0682 0.04 USA300HOU_1933 0.09 
USA300HOU_0031 0.03 USA300HOU_0809 0.08 
USA300HOU_0482 0.03 USA300HOU_2109 0.08 
  
USA300HOU_1357 0.08 
  
USA300HOU_0681 0.08 
  
USA300HOU_2120 0.08 
  
USA300HOU_0645 0.08 
  
USA300HOU_0722 0.08 
  
USA300HOU_0784 0.08 
  
USA300HOU_0636 0.07 
  
USA300HOU_1067 0.07 
  
USA300HOU_0072 0.07 
  
USA300HOU_2254 0.07 
  
USA300HOU_1880 0.07 
  
USA300HOU_1308 0.06 
  
USA300HOU_0100 0.06 
  
USA300HOU_1093 0.06 
  
USA300HOU_0684 0.06 
  
USA300HOU_0588 0.06 
  
USA300HOU_1846 0.05 
  
USA300HOU_0683 0.05 
  
USA300HOU_2587 0.05 
  
USA300HOU_1872 0.05 
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USA300HOU_1495 0.05 
  
USA300HOU_0693 0.05 
  
USA300HOU_1022 0.05 
  
USA300HOU_1876 0.04 
  
USA300HOU_1859 0.04 
  
USA300HOU_2038 0.04 
  
USA300HOU_0794 0.04 
  
USA300HOU_1913 0.04 
  
USA300HOU_1154 0.04 
  
USA300HOU_2175 0.04 
  
USA300HOU_1224 0.03 
  
USA300HOU_1042 0.03 
  
USA300HOU_2361 0.03 
  
USA300HOU_0480 0.02 
  
USA300HOU_0682 0.02 
  
USA300HOU_1556 0.02 
  
USA300HOU_0485 0.02 
  
USA300HOU_1155 0.02 
  
USA300HOU_2091 0.02 
  
USA300HOU_0889 0.02 
  
USA300HOU_0785 0.01 
  
USA300HOU_0031 0.01 
  
USA300HOU_0482 0.01 
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MW2 32ug/ml 
mecillinam 
 
MW2 0.4ug/ml 
cefoxitin 
 Locus ratio Locus ratio 
MW1169 164.125 rpsC 130.583 
relA 106.987 rpsB 52.800 
MW0465 73.078 fab 35.833 
rpoC 49.318 pnpA 21.351 
murE 24.125 murC 19.000 
MW0746 18.636 relA 14.094 
MW0413 17.364 MW0465 10.882 
fabZ 17.100 rpmB 10.833 
ksgA 15.667 leuS 0.098 
MW0766 14.283 MW2178 0.095 
MW0014 11.830 MW1502 0.081 
MW0896 11.233 mvaS 0.080 
menD 0.077 bfmBAB 0.076 
MW0408 0.076 MW1548 0.069 
MW0972 0.075 gyrB 0.067 
MW2178 0.070 recU 0.065 
mvaS 0.069 menD 0.063 
infB 0.065 dnaA 0.062 
bfmBAB 0.057 infB 0.043 
MW2509 0.055 MW0986 0.037 
recU 0.037 codY 0.027 
MW0718 0.028 MW1567 0.025 
dnaA 0.026 rplS 0.022 
MW1567 0.025 tagA 0.022 
codY 0.025 tagD 0.021 
gyrB 0.022 fni 0.007 
tagA 0.018 lexA 0.004 
rplS 0.015 
  tagD 0.010 
  fni 0.010 
  lexA 0.008 
  MW1548 0.005 
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H. How to run all custom R and Python scripts for analysis of Tn-Seq data  
 
The Python scripts for creating igv formatted files, finding the number of TA sites hit, performing 
the Mann-Whitney U analysis, and performing the Benjamini Hochberg correction were modified 
from ones made available upon request by Eric Rubin (Harvard Medical School). I wrote the 
rest. The simulation-based sampling normalization method was adapted from the EL-ARTIST 
Matlab scripts.  
 
Python scripts for identifying significant differences in mapped-reads 
Script: igv_staph_saouhsc_all_11-12.py  
This script takes the tabular hopcount files downloaded from Galaxy, and it converts them into 
igv-formatted files.  
Run: python igv_staph_saouhsc_all_11-12.py staph_TA.txt staph_genes.txt hopcountfile.tabular 
> output.igv 
Staph_TA.txt is any tab delimited file listing the genome, start of the TA site, and end of the TA 
site in three columns.  
Staph_genes.txt is any tab delimited file listing each gene, its starting location, and its ending 
location in three columns.  
Hopcountfile.tabular is the tab-delimited hop counts file downloaded from Galaxy 
Output will be in igv format 
1. import sys   
2.    
3. ## Gather all TA sites into dictionary   
4. TAsites = {}  
5. for line in open(sys.argv[1]):   
6.     split = line.split()   
7.     if split[0] == 'TA':   
8.         TAsites[int(split[4])] = [0]   
9. #print TAsites   
10.    
11. ## Add gene name as second string in dictionary value   
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12. for line in open(sys.argv[2]):   
13.     split = line.split('\t')   
14.     name = split[0]; start = int(split[1]); end = int(split[2])+1   
15.     for i in range(start, end):   
16.         if i in TAsites: TAsites[i].append(name)   
17. #print TAsites   
18.           
19. ## Add read counts to first item in dictionary value list   
20. whole_text=file(sys.argv[3]).read()   
21. arrayed = whole_text.split('\n')   
22. #lenarrayed = len(arrayed)   
23. #print lenarrayed   
24. #    print line   
25. for line in arrayed:   
26.     split = line.split("\t")   
27.     #print split[1]   
28.     #split = line.split('\t')   
29.     pos = 0 ## set pos as int denoting position   
30.     if len(split)>= 6 and split[1].isdigit() == True:   
31.         if int(split[4]) != 0:   
32.             pos = int(split[1]) ##    
33.             if pos+15 in TAsites:   
34.                 TAsites[pos+15][0] = TAsites[pos+15][0]+int(split[4])   
35.             elif pos+14 in TAsites:   
36.                 TAsites[pos+14][0] = TAsites[pos+14][0]+int(split[4])   
37.         if int(split[5]) != 0:   
38.             pos = int(split[1])   
39.             if pos-15 in TAsites:    
40.                 TAsites[pos-15][0] = TAsites[pos-15][0]+int(split[5])   
41.             elif pos-16 in TAsites:   
42.                 TAsites[pos-16][0] = TAsites[pos-16][0]+int(split[5])   
43.         else:   
44.             pass                   
45. ## Print   
46.    
47. keys = TAsites.keys()   
48. keys.sort()   
49.    
50. #print "#track name=vanc10_all color=255,255,255 altColor=RRR,GGG,BBB maxHeightPixels=1
28:128:11 graphType=bar midRange=20:80 midColor=200,200,200 viewLimits=0:600000 windowi
ngFunction=maximum coords=0 scaleType=linear featureVisivilityWindow=50 gffTags=off"   
51. for k in keys:   
52.     print 'SAOHSC', '\t', int(k), '\t', int(k) + 2, '\t', TAsites[k][0],   
53.     if len(TAsites[k]) > 1: print '\t', TAsites[k][1]   
54.     else: print  
 
Script: Hit_Sites_Counter.py 
This script only takes one argument, the igv file created above. It outputs the total possible 
number of TA sites, the number of reads that map to TA sites, and the number of TA sites those 
reads map to.  
Run: python Hit_Sites_Counter.py output.igv  
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1. import sys   
2.    
3. TA = 0; Reads = 0; HitSites = 0   
4.    
5. for line in open(sys.argv[1]):   
6.     split=line.split()   
7.     if len(split) > 3:   
8.         if split[3][0].isdigit() == True:   
9.             TA += 1   
10.             Reads += float(split[3])   
11.             if float(split[3]) > 0: HitSites += 1   
12.        
13. print 'TA = %d' % (TA)   
14. print 'Reads = %d' % (Reads)   
15. print 'Sites Hit = %d' % (HitSites)   
 
Script: combineigv.py 
If multiple biological replicates are done or if you simply want to combine multiple igv files, this 
script will do it. Takes any number of igv files as arguments, outputs combined igv file.  
Run: python igv1.igv, igv2.igv, igv3.igv, etc. > combinedigv.igv 
1. import sys   
2.    
3. #need to make dictionary of TA site and reads   
4.    
5. TAsites = {}   
6. for line in open(sys.argv[1]):   
7.     split = line.split('\t')   
8.     TAsites[int(split[1])]=[]   
9.    
10. #print TAsites   
11.    
12. for arg in sys.argv[1:]:   
13.     for line in open(arg):   
14.         split = line.split('\t')   
15.         site = int(split[1])   
16.         reads = int(split[3].rstrip())   
17.         if site in TAsites:   
18.             TAsites[site].append(reads)   
19.    
20. #print TAsites   
21.    
22. #Next add together read numbers and output as original igv   
23. allreads = {}   
24. for k,v in TAsites.iteritems():   
25.     sumreads = sum(v)   
26.     allreads[k]=sumreads   
27. #print allreads   
28.    
29. for line in open(sys.argv[1]):   
30.     split = line.split('\t')   
31.     #print len(split)   
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32.     site = int(split[1])   
33.     if site in allreads:   
34.         if len(split)<5:   
35.             print "%s\t%d\t%d\t%d" % (split[0],site,int(split[2]),allreads[site])   
36.         elif len(split)<6:   
37.             print "%s\t%d\t%d\t%d\t%s" % (split[0],site,int(split[2]),allreads[site],sp
lit[4].rstrip())  
 
Script: normalization.py 
This script is essentially a translation of the EL-ARTIST normalization method from MatLab to 
Python. It takes two arguments. The first should be the igv file with more TA sites hit, and the 
second the one with fewer TA sites hit. It outputs the first argument normalized down to the 
second argument’s level of diversity.  
Run: python normalization.py moretasiteshit.igv fewertasiteshit.igv > normalizedfirstigvfile.igv 
1. from math import *   
2. from numpy import *   
3.    
4. TActrl = 0; Readsctrl = 0; HitSitesctrl = 0   
5. inputreads = []   
6. saouhsc= []   
7. start = []   
8. end = []   
9. window = []   
10. for line in open(sys.argv[1]):   
11.     split=line.split('\t')   
12.     if len(split) > 4:   
13.         if split[3][0].isdigit() == True:   
14.             inputreads.append(float(split[3]))   
15.             saouhsc.append(split[0])   
16.             start.append(split[1])   
17.             end.append(split[2])   
18.             window.append(split[4].rstrip('\n'))   
19.             TActrl += 1   
20.             Readsctrl += float(split[3])   
21.             if float(split[3]) > 0: HitSitesctrl += 1   
22.    
23. TAexp = 0; Readsexp = 0; HitSitesexp = 0   
24. for line in open(sys.argv[2]):   
25.     split=line.split()   
26.     if len(split) > 3:   
27.         if split[3][0].isdigit() == True:   
28.             TAexp += 1   
29.             Readsexp += float(split[3])   
30.             if float(split[3]) > 0: HitSitesexp += 1   
31.    
32. TAproportion =  float(HitSitesexp)/HitSitesctrl      
33.    
34. inputproportion = []   
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35. for i in inputreads:   
36.     inputproportion.append(float(i)/Readsctrl)   
37. inputproportiontanorm = []   
38. for i in inputproportion:   
39.     inputproportiontanorm.append(float(i)*TAproportion)   
40.    
41. inputproportiontanorm.append(TAproportion-1)   
42.    
43. multinominputsample = numpy.random.multinomial(Readsexp,inputproportiontanorm,100)   
44. multinominputsample = multinominputsample.T   
45. for i in range(len(multinominputsample[0])):   
46.     summulti = sum(multinominputsample[:,i])   
47. multisum = numpy.repeat(summulti,100)   
48. difference=numpy.repeat(multisum-multinominputsample[-1,0],100)   
49. correctionfactor = round(float(Readsexp)/difference[0],4)   
50. correctedinput = [i*correctionfactor for i in multinominputsample]   
51. bootstrapcontrol = numpy.delete(correctedinput, (-1), axis=0)   
52. avgbootstrapcontrol = bootstrapcontrol.mean(axis=1)   
53.    
54. x = 0   
55. for x in range(0,len(avgbootstrapcontrol)):   
56.     print saouhsc[x], '\t', start[x], '\t', end[x], '\t', avgbootstrapcontrol[x], '\t',
 window[x]   
57.     x+=1   
 
Script: mannwhitneyu_8-24-15.py 
This program collects the reads mapping to each gene and identifies statistically significant 
differences between the control and experimental condition using the Mann-Whitney U test. It 
also performs some other calculations on the data which can be used to further analyze the 
data.  
Run: python mannwhitneyu_8-24-15.py staph_genes.txt control.igv experiment.igv > output.txt 
Staph_genes.txt is tab-delimited staph genes file described above 
Control.igv is igv file from control datasets 
Experiment.igv is igv file from experiment datasets 
Output.txt is a tab-delimited file that can be opened in Microsoft Excel. Column 1: gene loci, 
column 2, number of TA sites in that gene, column 3: number reads mapping to that gene in the 
control data, column 4: number of reads mapping to that gene in the experimental data, column 
5: U statistic, column 6: p-value, column 7: ratio in reads in the experiment normalized to the 
control, 8: length of the gene, column 9: reads mapping to that gene in the control normalized to 
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gene length, column 10: same as column 9 but for the experimental condition, column 11: 
location of the start of the gene, column 12: location of the end of the gene.  
1. import sys, random, scipy, numpy   
2. from math import *   
3. from scipy import stats   
4.    
5.    
6. ## DEFINE GENE NAMES, STARTS, ENDS   
7.    
8. genes = {}; genereads = {}   
9.    
10. init = 0   
11. count = 1   
12.    
13. for line in open(sys.argv[1]):   
14.     split = line.split('\t')   
15.     name = split[0]; start = int(split[1]); end = int(split[2])   
16.     genes[name] = [start, end]   
17.     genereads[name] = [[],[]]   
18. #print genes       
19.            
20. genelist = genes.keys()   
21. genelist.sort()   
22. #print genelist   
23. #print genereads   
24.    
25. ## DEFINE RATIO BETWEEN TOTAL READ COUNTS AS CORRECTION   
26. Lib1Reads = 0; Lib2Reads = 0   
27. Lib1TA = 0; Lib2TA = 0   
28.    
29. for line in open(sys.argv[2]):   
30.     #print line   
31.     split = line.split()   
32.     #print split[3][0]   
33.     if len(split)>1 and split[3][0].isdigit()==True:   
34.         Lib1TA += 1   
35.         Lib1Reads += float(split[3])   
36. #print Lib1Reads   
37.    
38. for line in open(sys.argv[3]):   
39.     split = line.split()   
40.     if len(split)>1 and split[3][0].isdigit()==True:   
41.         Lib2TA += 1   
42.         Lib2Reads += float(split[3])   
43.    
44. ratio = float(Lib1Reads)/float(Lib2Reads)   
45.    
46. ## SET DICTIONARIES WITH GENE READS   
47.    
48. ## set first for Library 1   
49. for line in open(sys.argv[2]):   
50.     split = line.split()   
51.     #print split   
52.     if len(split) > 4 and split[3][0].isdigit() == True and split[4] in genereads:   
53.         site = int(split[1]); start = int(genes[split[4]][0]); end = int(genes[split[4]
][1])   
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54.         length = end - start   
55.         if (start+(0.03*length)) <= site <= (end-(0.03*length)):   
56.             genereads[split[4]][0].append(float(split[3]))   
57.     #else:   
58.     # print split [4]   
59.    
60. ## set for Library 2   
61. for line in open(sys.argv[3]):   
62.     split = line.split()   
63.     if len(split) > 4 and split[3][0].isdigit() == True and split[4] in genereads:   
64.         site = int(split[1]); start = int(genes[split[4]][0]); end = int(genes[split[4]
][1])   
65.         length = end - start   
66.         if (start+(0.03*length)) <= site <= (end-(0.03*length)):   
67.             genereads[split[4]][1].append(float(split[3]))   
68.    
69. ## MANN-WHITNEY U TEST FOR ALL GENES   
70. #print genereads   
71. #print len(genelist)   
72. for i in range(len(genelist)):   
73.     #print genelist[i]   
74.     SAO = genelist[i]   
75.     start = genes[SAO][0]; end = genes[SAO][1]   
76.     #print end   
77.     Lib1Counts = genereads[SAO][0]   
78.     Lib2Counts = genereads[SAO][1]   
79.     TA = len(Lib1Counts)   
80.     readslib1 = sum(Lib1Counts)   
81.     readslib2 = sum(Lib2Counts)   
82.     length = end - start   
83.     if length > 0:   
84.         index1 = readslib1/length   
85.         index2 = readslib2/length   
86.     if TA == 0:   
87.         print "%s\t%d\t%s" % (SAO,TA,'Gene Has No TAs')   
88.     else:   
89.         if sum(Lib1Counts) == 0 and sum(Lib2Counts) ==0:   
90.             print "%s\t%d\t%s\t%s\t%s\t%s\t%s\t%d\t%s\t%s\t%r\t%r" % (SAO,TA,'0','0','0
','0','0',length,'0','0',start,end)   
91.         else:   
92.             try:   
93.                 U, p_val = scipy.stats.mannwhitneyu(Lib1Counts,Lib2Counts)   
94.                 CountRatio = float(sum(Lib2Counts)+1)/float(sum(Lib1Counts)+1)   
95.                 #print "%s\t%d\t%d\t%0.5f\t%0.3f" % (SAO,TA,U,p_val,CountRatio)   
96.                 print "%s\t%d\t%d\t%d\t%d\t%0.100f\t%0.10f\t%d\t%0.10f\t%0.10f\t%r\t%r"
 %    
97. (SAO,TA,readslib1,readslib2,U,p_val,CountRatio,length,index1,index2,start,end)   
98.             except (ValueError):   
99.                 pass   
 
Script: gene_fdr_taboutput.py 
This script corrects for multiple hypothesis testing by modifying the p-value using the Benjamini 
Hochberg procedure. It outputs a tab-delimited file with two columns: the gene locus and the 
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new p-value. This can be manually inserted into the Mann-Whitney output file. Note: This script 
does not work if there are non-numbers in your Mann-Whitney p-value column. Sometimes, 
SAOUHSC_01447 results in a p-value = nan. If script does not work, this could be why.  
Run: python gene_fdr_taboutput.py mannwhitneyoutput.txt > corrpvalue.txt 
Mannwhitneyoutput.txt should be the output of the previous script. Adding headings to columns 
will mess it up. After performing this analysis, headings can be added.  
1. import operator, random, sys   
2.    
3. ## Create Dictionary with genes and P-vals {gene:[p-val],...}   
4.    
5. gene_dict = {}   
6.    
7. for line in open(sys.argv[1]):   
8.     split = line.split('\t')   
9.     #print split   
10.     if len(split) >= 7:   
11.         gene_dict[split[0]] = [split[5]]   
12.    
13. #print gene_dict   
14. ## Function that calculates Benjamini-Hochberg FDR q-
values. Argument required is ordered list of p-values.   
15.    
16. def bh_qvalues(pv):   
17.     """  
18.     Return Benjamini-Hochberg FDR q-values corresponding to p-values C{pv}.  
19.   
20.     This function implements an algorithm equivalent to L{bh_rejected} but  
21.     yields a list of 'adjusted p-values', allowing for rejection decisions  
22.     based on any given threshold.  
23.   
24.     @type pv: list  
25.     @param pv: p-values from a multiple statistical test  
26.   
27.     @rtype: list  
28.     @return: adjusted p-values to be compared directly with the desired FDR  
29.       level  
30.     """   
31.     if not pv:   
32.         return []   
33.     m = len(pv)   
34.     args, pv = zip(*sorted(enumerate(pv), None, operator.itemgetter(1)))   
35.     #print args   
36.     qvalues = m * [0]   
37.     mincoeff = pv[-1]   
38.     qvalues[args[-1]] = mincoeff   
39.     for j in xrange(m-2, -1, -1):   
40.         coeff = m*pv[j]/float(j+1)   
41.         if coeff < mincoeff:   
42.             mincoeff = coeff   
43.         qvalues[args[j]] = mincoeff   
44.     return qvalues   
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45.    
46. ## Create ordered list of p_values with their corresponding genes   
47.    
48. genes_list = []   
49.    
50. for k,v in gene_dict.iteritems():   
51.     genes_list.append([v[0],k])   
52.    
53. genes_list.sort()   
54.    
55. p_vals = []; genes = []   
56.    
57. for i in genes_list:   
58.     p_vals.append(float(i[0]))   
59.     genes.append(i[1])   
60. #print p_vals   
61.    
62. ## Assign q values for each p value   
63.    
64. q_vals = bh_qvalues(p_vals)   
65. #print q_vals   
66.    
67. ## Return q values to dictionary   
68.    
69. for i in range(len(p_vals)):   
70.     if genes[i] in gene_dict:   
71.         gene_dict[genes[i]].append(q_vals[i])   
72. #print gene_dict   
73. ## Print   
74.    
75. for line in open(sys.argv[1]):   
76.     split = line.split('\t')   
77.     print "%s\t" % split[0],   
78.     if split[0] in gene_dict: print gene_dict[split[0]][1],   
79.     print  
 
Python scripts for identifying upregulated genes 
Script: igv_staph_saouhsc_plus.py and igv_staph_saouhsc_minus.py 
These scripts are both converts from tabular hopcount files to igv-formatted files and are run in 
the same way as igv_staph_saouhsc.py. The only differences are that the output for one 
consists of only reads mapping to the plus strand and the other consists of reads mapping only 
to the minus strand 
Run: python igv_staph_saouhsc_plus.py staph_TA.txt windowstable.txt hopcount.tabular > 
outputplusstrand.igv 
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Run: python igv_staph_saouhsc_minus.py staph_TA.txt staph_genes.txt hopcount.tabular > 
outputminusstrand.igv 
Windows_table.txt is a tab-delimited file that has split the entire genome into 270bp segments or 
windows. It consists of column 1: genome name, column 2: start of the window, and column 3: 
end of the window 
Igv_staph_saouhsc_plus.py 
1. import sys   
2.    
3. ## Gather all TA sites into dictionary   
4.    
5. TAsites = {}   
6.    
7. for line in open(sys.argv[1]):   
8.     split = line.split()   
9.     if split[0] == 'TA':   
10.         TAsites[int(split[4])] = [0]   
11. #print TAsites   
12. ## Add gene name as second string in dictionary value   
13.    
14. for line in open(sys.argv[2]):   
15.     split = line.split('\t')   
16.     name = split[0].rstrip(); start = int(split[1]); end = int(split[2])+1   
17.     for i in range(start, end):   
18.         if i in TAsites: TAsites[i].append(name)   
19. #print TAsites   
20.     
21.            
22.    
23. ## Add read counts to first item in dictionary value list   
24. whole_text=file(sys.argv[3]).read()   
25. arrayed = whole_text.split('\n')   
26. #lenarrayed = len(arrayed)   
27. #print lenarrayed   
28. #    print line   
29. for line in arrayed:   
30.     split = line.split("\t")   
31.     #print split[1]   
32.     #split = line.split('\t')   
33.     pos = 0 ## set pos as int denoting position   
34.     if len(split)>= 6 and split[1].isdigit() == True:   
35.         if int(split[4]) != 0:   
36.             pos = int(split[1]) ##    
37.             if pos+15 in TAsites:   
38.                 TAsites[pos+15][0] = TAsites[pos+15][0]+int(split[4])   
39.             elif pos+14 in TAsites:   
40.                 TAsites[pos+14][0] = TAsites[pos+14][0]+int(split[4])         
41.             else:   
42.                 pass              
43. ## Print   
44.    
45. keys = TAsites.keys()   
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46. keys.sort()   
47.    
48. for k in keys:   
49.     print 'SAOHSC', '\t', int(k), '\t', int(k) + 2, '\t', TAsites[k][0],   
50.     if len(TAsites[k]) > 1: print '\t', "'""'",TAsites[k][1],"'"   
51.     else: print   
52. import sys   
igv_staph_saouhsc_minus.py 
1. import sys   
2.    
3. ## Gather all TA sites into dictionary   
4.    
5. TAsites = {}   
6.    
7. for line in open(sys.argv[1]):   
8.     split = line.split()   
9.     if split[0] == 'TA':   
10.         TAsites[int(split[4])] = [0]   
11. #print TAsites   
12. ## Add gene name as second string in dictionary value   
13. for line in open(sys.argv[2]):   
14.     split = line.split('\t')   
15.     name = split[0].rstrip(); start = int(split[1]); end = int(split[2])+1   
16.     for i in range(start, end):   
17.         if i in TAsites: TAsites[i].append(name)   
18. #print TAsites   
19.     
20.            
21.    
22. ## Add read counts to first item in dictionary value list   
23.    
24.    
25. whole_text=file(sys.argv[3]).read()   
26. arrayed = whole_text.split('\n')   
27. #lenarrayed = len(arrayed)   
28. #print lenarrayed   
29. #    print line   
30. for line in arrayed:   
31.     split = line.split("\t")   
32.     #print split[1]   
33.     #split = line.split('\t')   
34.     pos = 0 ## set pos as int denoting position   
35.     if len(split)>= 6 and split[1].isdigit() == True:   
36.         if int(split[5]) != 0:   
37.             pos = int(split[1])   
38.             if pos-15 in TAsites:    
39.                 TAsites[pos-15][0] = TAsites[pos-15][0]+int(split[5])   
40.             elif pos-16 in TAsites:   
41.                 TAsites[pos-16][0] = TAsites[pos-16][0]+int(split[5])   
42.             else:   
43.                 pass                   
44. ## Print   
45.    
46. keys = TAsites.keys()   
47. keys.sort()   
48.    
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49. for k in keys:   
50.     print 'SAOHSC', '\t', int(k), '\t', int(k) + 2, '\t', TAsites[k][0],   
51.     if len(TAsites[k]) > 1: print '\t', "'""'",TAsites[k][1],"'"   
52.     else: print   
Script: normalization.py 
Essentially the same as the previously-described normalization file.  
Run: python normalization.py moretasiteshit.igv fewertasiteshit.igv > normalizedfirstigvfile.igv  
1. import sys, numpy   
2. from math import *   
3. from numpy import *   
4.    
5. TActrl = 0; Readsctrl = 0; HitSitesctrl = 0   
6. inputreads = []   
7. saouhsc= []   
8. start = []   
9. end = []   
10. window = []   
11. for line in open(sys.argv[1]):   
12.     split=line.split('\t')   
13.     if len(split) > 3:   
14.         if split[3][0].isdigit() == True:   
15.             inputreads.append(float(split[3]))   
16.             saouhsc.append(split[0])   
17.             start.append(split[1])   
18.             end.append(split[2])   
19.             window.append(split[4].rstrip('\n'))   
20.             TActrl += 1   
21.             Readsctrl += float(split[3])   
22.             if float(split[3]) > 0: HitSitesctrl += 1   
23.    
24. TAexp = 0; Readsexp = 0; HitSitesexp = 0   
25. for line in open(sys.argv[2]):   
26.     split=line.split()   
27.     if len(split) > 3:   
28.         if split[3][0].isdigit() == True:   
29.             TAexp += 1   
30.             Readsexp += float(split[3])   
31.             if float(split[3]) > 0: HitSitesexp += 1   
32.    
33. TAproportion =  float(HitSitesexp)/HitSitesctrl      
34.    
35. inputproportion = []   
36. for i in inputreads:   
37.     inputproportion.append(float(i)/Readsctrl)   
38. inputproportiontanorm = []   
39. for i in inputproportion:   
40.     inputproportiontanorm.append(float(i)*TAproportion)   
41.    
42. inputproportiontanorm.append(TAproportion-1)   
43.    
44. multinominputsample = numpy.random.multinomial(Readsexp,inputproportiontanorm,100)   
45. multinominputsample = multinominputsample.T   
46. for i in range(len(multinominputsample[0])):   
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47.     summulti = sum(multinominputsample[:,i])   
48. multisum = numpy.repeat(summulti,100)   
49. difference=numpy.repeat(multisum-multinominputsample[-1,0],100)   
50. correctionfactor = round(float(Readsexp)/difference[0],4)   
51. correctedinput = [i*correctionfactor for i in multinominputsample]   
52. bootstrapcontrol = numpy.delete(correctedinput, (-1), axis=0)   
53. avgbootstrapcontrol = bootstrapcontrol.mean(axis=1)   
54.    
55. x = 0   
56. for x in range(0,len(avgbootstrapcontrol)):   
57.     print saouhsc[x], '\t', start[x], '\t', end[x], '\t', avgbootstrapcontrol[x], '\t',
 window[x]   
58.     x+=1   
 
Script: promoter_analysis.py 
This takes the igv files and the normalized igv files and identifies TA sites with a large increase 
in number of reads compared to the control and a preference for insertion orientation. If 
experiment condition hit more TA sites and is the normalized one, arguments are run in the 
same order.  
Run: python promoter_analysis.py normalizedctrlplusreads.igv experimentplusreads.igv 
normalizedminusreads.igv experimentminusreads.igv > output.txt 
Output is a tab-delimited file with column 1: window name, column 2: TA site location, column 3: 
hit direction (if plus, upregulating downstream genes, if minus upregulating upstream genes, 
column 4: log(ratio) plus strand, column 5: log(ratio)minus strand, column 6: log(reads) plus 
strand, and column 7: log(reads) minus strand. Values are converted to log(1+value) to make 
distribution more normal.  
1. import sys, numpy   
2. from math import *   
3. from numpy import *   
4.    
5. TAdict = {}   
6. hitdict = {}   
7. #extract TAsite location and put it in as key for dictionary   
8. for line in open(sys.argv[1]):   
9.     split = line.split('\t')   
10.     TAsite = int(split[1])   
11.     TAdict[TAsite] = []   
12.     hitdict[TAsite] = []   
13.    
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14. #put reads into dictionary   
15. for line in open(sys.argv[1]):   
16.     split = line.split('\t')   
17.     name = split[4].rstrip('\n')   
18.     TAdict[int(split[1])].append(name)   
19.     reads = int(round(float(split[3]),0))   
20.     reads = reads + 1   
21.     TAdict[int(split[1])].append(reads)   
22.    
23. for line in open(sys.argv[2]):   
24.     split = line.split('\t')   
25.     reads = int(round(float(split[3]),0))   
26.     reads = reads+1   
27.     TAdict[int(split[1])].append(reads)   
28.    
29. for line in open(sys.argv[3]):   
30.     split = line.split('\t')   
31.     reads = int(round(float(split[3]),0))   
32.     reads = reads+1   
33.     TAdict[int(split[1])].append(reads)   
34.    
35. for line in open(sys.argv[4]):   
36.     split = line.split('\t')   
37.     reads = int(round(float(split[3]),0))   
38.     reads = reads+1   
39.     TAdict[int(split[1])].append(reads)   
40.    
41. #print TAdict   
42. #calculate and add ratios to dictionary   
43. for k in TAdict:   
44.     #print TAdict[k][3]   
45.     ratioplus = float(TAdict[k][2])/TAdict[k][1]   
46.     #print ratioplus   
47.     TAdict[k].append(ratioplus)   
48.     logratioplus = log10(ratioplus)   
49.     #print logratioplus   
50.     TAdict[k].append(logratioplus)   
51.     ratiominus = float(TAdict[k][4])/TAdict[k][3]   
52.     #print ratiominus   
53.     TAdict[k].append(ratiominus)   
54.     logratiominus = log10(ratiominus)   
55.     #print logratiominus   
56.     TAdict[k].append(logratiominus)   
57.     readsplus = int(TAdict[k][2])   
58.     logreadsplus = log10(readsplus)   
59.     TAdict[k].append(logreadsplus)   
60.     logreadsminus = log10(TAdict[k][4])   
61.     TAdict[k].append(logreadsminus)   
62.    
63. #print TAdict   
64. #make lists of logplus and log minus also of reads for exp   
65. logplus = []   
66. logminus = []   
67. logreadsplus = []   
68. logreadsminus = []   
69. for k in TAdict:   
70.     logplus.append(TAdict[k][6])   
71.     logminus.append(TAdict[k][8])   
72.     logreadsplus.append(TAdict[k][9])   
73.     logreadsminus.append(TAdict[k][10])   
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74.    
75. #calculate average and standard deviations - ADJUST NUMBERS HERE!   
76. meanplus = float(sum(logplus))/len(logplus)   
77. meanminus = float(sum(logminus))/len(logminus)   
78. meanreadsplus = float(sum(logreadsplus))/len(logreadsplus)   
79. meanreadsminus = float(sum(logreadsminus))/len(logreadsminus)   
80. twosdplus = 7*(numpy.std(logplus, axis=0)) #This value can be modified to increase/decr
ease cutoffs   
81. twosdminus = 7*(numpy.std(logminus, axis=0)) #This value can be modified to increase/de
crease cutoffs   
82. sdreadsplus = 7*(numpy.std(logreadsplus, axis=0)) #This value can be modified to increa
se/decrease cutoffs   
83. sdreadsminus = 7*(numpy.std(logreadsminus, axis=0)) #This value can be modified to incr
ease/decrease cutoffs   
84. ratiocutoffplus = meanplus+twosdplus   
85. ratiocutoffminus = meanminus+twosdminus   
86. readscutoffplus = meanreadsplus+sdreadsplus   
87. readscutoffminus = meanreadsminus+sdreadsminus   
88.    
89. #filter and print   
90. keys = TAdict.keys()   
91. keys.sort()   
92.    
93. hitsplus = "hitsplus"   
94. hitsminus = "hitsminus"   
95. #find hits   
96. for k in keys:   
97.     if TAdict[k][6] > ratiocutoffplus and TAdict[k][9] > readscutoffplus:   
98.         TAdict[k].append(hitsplus)   
99.     elif TAdict[k][8] > ratiocutoffplus and TAdict[k][10] > readscutoffminus:   
100.         TAdict[k].append(hitsminus)   
101. #print TAdict   
102. for k in keys:   
103.     #print TAdict[k][-1]   
104.     #print isinstance(TAdict[k][-1], str)   
105.     if isinstance(TAdict[k][-1],str)==True:   
106.         #print TAdict[k][-1]   
107.         #print k   
108.         hitdict[k].append(TAdict[k][0])   
109.         hitdict[k].append(TAdict[k][6])   
110.         hitdict[k].append(TAdict[k][8])   
111.         hitdict[k].append(TAdict[k][9])   
112.         hitdict[k].append(TAdict[k][10])    
113.         hitdict[k].append(TAdict[k][-1])      
114.    
115. hitkeys = hitdict.keys()   
116. hitkeys.sort()   
117.    
118. #this is the new printing part   
119. print 'window name \t TAsite \t hitdirection \t logratioplus \t logratiominus \t
 logreadsplus \t logreadsminus'   
120. for k in keys:   
121.     if len(hitdict[k]) > 4:      
122.         print hitdict[k][0], '\t', k, '\t', hitdict[k][-
1], '\t', hitdict[k][1], '\t', hitdict[k][2], '\t', hitdict[k][3], '\t', hitdict[k][4] 
  
123.        
124. #print hitdict 
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Script: driver.py 
Running the promoter analysis for each sample one script at a time is somewhat time-intensive, 
so this script can be run on everything at once. All control and experiment tabular files need to 
be in a directly with only the other scripts necessary for running this analysis. In addition, files 
must be named in a certain way. Control files must be named “control_tnconstruct.tabular” and 
experiment files must be named “experimentalcondition_tnconstruct.tabular” where tnconstruct 
= blunt, cap, dual, erm, pen or tuf.  
Run: python driver.py 
This file automatically outputs the files in the same format described above.  
1. import os   
2. from subprocess import call   
3.    
4. def without_extension(filename):   
5.     return os.path.splitext(filename)[0]   
6.    
7. def get_hit_sites(path):   
8.     TA = 0; Reads = 0; HitSites = 0   
9.    
10.     input_file = open(path)   
11.     for line in input_file:   
12.         split = line.split()   
13.         if len(split) > 3:   
14.             if split[3][0].isdigit() == True:   
15.                 TA += 1   
16.                 Reads += float(split[3])   
17.                 if float(split[3]) > 0: HitSites += 1   
18.     input_file.close()   
19.     return HitSites   
20.    
21. inputs = [path for path in os.listdir('.') if path.endswith('.tabular')]   
22. igv_files = []   
23. for data in inputs:   
24.     name = without_extension(data)   
25.     map_to_ta_plus = name + 'plus.igv'   
26.     map_to_ta_minus = name + 'minus.igv'   
27.     run_command = "python %s Staph_TA.txt windows_table.txt " + data   
28.     os.system(run_command % "igv_staph_saouhsc_plus.py" + " > " + map_to_ta_plus)   
29.     os.system(run_command % "igv_staph_saouhsc_minus.py" + " > " + map_to_ta_minus)   
30.     igv_files.append(map_to_ta_plus)   
31.     igv_files.append(map_to_ta_minus)   
32.    
33.    
34. def get_promoter_analysis_name(filename):   
35.     name = without_extension(filename)   
36.     # names are usually like moe16_tufminus   
37.     return name.split('_')[1]   
 255 
 
38.    
39. # Normalize!   
40. # We need to group the igv files by promoter analysis name so we can   
41. # pass the control and experiment to normalize   
42. group_labels = set(map(get_promoter_analysis_name, igv_files))   
43. grouped_items = []   
44. for group_label in group_labels:   
45.     group = []   
46.     for igv_file in igv_files:   
47.         if group_label in igv_file: group.append((igv_file, get_hit_sites(igv_file)))   
48.     grouped_items.append(group)   
49.    
50. # We want to sort by the hit sit count. We already stored this count in the tuple:   
51. # [[(ctrl_path1, hit_site), (expr_path1, hit_site)], [(ctrl_path2, hit_site), (expr_pat
h2, hit_site)]]   
52. normalized_args = [sorted(group, key=lambda item: item[1], reverse=True) for group in g
rouped_items]   
53.    
54. # Extract only path from each tuple in the groups   
55. paths = [(group[0][0], group[1][0]) for group in normalized_args]   
56.    
57. # We will generate a list of the inputs for each pair to promoter_analysis   
58. # will have to repair plus and minus later   
59. # TODO make this not suck   
60. promoter_analysis_inputs = []   
61. for arg1, arg2 in paths:   
62.     # output arg1 with norm before extension   
63.     destination = without_extension(arg1) + ".norm.igv"   
64.     os.system("python normalization.py %s %s > %s" % (arg1, arg2, destination))   
65.     if arg1.startswith('control_'):   
66.         promoter_analysis_inputs.append((destination, arg2))   
67.     else:   
68.         promoter_analysis_inputs.append((arg2, destination))   
69.    
70. promoter_args = []   
71. # We need to re-pair plus with minus before calling promoter analysis   
72. plus_strands = [strand for strand in promoter_analysis_inputs if "plus" in strand[0]]   
73. minus_strands = [strand for strand in promoter_analysis_inputs if "plus" not in strand[
0]]   
74. for plus_strand in plus_strands:   
75.     promoter_name = str.replace(get_promoter_analysis_name(str.replace(plus_strand[0], 
'.norm', '')), 'plus', '')   
76.     for minus_strand in minus_strands:   
77.         if promoter_name in minus_strand[0]:   
78.             promoter_args.append(plus_strand + minus_strand)   
79.    
80. for arglist in promoter_args:   
81.     print arglist   
82.   # Changed line!   
83.     output_name = str.replace(str.replace(arglist[0].split('_')[1], '.norm.igv', ''), '
plus', '') + ".promoter.out"   
84.     command = "python promoteranalysis.py %s %s %s %s > " + output_name   
85.     # Changed line!   
86.     os.system(command % (arglist[1],arglist[0],arglist[3],arglist[2]))   
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Python scripts for identifying genes with similar resistance and sensitization patterns 
Script: mwu_to_cluster_11-1-15.py 
This converts a mann-whitney U output file and a false discovery rate file to put the data into the 
format required for performing the k-nearest neighbors classifier analysis. It modifies the ratio to 
account for a few number of reads in both the control and the experiment, and it also calculates 
the normalized fitness value which we use in these clustering analyses.  
Run: python mwu_to_cluster.py mwu_sample.txt fdr_sample.txt > outputforclustering.txt 
Output consists of a csv (comma-separated) file with column1: gene locus, column 2: number of 
TA sites, column 3: length, column 4: number of reads in the control sample mapping to this 
gene, column 5: number of reads in the experimental sample mapping to this gene, column 6: 
raw ratio value, column 7: corrected p-value, column 8: modified ratio, column 9: Reads 
mapping to the gene in the experiment normalized to the length of the gene, column 10: 
normalized fitness value (used for clustering) 
1. import operator, random, sys   
2.    
3. ## Create Dictionary with genes and P-vals {gene:[p-val],...}   
4.    
5. gene_dict = {}   
6.    
7. #find total reads in ctrl and exp   
8. readcountctrl = 0   
9. readcountexp = 0   
10. for line in open(sys.argv[1]):   
11.     split = line.split('\t')   
12.     #print split   
13.     if split[0][0:3]=='SAO':   
14.         try:   
15.             readcountctrl = readcountctrl + int(split[2])   
16.             readcountexp = readcountexp + int(split[3])   
17.         except Exception:   
18.             pass   
19.    
20.    
21. mincountctrl = float(readcountctrl)/10000   
22. mincountexp = float(readcountexp)/10000   
23.    
24. #put important info in a dictionary: 0-#TA sites, 1-length, 2-readsctrl,3-readsexp, 4-
rawratio, 5-modratio, 6-index, 7-rawfitscore   
25. for line in open(sys.argv[1]):   
26.     split = line.split('\t')   
27.     if split[0][0:3]=='SAO' and int(split[1])>=0:   
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28.         try:   
29.             readsctrl=int(split[2])   
30.         except Exception:   
31.             pass   
32.         if readsctrl < mincountctrl: readsctrl = mincountctrl   
33.         try:   
34.             readsexp = int(split[3])   
35.         except Exception:   
36.             pass   
37.         if readsexp <mincountexp: readsexp = mincountexp   
38.         ratio = float(readsexp)/readsctrl   
39.         try:   
40.             TAsites = int(split[1])   
41.             length = int(split[7])   
42.             rawratio = float(split[6])   
43.             #print split[6]   
44.             index = float(readsexp)/length   
45.             rawfit = ratio*index   
46.             gene_dict[split[0]] = [TAsites,length,int(split[2]),int(split[3]),rawratio,
ratio,index,rawfit]   
47.         except Exception:   
48.             pass   
49.           
50. #Add corrected pval from fdr file into dictionary   
51. #0-#TA sites, 1-length, 2-readsctrl,3-readsexp, 4-rawratio, 5-modratio, 6-index, 7-
rawfitscore, 8-corrpval   
52. for line in open(sys.argv[2]):   
53.     split = line.split('\t')   
54.     if split[0] in gene_dict:   
55.         gene_dict[split[0]].append(float(split[1].rstrip()))   
56.    
57. #print gene_dict   
58.    
59. #Make fitvals a list instead of a dict for calculating norm-fit value   
60. fitvals = []   
61. for k,v in gene_dict.iteritems():   
62.     fitvals.append([v[7],k])   
63.    
64. fitvals.sort()   
65. count=0   
66. for f in fitvals:   
67.     f.append(count)   
68.     count+=1   
69.     normorder = float(count)/len(fitvals)   
70.     f.append(normorder)   
71. #print fitvals   
72.    
73. #put normalized fitval into genedict   
74. for f in fitvals:   
75.     gene = f[1]   
76.     if gene in gene_dict:   
77.         gene_dict[gene].append(f[3])   
78. #print gene_dict   
79.    
80. genes = gene_dict.keys()   
81. genes.sort()   
82.    
83. for g in genes:   
84.     #print len(gene_dict[g])   
85.     if len(gene_dict[g]) > 6:   
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86.         print "%s,%d,%d,%d,%d,%0.10f,%0.100f,%0.10f,%0.10f,%0.6f" % (g,gene_dict[g][0],
gene_dict[g][1],gene_dict[g][2],gene_dict[g][3],gene_dict[g][4],gene_dict[g][8],gene_di
ct[g][5],gene_dict[g][6],gene_dict[g][9])   
87.    
88.         #genename,#TAsites,length,readsctrl,readsexp,rawratio,corrpval,modratio,index,n
ormfitscore   
 
Script: fit_to_array_for_knn_predictgene.py 
This script is used to identify the 5 nearest neighbors that have a similar resistance and 
sensitization pattern as a gene of interest. Inputs include outputs of mwu_to_cluster.py (as 
many as you want). Gene of interest is simply typed in. Essential genes are removed ahead of 
time for this analysis.  
Run: python fit_to_array_for_knn_predictgene.py essentials.txt clustfile1.txt clustfile2.txt 
clustfile3.txt etc SAOUHSC_01234 > output.txt 
Essentials.txt is list of essential genes  to be removed from the analysis 
Output is a list of every gene in the genome and the probability estimates for the list of five most 
similar genes. Probability estimates add up to one. Note: probability estimates will be one fewer 
than number of genes. You need to move the column down one row after your gene of interest 
to identify the correct most similar genes.  
1. import sys   
2. import numpy as numpy   
3. from sklearn import neighbors   
4.    
5. #put data in array format   
6.    
7. y = []   
8. X = []   
9. genenames = {}   
10. unknown = []   
11. essgenes = []   
12.    
13. #first value in dictionary is unknown   
14. for arg in sys.argv:   
15.     if "essentials" in arg:   
16.         for line in open(arg):   
17.             #print line.rstrip()   
18.             essgenes.append(line.rstrip())   
19.    
20. for arg in sys.argv:   
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21.     if arg.endswith('.txt') == True:   
22.         for line in open(arg):   
23.             split = line.split(',')   
24.             if len(split) > 2:   
25.                 name = split[0]   
26.                 if any(name in x for x in essgenes):   
27.                     pass   
28.                 else:   
29.                     fitval = float(split[9].rstrip())   
30.                     if name not in genenames:   
31.                         genenames[name]=[fitval]   
32.                     else:   
33.                         genenames[name].append(fitval)   
34.     else:   
35.         geneofinterest = arg   
36. #print essgenes   
37. #print len(genenames)   
38. for k,v in genenames.iteritems():   
39.     if k == geneofinterest:   
40.         unknown.append(v)   
41.     else:   
42.         X.append(v)   
43.         y.append(k)   
44. #print X   
45.    
46. #fit data wiht K nearest neighbors   
47. n_neighbors = 5 #this can be increased or decrease   
48. h=0.2 #this is the step size in mesh    
49.    
50. #see http://scikit-
learn.org/stable/modules/generated/sklearn.neighbors.KNeighborsClassifier.html for diff
erent options here   
51. for weights in ['uniform','distance']:   
52.     neigh = neighbors.KNeighborsClassifier(n_neighbors, weights=weights)   
53.     neigh.fit(X,y)   
54.    
55. #predict for unknown   
56.    
57. for i in neigh.predict_proba(unknown):   
58.     listofclosestneighbors = i   
59.     for i in listofclosestneighbors:   
60.         print i   
 
Python scripts for predicting antibiotic mechanism of action using machine learning 
Script: fit_to_array_for_knn_2-29.py 
This script identifies the antibiotic class most similar to a test/new antibiotic based on the 
resistance factor pattern for that antibiotic. First, you need to decide which antibiotics to use and 
how to classify them. Each class receives its own integer value to identify it. The unknown 
antibiotic must have the word “unknown” in its file name. This version of the script identifies the 
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unique set of genes in the top 25% and bottom 25% of fitness values for every antibiotic put into 
the training set and uses those genes to predict the mechanism of a new antibiotic.  
Run: python fit_to_array_for_knn_2-29.py clust_compound1.txt category1 clust_compound2.txt 
category2 clust_compound3.txt category3 etc. clust_unknown.txt 
Outputs the most similar category as well as the probability estimates for each category.  
1. import sys   
2. import numpy as numpy   
3. from sklearn import neighbors   
4.    
5. #put data in array format   
6.    
7. y = []   
8. X = []   
9. unknown = []   
10.    
11. cutoff=0.25   
12.    
13. for arg in sys.argv:   
14.     if arg.endswith('.txt') == True:   
15.         if "unknown" in arg:   
16.             for line in open(arg):   
17.                 split = line.split(',')   
18.                 #unknown.append(float(split[9].rstrip()))   
19.                 if float(split[5].rstrip()) >= 1-cutoff:   
20.                     unknown.append(split[5].rstrip())   
21.                 elif float(split[5].rstrip()) <= cutoff:   
22.                     unknown.append(split[5].rstrip())   
23.                 else:   
24.                     pass   
25.         else:   
26.             fitvals = []   
27.             for line in open(arg):   
28.                 split = line.split(',')   
29.                 #fitvals.append(float(split[9].rstrip()))   
30.                 if float(split[5].rstrip()) >= 1-cutoff:   
31.                     fitvals.append(split[5].rstrip())   
32.                 elif float(split[5].rstrip()) <= cutoff:   
33.                     fitvals.append(split[5].rstrip())   
34.                 else:   
35.                     pass   
36.             #print fitvals   
37.             X.append(fitvals)   
38.     else:   
39.         try:   
40.             y.append(int(arg))   
41.         except ValueError:   
42.             pass   
43. #print len(fitvals)   
44. print len(unknown)   
45. #print len(y)   
46. #print X   
47. #print y   
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48.    
49. #fit data wiht K nearest neighbors   
50.    
51. n_neighbors = 2   
52. h=0.2 #this is the step size in mesh - can change it to figure out what it does   
53. metric = "minkowski"   
54.    
55. #see http://scikit-
learn.org/stable/modules/generated/sklearn.neighbors.KNeighborsClassifier.html for diff
erent options here   
56. for weights in ['uniform','distance']:   
57.     neigh = neighbors.KNeighborsClassifier(n_neighbors, weights=weights, metric=metric)
   
58.     neigh.fit(X,y)   
59.    
60. #predict for unknown   
61. print neigh.predict(unknown)   
62. print neigh.predict_proba(unknown)  
 
R scripts 
R scripts can be run all at once or line by line in the RGui. I recommend running them line by 
line in the Gui to better troubleshoot issues 
 
Script: pca.R 
This performs principal component analysis on Tn-Seq data and plots it on a graph. Inputs 
should be a comma-separated value formatted array containing the treatment conditions and 
genes you are interested in comparing. It can also be done with every gene in the genome.  
1. #Principle components analysis   
2.    
3. #set working directory   
4. setwd("C:/Users/etc")   
5.    
6. #load data   
7. mydata <- read.csv("data.csv")   
8.    
9. # Pricipal Components Analysis   
10. # entering raw data and extracting PCs    
11. # from the correlation matrix    
12. fit <- princomp(mydata, cor=TRUE)   
13. summary(fit) # print variance accounted for    
14. loadings(fit) # pc loadings    
15. plot(fit,type="lines") # scree plot    
16. fit$scores # the principal components   
17. biplot(fit)   
18.    
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19. #Plot PCA graph   
20. png("pca_donors.png",width=500, height=500, res=100)   
21. plot(loadings(fit),type="n", main="Compounds", cex.main=1.5,xlab="Component 1", ylab="C
omponent 2",cex.lab=1.5)   
22. text(loadings(fit),labels=colnames(mydata))   
23. dev.off()   
 
Script: hierarchicalclustering.R 
This script performs hierarchical clustering on any set of Tn-Seq data and outputs a heatmap of 
the results. Input should be a tab-delimited file containing an array of the antibiotic treatments 
and genes of interest 
1. setwd("C:/Users/etc/")   
2.    
3. #load data   
4. data <- read.table("tab-
delimitedarray.txt",header=T, stringsAsFactors=T, row.names=1)   
5. mydata=na.omit(data)   
6.    
7.    
8. ## Hierarchical clustering routine   
9. y <- mydata   
10. hr <- hclust(as.dist(1-cor(t(y), method="pearson")), method="complete"); hc <-
 hclust(as.dist(1-
cor(y, method="spearman")), method="complete") # Generates row and column dendrograms. 
  
11. mycl <- cutree(hr, h=max(hr$height)/1.5); mycolhc <-
 rainbow(length(unique(mycl)), start=0.1, end=0.9); mycolhc <-
 mycolhc[as.vector(mycl)] # Cuts the tree and creates color vector for clusters.   
12.    
13. library(gplots); myheatcol <-
 redgreen(66) # Assign your favorite heatmap color scheme. Some useful examples: colorp
anel(40, "darkblue", "yellow", "white"); heat.colors(75); cm.colors(75); rainbow(75); r
edgreen(75); library(RColorBrewer); rev(brewer.pal(9,"Blues")[-
1]). Type demo.col(20) to see more color schemes.   
14.    
15. png('graphfitvalknowns1.png', width=720, height=720)   
16. heatmap.2(as.matrix(y), Rowv=as.dendrogram(hr), Colv=as.dendrogram(hc), col=myheatcol, 
scale="row", density.info="none", trace="none", RowSideColors=mycolhc, margin=c(20,10),
 cexCol=2.0, cexRow=0.001) # Creates heatmap for entire data set where the obtained clu
sters are indicated in the color bar.   
17. dev.off()   
18.    
19. x11(height=6, width=2); names(mycolhc) <-
 names(mycl); barplot(rep(10, max(mycl)), col=unique(mycolhc[hr$labels[hr$order]]), hor
iz=T, names=unique(mycl[hr$order])) # Prints color key for cluster assignments. The num
bers next to the color boxes correspond to the cluster numbers in 'mycl'.   
20.    
21. clid <- c(4,6); ysub <- as.matrix(y[names(mycl[mycl%in%clid]),]); hrsub <-
 hclust(as.dist(1-cor(t(ysub), method="pearson")), method="complete")    
22.     # Select sub-
cluster number (here: clid=c(1,2)) and generate corresponding dendrogram.   
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23.    
24. x11(); heatmap.2(ysub, Rowv=as.dendrogram(hrsub), Colv=as.dendrogram(hc), col=myheatcol
, scale="row", density.info="none", trace="none", RowSideColors=mycolhc[mycl%in%clid]) 
# Create heatmap for chosen sub-cluster.   
25.    
26. #This gets you genes from any point you care about   
27. genenames <-
 data.frame(Labels=rev(hrsub$labels[hrsub$order])) # Print out row labels in same order
 as shown in the heatmap.   
28. write.table(genenames, file="genenames.txt")   
